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ABSTRACT 
 
DESIGN, STRUCTURE, AND ACTION OF AN 
ARTIFICIAL PHOTOSYNTHETIC REACTION CENTER 
Nathan Ennist 
P. Leslie Dutton 
 
At the heart of photosystem II is the reaction center, where solar energy is used to 
separate charge.  Set within a large and highly complex protein system, the handful of redox 
cofactors that make up the reaction center form an electron transport chain that converts the 
energy of a central, light-activated pigment into a reductant at one end and an oxidant at the 
other.  The central aim of this thesis is to reproduce the charge separating function of 
photosystem II in a comparatively simple de novo designed protein maquette.  The maquette 
effectively eliminates the complexity contributed by parts of photosystem II that are not directly 
involved in charge separation and facilitates a streamlined investigation of fundamental factors 
essential to this function.  Previous work has produced light-activatable maquettes that are 
competent for electron transfer between tetrapyrroles but are unable to trap a charge 
separated state that is necessary for fuel generation. 
This thesis details the design, structure, and action of MZH3, a multi-cofactor maquette 
that stabilizes a long-lived charge separated state.  X-ray crystallographic structures of MZH3 are 
solved in complex with heme B, a synthetic zinc porphyrin, and metal ion cofactors.  Despite 
sharing low sequence identity with natural proteins, MZH3 exhibits significant structural 
similarity to cytochrome b at the heme site and bacterioferritin at the metal site.  Transient 
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absorption spectroscopy shows that the reduced state of heme B is stabilized in the presence of 
a tyrosine residue for 150 ms after light absorption at pH 9.5.  The binding of ferrous iron 
extends the charge separated state lifetime to 300 ms at pH 7.5.  Providing the tyrosine with a 
hydrogen bond to histidine increases the yield of the charge separated state but decreases its 
lifetime.  Mutation of a heme-ligating histidine to alanine gives rise to an unexpected oxygen 
binding function with an oxyferrous lifetime of 38 hours, comparable to natural oxygen 
transport proteins.  These results show that MZH3 is a uniquely structured, functional reaction 
center maquette that is readily adapted to new functions.  Continuing development will be 
directed toward multinuclear metal cluster assembly and in vivo generation of solar fuel from 
water. 
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Chapter 1: Thesis statement and introduction 
Given that nature conducts light driven water oxidation and hydrogenase activities using 
proteins, we know that in vivo enzymatic conversion of water and light to oxygen and hydrogen 
is possible.  Whether it is feasible to engineer a living system that generates large quantities of 
clean-burning fuel efficiently enough to compete with the price of fossil fuels remains an open 
question.  While it is sometimes taken for granted that an organic system is too susceptible to 
oxidative damage to be useful in the high potential oxidation of water, an in vivo protein system 
has several unique advantages over other catalysts.  For instance, enzymes can create 
microenvironments with precise interactions that afford lower overpotentials and faster 
reaction kinetics than chemical reactions in solution.  The ability to create these 
microenvironments precludes the need for non-aqueous solvents and extremes of temperature 
and pH.  Damaged protein can be replaced by a host organism, allowing for “self-healing” 
capabilities.  In addition, natural enzymes demonstrate that difficult high-energy reactions can 
be catalyzed using inexpensive, Earth-abundant elements.  With these advantages, proteins 
designed for solar-to-fuel energy conversion could become a significant contributor to a future 
alternative energy economy. 
In support of my thesis, I will present the design, characterization, and crystal structure 
of a highly soluble, thermostable, de novo maquette protein that expresses in high yield in E. 
coli, assembles a redox-active cofactor tetrad, and traps a long-lived charge-separated state 
when exposed to visible light.  This represents a first step toward artificial photosynthesis in a 
protein system.  Despite low sequence similarity to natural proteins, this maquette bears 
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striking structural similarity to natural proteins that were used to guide its design, suggesting 
that the engineering of some enzymes with sophisticated functions may be more facile than 
once thought. 
 
1.1 Photosynthesis, natural and artificial 
New technologies are needed to increase production of clean-burning, high-energy fuels 
that can compete economically with fossil fuels to mitigate the environmental impact of climate 
change and lessen the social and political burden of meeting our energy needs (1-9).  Society’s 
energy demands come in different forms, but fuels account for roughly 80% of global energy 
consumption, and approximately 20% is satisfied by electrical energy (2).  Unlike electrical 
energy, fuel can be readily stored and transported to allow energy to be released on demand, 
which is one reason why the dominant fraction of our energy needs are met by fossil fuel 
combustion (6).  Electrical energy is generated by numerous alternative energy technologies 
including photovoltaics, wind turbines, nuclear, and hydropower, but currently, no satisfactory 
method of generating renewable fuel can be relied upon to supplant fossil fuels (2). 
When averaged over a year, photosynthetic organisms convert about 100 TW of solar 
power into chemical energy (9).  For comparison, the combined rate of energy consumption by 
humans in 2010 was 16.3 TW and is expected to rise to at least 30 TW by 2050 (5, 10), but the 
total power of sunlight reaching the Earth’s surface is about 120,000 TW, making solar the most 
abundant form of renewable energy (4, 6, 7, 11).  The scientific community is looking to the 
potential of artificial photosynthesis to provide solar fuels on a large scale (1-9).  Because of the 
potentially transformative impact of efficient solar-to-fuel energy conversion, Faunce et al. 
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argue that, “Developing and globally deploying artificial photosynthesis . . . is one of the great 
scientific and moral challenges of our time . . .” (1). 
 
1.1.1  Structure and function of photosystem II and its reaction center 
An in-depth understanding of photosystem II structure and function will be instrumental 
in the development of artificial photosynthetic technologies.  Photosystem II is nature’s solar 
powered water oxidase and the only enzyme in biology capable of forming an oxygen-oxygen 
bond from two water molecules (12).  The study of photosystem II is difficult owing to its size, 
complexity, and fragility.  This membrane protein complex resides in the thylakoid membrane in 
cyanobacteria, algae, and plants, and it can function as either a monomer or a dimer (13).  Each 
monomer has a mass of about 350 kDa depending on the species, and is composed of upwards 
of 20 subunits and 50 cofactors including chlorophylls, pheophytins, β-carotenes, 
plastoquinones, hemes, non-heme iron, bicarbonate, chlorides, and a Mn4CaO5 oxygen evolving 
complex (OEC) (14).  In addition, an intricate network of channels conduct water, oxygen, and 
protons to and from the OEC (15). 
Despite this complexity, researchers have succeeded in crystallizing photosystem II from 
thermophilic cyanobacteria Thermosynechococcus vulcanus and Thermosynechococcus 
elongatus (14, 16-19).  In 2011, the T. vulcanus photosystem II was solved to 1.9 Å resolution, a 
breakthrough that yielded unprecedented insight into the structure-function relationship in the 
enzyme (14).  The overall structure of the photosystem II dimer is shown in the top left of Figure 
1.1 (14).  Continued progress on elucidation of photosystem II structure comes from recent free-
electron laser X-ray crystallography that provides “radiation damage-free” cyanobacterial 
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structures at cryogenic (20) and room temperature (21), as well as studies of eukaryotic 
photosystem II complexes using X-ray crystallography (22) and cryo-electron microscopy (23). 
While the overall complexity of photosystem II is impressive, the reaction center is 
conceptually simple (Figure 1.1, right).  The reaction center is essentially a string of redox-active 
cofactors that includes a light absorber in the middle (P680), electron donors on one end 
(tyrosine Z and the OEC), and electron acceptors on the other end (pheophytin and 
plastoquinones QA and QB) (24).  When P680 absorbs a photon, it enters a highly reducing singlet 
excited state (P680*) that has a midpoint potential Em(P680*/P680•+) value between −0.57 and 
−0.58 V vs SHE, and it initiates an electron transfer cascade (25, 26).  Within picoseconds of 
activation, P680* reduces the nearby pheophytin (Pheo in Figure 1.1), which passes the electron 
to plastoquinone QA on a hundreds of picoseconds timescale.  QA then reduces QB within 
hundreds of microseconds.  When a second photon absorption causes QB to be reduced a 
second time, QB dissociates from photosystem II and is replaced by an oxidized quinone from 
the quinone pool in the thylakoid membrane (24, 27).  Meanwhile, on the electron donating side 
of the reaction center, P680•+, which has an Em(P680/P680•+) of 1.25 to 1.26 V (25, 26), oxidizes 
tyrosine Z, with an Em(YZ/YZ•) of about 1.2 V (25), within tens of nanoseconds (28-30).  This 
oxidation is followed by slower conformational rearrangement steps around tyrosine Z (31-33), 
which take tens of microseconds.  YZ•, in turn, oxidizes the OEC on a tens of microseconds to 
milliseconds timescale, depending on the oxidation state of the OEC (34-36).  When the OEC is 
oxidized four times, it oxidizes two water molecules to make O2 and returns to its initial state.  
These reaction kinetics are reviewed in more detail in Vinyard et al., 2013 (37).  (All midpoint 
potentials in this thesis are measured against the standard hydrogen electrode (SHE), unless 
otherwise noted). 
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Figure 1.1: Photosystem II crystal structure 
Structure at 1.9 Å resolution from (PDB ID: 
3WU2) (14).  Top left: Overall structure of the 
photosystem II dimer The protein backbone is 
shown as ribbons, organic cofactors are 
shown as sticks, and the Mn4CaO5 oxygen 
evolving complex (OEC) is shown as spheres.  
Right: Reaction center of photosystem II 
showing light absorption and electron transfer 
pathway.  Substituent groups of chlorophylls, 
pheophytins, and quinones that do not 
directly participate in electron transfer are 
removed for clarity. 
Images rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
 
The extreme potentials necessary for water oxidation are dangerous in an organic 
scaffold such as a protein.  Water oxidation in a protein has been likened to “setting a fire in a 
wicker basket, without burning the basket” (38).  However, photosynthetic organisms are able 
to manage the risk.  Replacement of the D1 polypeptide that houses the OEC occurs as 
frequently as every 30 minutes in full sunlight due to oxidative damage (39). 
One peculiarity of the photosystem II reaction center is the nature of P680, the light-
absorbing pigment.  P680 consists of four weakly coupled monomeric chlorophyll a molecules.   
In the excited singlet P680* state, the excitation energy is delocalized across the chlorophylls.  
The special properties of the P680 chlorophylls give them exceedingly high midpoint potentials 
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and cause their absorbance spectra to shift to longer wavelengths.  Typical antenna chlorophylls 
have an absorbance peak in the range of 670 to 675 nm and use energy transfer to pass photon 
energy to the reaction center, but in P680, this absorbance peak shifts to 680 nm.  This red shift 
creates an “exciton trap” that is unable to transfer energy from P680* to other chlorophylls in 
photosystem II, because the other chlorophylls absorb higher energy light (40).  The unusual 
association of the four chlorophylls of P680 does not necessarily need to be reproduced in order 
to create a working reaction center. 
Despite detailed knowledge of photosystem II structure from high-resolution structures 
and decades of intense research, many important facets of photosystem II function remain 
elusive.  As with any complex natural protein, different parts of photosystem II have 
interconnected and overlapping functions (41).  Practical limitations have often lead researchers 
to make compromises such as conducting experimental studies on tyrosine Z using photosystem 
II in its manganese-depleted form, even though it is well known that manganese depletion 
affects the properties of tyrosine Z (32, 42, 43).  As a result, the unraveling of mechanistic details 
of photosystem II has been painstaking.  Debates continue with regard to the proton transfer 
pathway of tyrosine Z, the function of tyrosine D, the steps of the photoactivation process that 
assembles the OEC, the mechanism of water oxidation at the OEC, and even which water 
molecules and/or hydroxide/oxide ligands are the substrates of the oxygen evolving reaction 
(21, 31, 44-46).  These shortfalls open the door to model systems to pave the way toward a 
deeper understanding of photosystem II functions. 
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1.1.2  Photosynthetic reactions and the potential for improvement 
By developing the ability to extract electrons from water as a widely available substrate, 
the advent of oxygenic photosystem II roughly 2.5 billion years ago gave way to a “big bang of 
evolution” and a new age of abundant life under an oxidizing atmosphere (9, 24, 44).  Electrons 
and protons abstracted from water could be used to convert a substrate (carbon dioxide) to a 
fuel (carbohydrates).  The four-electron oxidation of water requires an energy input equivalent 
to 0.82 V vs. SHE per electron at pH 7 (47).  The water oxidation half reaction of photosystem II 
is catalyzed upon absorption of four photons and is given below in Reaction 1.1: 
Em,7 = +0.82 V 2H2O → O2 + 4H+ + 4e- Reaction 1.1 
 
In oxygenic photosynthetic organisms (plants, algae, and cyanobacteria), the second half 
reaction is the reduction of carbon dioxide to make carbohydrates (24).  In place of 
carbohydrates, artificial photosynthesis seeks to produce a high energy density fuel such as 
hydrogen.  In this case, the protons and electrons released by water oxidation could be 
combined, as shown in Reaction 1.2: 
Em,7 = −0.41 V 2H+ + 2e- → H2 Reaction 1.2 
 
All oxygenic photosynthetic organisms use two separate photosystems in the oxidation 
of water and reduction of carbon dioxide (48).  Photosystem II carries out water oxidation, while 
photosystem I generates NADPH to drive the carbon dioxide fixation process (9).  In theory, 
however, only a single photosystem is necessary.  The energy gap between the water oxidizing 
half reaction at 0.82 V (Reaction 1) and the proton reducing half reaction at −0.41 V (Reaction 2) 
is 1.23 eV, which is ~67% of the energy of the 680 nm (1.8 eV) photon used by P680 to enter the 
excited state and begin charge separation in photosystem II.  This shows that photosynthetic 
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water oxidation and hydrogen evolution could conceivably be conducted using only a single 
photosystem (3).  Figure 1.2 illustrates that the two half reactions fall within the range of 
potentials used in photosystem II.  Some of the initial photon energy will need to be used to 
stabilize the charge separated state and allow for catalysis, but in principle, a second 
photosystem is not required; there is enough energy in a single photon to be used for evolution 
of both oxygen and hydrogen in the same reaction center.  To do this, however, would require a 
new reaction center with inter-cofactor distances and potentials optimized to facilitate energy 
conversion. 
 
Figure 1.2: Energy diagram of photosystem II 
Cofactors in the photosystem II reaction center are placed according to the scale on the left.  
Potentials are measured against SHE.  The blue box represents the potential range where 
water oxidation occurs (Reaction 1), and the green dotted line represents the potential of the 
hydrogen evolution half reaction (Reaction 2).  Modified from Vinyard, et al., 2013 (37). 
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1.1.3  The oxygen evolving complex (OEC) of photosystem II 
In photosystem II, the water oxidation half reaction (Reaction 1.1) is catalyzed at the 
oxygen evolving complex (OEC), a Mn4Ca oxo-bridged cubane-like structure (14).  The OEC is the 
terminal cofactor on the electron donating end of the photosystem II reaction center.  With 
each photon absorption, the OEC is progressively oxidized through the S-state cycle (Kok cycle) 
from S0 (most reduced) to S4 (most oxidized).  At S4, the OEC converts two water molecules to 
dioxygen and returns to the reduced S0 state (44, 49).  In this way, the OEC couples the 
sequential one-electron reactions of the reaction center to the four-electron reaction of water 
oxidation by storing oxidizing equivalents until the OEC is oxidized four times. 
 The OEC catalyzes one of the most difficult reactions in biology with a low overpotential, 
high turnover frequency, and high turnover number and uses only Earth-abundant metals (12, 
50).  However, the structure of the OEC does not need to be reproduced exactly in order to 
achieve water oxidation.  The catalyst remains functional if the calcium ion is replaced by 
strontium (51, 52), and most of the highly conserved amino acid ligands of the OEC can be 
removed by mutation without abolishing water oxidation (although the rate of the reaction is 
usually decreased) (44).  Some small molecule manganese-containing mimics of the OEC have 
been shown to be capable of oxygen evolution (53-55), and various metal oxides have been 
used as heterogeneous water oxidation catalysts including manganese, cobalt, ruthenium, and 
iridium oxides (56).  While iridium and ruthenium complexes can be used for impressive water 
oxidation activity (57, 58), the low abundance of these elements means that they are not useful 
as fuel generating catalysts in the long run.  The Nocera group has reported a film for 
heterogeneous water oxidation composed of Earth-abundant cobalt oxide (59, 60).  These 
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studies show that many different oxo-bridged metal compounds can be useful for water 
oxidation. 
  
1.1.4  Photoassembly of the oxygen evolving complex (OEC) 
 The Mn4Ca OEC cluster is not chemically stable when released from its binding site in 
photosystem II (37), and it must be assembled in place by a process known as photoactivation 
(61).  During photoactivation, manganese ions (initially in the Mn(II) state) are oxidized using the 
same process of light-driven charge separation that the reaction center uses for normal water 
oxidation activity.  It may seem counterintuitive that increasing the charge of the manganese 
ions would help bring them together in the OEC, but manganese oxidation is accompanied by 
proton release from Mn-ligating water and hydroxide ligands, exposing negatively charged 
oxygens that are capable of forming additional ligands to create bridging μ-hydroxo or μ-oxo 
ligands to multiple manganese ions (45).  In the photoactivated state, five μ-oxo bridges bind 
the manganese and calcium ions together in the fully assembled OEC (14). 
Photoactivation begins with the binding of a single Mn(II) ion to the OEC site in photosystem 
II with a dissociation constant of ~40-50 μM (45, 62).  The Mn(II) ion is believed to bear a water 
ligand, and oxidation to Mn(III) by YZ• causes a charge-compensating release of a proton, 
allowing the ligating hydroxide anion to form a bridging ligation to a second metal ion (45, 62).  
A second oxidation event leads to a more stable state, and the cluster continues to iteratively 
reduce YZ•, release protons, and bind additional metal ions until the cluster is fully assembled, as 
illustrated in Figure 1.3 (45, 63). 
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Figure 1.3: Photoactivation of the oxygen evolving complex 
Left: OEC photoassembly process prepares the metal cluster for the oxygen evolving reaction.  
Right: Photoactivated OEC is competent for water oxidation (Reaction 1.1), and proceeds 
through the S-state cycle (Kok cycle).  Figure adapted from Burnap, 2004 (63). 
 
 Ca(II) binds to the photoassembling OEC in the early steps of photoactivation and is 
required for proper formation of the Mn4Ca cluster.  In the absence of Ca(II), a runaway 
photoassembly of oxidized manganese ions takes place, building up to 5-10 manganese ions per 
photosystem II (64).  The resulting cluster is not a functional OEC, but the fact that 
photoassembly proceeds without calcium suggests that it might be possible to engineer a similar 
photoassembly mechanism in a simpler protein system that is able to trap a charge separated 
state and bind metal ions.  This would afford a path toward building an OEC in a new protein 
designed for artificial photosynthesis. 
 
1.1.5  Redox active tyrosines of photosystem II: YD and YZ 
In the de novo design of a reaction center protein, tyrosine has the supreme advantage 
of being a covalently attached amino acid cofactor; a specialized binding site is not needed to 
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pluck the cofactor out of solution and hold onto it tightly.  High affinity cofactor binding sites can 
be difficult to engineer in de novo proteins, and a non-covalently bound cofactor in an in vivo 
system may require a separate cofactor production pathway to generate stoichiometric 
quantities of cofactor.  In addition, tyrosine has a high midpoint potential, and photosystem II 
demonstrates the applicability of tyrosine redox reactions to water oxidation. 
 The oxidation and reduction of tyrosine at neutral pH is a proton coupled electron 
transfer (PCET) reaction.  This is because the pKa of tyrosine changes dramatically from ~10 in 
the reduced state to ~−2 when oxidized (65, 66). 
 There are two redox active tyrosine residues in photosystem II, YZ (D1-Tyr161) and YD 
(D2-Tyr160) that have symmetrically-related positions in the homologous D1 and D2 
polypeptides (see Figure 1.1, right).  Both of these tyrosines can participate in light-activated 
electron transfer reactions, are universally conserved, and lie within 9.0 to 9.3 Å of P680 
according to recent crystal structures (14, 20, 21).  However, only one of them, YZ, is critical to 
the function of photosystem II, as YD is not required for water oxidation (46, 67, 68).  YZ plays an 
instrumental role as it directly reduces P680•+ and directly oxidizes the OEC during normal 
oxygen evolving activity (46). 
Despite their analogous positions in homologous polypeptides, YZ and YD have very 
different oxidation/reduction kinetics, midpoint potentials, and local environments.  Tyrosine Z 
is a powerful oxidant, with a midpoint potential of 1.2 V (25), significantly higher than the 700-
800 mV potential of YD (69).  In the fully operational photosystem II, YZ is oxidized by P680•+ 
through a PCET reaction that takes tens of nanoseconds (28, 29), exhibits no deuterium isotope 
effect on the kinetics (30), and is rate-limited by electron transfer (70).  It has been speculated 
that the oxidation of YZ by P680•+, which must involve a proton transfer that takes less than 20 
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ns, might be the fastest PCET reaction in nature (46).  Reduction of YZ• by the OEC takes longer, 
up to 1.4 ms, depending on the S-state of the OEC (34-36).  YD is also capable of fast reduction of 
P680•+ on the nanoseconds timescale (71), but reduction of YD• takes all day; the YD• radical is 
highly stable and remains in the oxidized state during illumination, only going reduced again 
when it oxidizes the OEC from the S0 to the S1 state after hours in the dark (46, 69, 72). 
 These differences in the driving forces and kinetics of YZ and YD PCET reactions can be 
attributed to the local environments of the residues.  YD is located in a hydrophobic pocket that 
might restrict its ability to become protonated once oxidized, while YZ is positioned near the 
opening of a solvent channel that leads to the thylakoid lumen and is surrounded by water in an 
extensive hydrogen-bonding network that connects it to the OEC (14).  Both YZ and YD make 
hydrogen bonds to nearby histidines that are important for modulating electron transfer 
function (14).  D1-His190 (His-Z), which hydrogen bonds YZ using its imidazole Nε atom, donates 
a second hydrogen bond to an asparagine oxygen with the Nδ atom.  In contrast, D2-H189 (His-
D), which hydrogen bonds YD with its Nε atom, accepts a hydrogen bond from an arginine N-H 
group at the imidazole Nδ atom (Figure 1.4) (14). 
 
 
Figure 1.4: Redox active tyrosines of photosystem II 
Hydrogen bonding networks around Tyr-Z (left) and 
Tyr-D (right) in photosystem II crystal structure (PDB 
ID: 3WU2) (14).  Images rendered using The PyMOL 
Molecular Graphics System, Version 1.7 Schrödinger, 
LLC. 
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Upon oxidation, YZ is known to pass its proton to His-Z (32, 33, 42, 43, 46, 73).  This 
proton transfer might be promoted by the conserved residue D1-Asn298, which accepts a 
hydrogen bond from the Nδ-H group of His-Z, thereby stabilizing the protonated form of the His-
Z Nδ atom (14, 42, 43, 74).  If the His-Z Nδ atom is protonated, then the neutral form of His-Z 
must accept a hydrogen bond from YZ.  In this way, D1-Asn298 might force His-Z into a 
protonation state that is capable of accepting a proton from YZ when YZ becomes oxidized (see 
Figure 1.4, left).  An exhaustive mutagenesis study of D1-Asn298 showed that all 19 possible 
mutations of D1-Asn298 resulted in either total abolition of oxygen evolving activity or a 
significantly decreased rate of oxygen evolution combined with a marked increase in 
photosensitivity (74).  This supports the hypothesis that D1-Asn298 plays an important role in 
the electron transfer pathway of the photosystem II reaction center. 
  Although it has been suggested that YD similarly donates its proton to His-D upon 
oxidation to YD• (46, 69), it seems that the arginine would prevent this from happening, because 
the neutral state of His-D must accept a hydrogen bond from D2-Arg294, meaning that its Nε 
atom is protonated and donating a hydrogen bond to the YD phenolic oxygen; the His-D state in 
the crystal structure is not competent to accept a proton from YD (see Figure 1.4, right) (14).  
Indeed, a study by Nakamura et al., 2014 provides evidence by Fourier transform infrared 
spectroscopy that His-Z accepts a proton when YZ is oxidized, but YD oxidation leads to proton 
release into a hydrogen bonding network around YD rather than protonation of His-D (43).  This 
supports the hypothesis that the water molecule that hydrogen bonds YD in Figure 1.4 (right) is 
the likely proton donor and acceptor in YD PCET reactions, and not His-D.  This water molecule 
only has partial occupancy in some crystal structures and is absent from others (14, 20, 21); the 
absence of a proton donor might restrict PCET reaction rates of YD and help give rise to its 
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observed hours-timescale stability in the oxidized state (46, 69, 72).  Regardless of the precise 
mechanisms of proton transfer, the distal hydrogen bonds of D1-Asn298 to D1-His190 and D2-
Arg294 to D2-His189 appear to play important roles in dictating PCET reaction rates of YZ and YD.  
Therefore, a model system involving tyrosine oxidation and reduction should use an extended 
hydrogen bonding network to modulate PCET properties of the tyrosine. 
 
1.1.6  Functions of YD and YZ 
When considering how to build a new reaction center for artificial photosynthesis, it is 
constructive to examine the purpose of including YD and YZ in photosystem II.  YD is not 
necessary for oxygen-evolving activity, but it is completely conserved (46, 67, 68).  No single 
function of YD stands out as obviously necessary, but some important roles have been identified.  
The ability of YD to store an oxidizing equivalent for extended periods (75) supports 
photoassembly of the OEC (76).  In addition, if P680•+ formation outpaces S-state cycling, or if 
the OEC is not assembled, YD can reduce P680•+ and prevent a damaging side reaction (71, 77). 
 In contrast to YD, YZ is essential to water oxidation in photosystem II, and it serves as an 
intermediate electron donor between the OEC and P680 (46).  Since YZ bridges the gap between 
the OEC and P680, YZ allows the OEC to be positioned further from P680 than it would otherwise 
need to be for rapid electron transfer.  The distance between cofactors decreases electron 
transfer rates by a factor of 10 for every additional ~1.6 Å of distance (78, 79), so the extension 
of the P680-OEC distance by YZ may inhibit reduction of the OEC by P680*.  Furthermore, the 
increased distance may decrease quenching of the P680* excited state by manganese ions of 
the OEC (80).  Another function of YZ is to quickly reduce P680•+ on a nanoseconds timescale (28-
30), which helps avoid short circuiting charge recombination and damaging side reactions.  The 
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OEC undergoes relatively slow structural reorganization steps between different S-states that 
result in electron transfer rates as slow as milliseconds (34-36); if P680•+ routinely persisted for 
milliseconds, the turnover number and quantum yield of photosystem II would be greatly 
diminished.  As a result, YZ couples the fast initial charge separation events to the slower S-state 
cycling of the OEC.  In addition, the proton coupling of YZ oxidation and reduction might serve to 
raise the activation energy barrier to charge recombination (81, 82). 
The hydrogen abstraction model of YZ function offers another possible function (65, 83, 
84).  In this model, the reduction of the deprotonated YZ• radical occurs with concomitant 
protonation by a water molecule in the hydrogen bonding network that connects YZ to the OEC.  
In this way, YZ might help to extract protons from substrate water molecules to facilitate water 
oxidation and deliver protons to a solvent channel.  Alternatively, the proton rocking model 
argues that YZ• receives its proton from His-Z upon reduction and does not participate in proton 
transfer with the surrounding water (85-87).  YZ does not necessarily behave the same way in 
every S-state transition (46), and it has been suggested that hydrogen abstraction may occur 
between some S-state transitions, such as S2 to S3, but that proton rocking may be used in 
others (43). 
 A simplified reaction center protein may benefit from the use of a tyrosine residue for 
extension of the distance between the pigment and metal cluster, rapid reduction of the 
pigment radical cation, and raising the energy barrier to charge recombination by coupling 
electron transfer to proton transfer.  Hydrogen abstraction is probably too advanced for a small, 
simple protein, especially if the metal binding site is exposed to bulk solvent. 
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1.1.7  Tyrosine Z model systems 
 Many different molecular mimics of YZ have been produced to probe mechanistic details 
of tyrosine PCET reactions, investigate whether the YZ to His-Z proton transfer can be 
reproduced easily, and begin developing bio-inspired artificial photosynthetic units.  In one 
example, the Hammarström group synthesized a series of four different YZ mimics in which a 
phenolic proton made a hydrogen bond to a benzimidazyl or pyridyl group, and light driven 
phenol oxidation was carried out by an attached ruthenium tris-bipyridine moiety (88).  This 
study showed nearly a 1000-fold decrease in the phenol oxidation rate for every ~0.2 Å increase 
in hydrogen bond length.  Evidently, hydrogen bond lengths play an important role in PCET 
rates, which helps explain the short hydrogen bond between YZ and His-Z of about 2.5 Å and the 
fast PCET reduction of P680•+ by YZ in tens of nanoseconds (14, 20, 21, 28-30, 42, 46). 
 The Moore group and collaborators have developed small molecule mimics of YZ and YD 
using hydrogen bonding phenol-benzimidazole pairs with the goal of developing an artificial 
photosynthetic unit.  They showed that the irreversible oxidation of a phenol lacking a hydrogen 
bond in aprotic solvent can be made reversible by creating a hydrogen bond to a benzimidazole.  
The reversibility was attributed to the proton being able to shuttle between the phenol and 
benzimidazole groups depending on the oxidation state, instead of being lost to the solvent 
upon phenol oxidation (89).  This proton shuttling is reminiscent of the proton rocking 
mechanism proposed for YZ oxidation and reduction in photosystem II (85-87).  In another mimic 
of YZ and YD, the Moore group showed that low temperature phenol oxidation at 13 K led to an 
intermediate radical state that was only able to donate its proton to the benzimidazole when 
warmed to 100 K (90).  This is very similar to the behavior of YD, which was shown to be trapped 
in an intermediate at 1.8 K that relaxed with a proton transfer at 77 K (81).  The phenol-
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benzimidazole pair was incorporated into a redox triad to trap a charge separated state.  Using a 
di-pentafluorophenyl porphyrin as the pigment, the phenol-benzimidazole as the electron 
donor, and a tetracyanoporphyrin as the electron acceptor, the triad was able to convert light 
energy to a charge separated state that persisted for 3.8 μs (82).  This short lifetime isn’t long 
enough to support water oxidation chemistry, which takes milliseconds in photosystem II (34-
36, 50), but it approaches the longest recorded charge separation lifetime in a synthetic triad of 
34 μs (91).  Small molecule tetrads can trap a charge separated state for much longer, but they 
must be frozen or embedded in nanoparticles to prevent intermolecular charge recombination, 
and their synthesis is extremely costly and time-consuming (92, 93). 
 The synthetic complexity and intermolecular charge recombination limitations of small 
molecules can be avoided through the use of proteins.  Proteins can protect redox centers from 
recombination by shielding them in the hydrophobic core, and sometimes they can be 
expressed in high yield in bacteria.  The Barry group and collaborators synthesized a β-hairpin 
peptide to study tyrosine oxidation in the presence and absence of a nearby histidine.  The 
histidine was shown to accelerate tyrosine oxidation at pH 9, but not pH 11, consistent with 
PCET facilitated by the histidine.  While the histidine was shown not to make a hydrogen bond 
to the tyrosine or affect the tyrosine pKa, it was speculated that a proton could be passed from 
the oxidized tyrosine to the histidine through hydrogen bonding water molecules (94, 95).  The 
Tommos group and collaborators designed a three-helix bundle protein to study tyrosine 
oxidation (96).  The protein was expressible in E. coli, and the deeply buried tyrosyl radical was 
highly stable for seconds when oxidized photochemically (97).  The reversibility of the tyrosine 
oxidation allowed detailed study of midpoint potentials (0.92 V at pH 8.4 and 1.07 V at pH 5.5) 
(98), and insertion of histidines in different positions was shown to modulate tyrosine 
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fluorescence (99).  However, as with the Barry β-hairpin peptide, no conclusive evidence of a 
His-Tyr hydrogen bond was found. 
 These model systems have advanced our understanding of tyrosine oxidation and the 
influence of hydrogen bonds.  Small molecules have reproduced the phenol-imidazole hydrogen 
bonds of photosystem II and demonstrated their power in influencing PCET reactions, but direct 
tyrosine-histidine hydrogen bonds have not been inserted into protein frameworks, and no 
model system has produced an extended hydrogen bonding network such as the tyrosine-
histidine-asparagine network involving YZ.  If a protein could be tailored to exert precise control 
over tyrosine PCET reactions, a tyrosine residue might be a useful electron donor in a de novo 
designed reaction center protein for artificial photosynthesis. 
 
1.1.8  Hydrogen evolution in artificial photosynthesis 
 The reducing end of a reaction center protein designed for artificial photosynthesis 
needs to include an active site that can reduce a substrate to make fuel such as hydrogen, as in 
Reaction 1.2.  Natural hydrogenase enzymes demonstrate the feasibility of this approach; they 
exhibit efficient, reversible proton reduction with low overpotentials at neutral pH using Earth-
abundant elements including nickel and iron (100).  A molecular mimic of the hydrogen evolving 
cofactor of [Fe-Fe] hydrogenases has been shown to be capable of proton reduction activity 
when incorporated into different natural protein scaffolds (101-103). 
Another method of generating hydrogen in a protein framework involves the use of 
cobalt tetrapyrroles, which have been shown to be capable of hydrogen evolution in 
electrocatalytic and photocatalytic systems (104, 105).  Recent work has demonstrated that 
hydrogen production may be attainable in natural tetrapyrrole-binding proteins with modified 
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cofactors, such as a cobinamide cofactor in ethanolamine ammonia lyase (106) or a cobalt 
protoporphyrin IX cofactor in cytochrome b562 (107) or myoglobin (108).  Proton reduction may 
proceed from either the Co(I) or Co(0) state of a cobalt porphyrin (109).  Midpoint potentials of 
cobalt protoporphyrin IX in myoglobin have been reported with Em(Co(III)Mb/Co(II)Mb) of 100 
mV (110) and Em(Co(II)Mb/Co(I)Mb) of −610 mV vs SHE (111).  Unfortunately, Co(III) 
protoporphyrin IX reduction to the Co(II) state in proteins is slow (110-112), which may mean 
that a structural rearrangement occurs in the transition.  However, it may be possible to adapt 
the local environment of the cofactor in order to facilitate faster electron transfer. 
 
1.1.9  Reengineering natural proteins for artificial photosynthesis 
One approach to artificial photosynthesis is to reengineer natural proteins with the aim 
of exploiting solar energy to drive proton reduction and water oxidation.  For example, multiple 
groups have directly coupled photosystem I to a cobalt catalyst or a [Ni-Fe] or [Fe-Fe] 
hydrogenase in order to generate solar hydrogen (113-116).  This demonstrates the feasibility of 
solar-to-hydrogen energy conversion in a biological system; photosystem II and the modified 
photosystem I could work together in vivo to produce hydrogen and oxygen from sunlight and 
water.  An in vivo system allows for the possibility of a self-repairing mechanism in which the cell 
replaces protein as it becomes damaged. 
However, reengineering of a photosystem I-hydrogenase complex would probably have 
to be done without the aid of high resolution structural characterization, because this complex 
is too big for NMR and crystallography would be extremely difficult.  Without a precise 
understanding of how changes to the system improve or inactivate function, progress may not 
yield insights into the inner workings of the photosynthetic machinery or how best to develop 
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an artificial photosynthetic system.  In addition, repurposing such large, complicated, and 
delicate proteins for a new function is no simple task.  Moreover, as explained in section 1.1.2, 
natural photosynthetic efficiency is not as high as it could be.  The efficiency of photosynthesis 
could be increased by covering the solar spectrum with different pigments, or by integrating 
both the water oxidizing and fuel generating half reactions into a single photosystem (3). 
 A natural reaction center protein that is not involved in oxygenic photosynthesis was 
reengineered by Allen, Williams, and colleagues.  In this body of work, a bacterial reaction 
center was modified for tyrosine oxidation (117) and manganese(II) oxidation (118).  The Mn-
bound complex was structurally characterized by X-ray crystallography (119), and has even been 
used as a light-driven superoxide dismutase to convert superoxide to oxygen (120). 
 In another example of protein reengineering to build a reaction center, the Wydrzynski 
group modified the natural four-helix bundle protein bacterioferritin to bind the light-
activatable zinc chlorin e6 (ZnCe6) in place of the natural cofactor heme B.  The modified 
bacterioferritin was assembled with manganese instead of the natural iron cofactor.  Under 
illumination, ZnCe6 photo-oxidized Mn(II) to Mn(III), and three nearby tyrosine residues were 
found to participate in electron transfer (121-123).  However, no electron acceptor was 
incorporated into the modified bacterioferritin reaction center, so it is unclear how the excited 
state of ZnCe6 became oxidized. 
 These successes pave the way for the design of other reaction centers from scratch.  
When the protein scaffold is designed de novo, the designer has more control over the 
parameters that govern electron transfer rates.  In order to avoid the complexities of natural 
proteins, the Dutton group has produced a series of de novo designed protein maquettes.  In 
one example, the maquette BT6 was used for light-driven electron transfer from a zinc 
22 
 
tetrapyrrole to a heme B.  However, because the maquette lacked an electron donor such as a 
metal ion or a tyrosine residue, the charge separated state could not be trapped; the reduced 
state of the electron acceptor was only observed when a sacrificial electron donor was 
introduced into the system (124).  In order to improve upon this result, this thesis is aimed at 
stabilizing a charge separated state in a new maquette that extends the electron transfer chain 
so that it includes a tyrosine residue and a metal center akin to the donor side of the 
photosystem II reaction center.  The next section will outline the design rules for four-helix 
bundles with a focus on the goal of building a new reaction center protein for artificial 
photosynthesis. 
 
1.2 Four-helix bundle design 
The field of de novo protein design, that is, protein design from first principles, has 
progressed steadily since its inception in the 1980s.  Today, basic design rules for four helix 
bundles are firmly established.  A protein designer who is well versed in the literature can 
readily produce an amino acid sequence with a high likelihood of folding into a stable four helix 
bundle.  Ensuring a singular structure, however, requires some finesse, and imparting a high-
level function to a de novo designed protein remains a challenge (125). 
Four-helix bundles are very common in nature, and they perform a wide variety of 
functions: electron transfer using heme (cytochromes b (126), b6 (127), b562 (128), C′ (129), 
bacterioferritin (130)), redox chemistry of carboxylate-bridged diiron and dimanganese proteins 
(ribonucleotide reductase (131), alternative oxidase (132), methane monooxygenase (133), 
bacterioferritin (130)), signaling (cytokines (134), growth hormone (135)), and protein 
oligomerization (Lac repressor) (136).  All of these four-helix bundle examples have an 
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antiparallel helical topology, meaning that each helix is oriented antiparallel to its two adjacent 
helices and parallel to the one diagonally across the bundle on the other side.  The abundance of 
antiparallel four-helix bundles in nature attests to the “designability” of this protein fold (137, 
138). 
Extensive work has been done on designed four-helix bundle proteins that bind heme 
and other tetrapyrroles (112, 124, 139-144).  Heme is one of the most common and most 
versatile cofactors in nature, with functions that include quinone oxidation and reduction 
(redox) activity (cytochrome bc1 complex) (145), electron transport (cytochrome c) (146), small 
molecule binding (guanylate cyclase, myoglobin) (147, 148), and carbon hydroxylation 
(cytochrome P450) (149).  The field of de novo protein design has produced many proteins that 
can bind different tetrapyrroles like heme and use them for an impressive array of functions, but 
de novo proteins seldom rival the catalytic performance of their natural counterparts (125), and 
despite our progress, no high-resolution structure of a de novo designed protein with a 
tetrapyrrole cofactor has yet been solved.  This limits our understanding of the structure-
function relationship and makes it all the more difficult to engineer proteins with sophisticated 
functions. 
Much of the background presented in this section was instructive in the creation of 
MZH3, whose design and characterization is the focus of this thesis.  MZH3 was designed for 
high affinity binding of heme B, a zinc tetrapyrrole, and a di-metal center in an antiparallel four-
helix bundle in order to absorb light and separate charge. 
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1.2.1  Introduction to protein maquettes 
A protein maquette is a de novo designed functional protein that avoids reference to 
natural protein sequences and is minimalistic in the complexity of its design (41).  Four-helix 
bundle maquettes use basic principles of binary patterning of polar and nonpolar amino acids to 
produce robust protein folds that can tolerate successive iterations of redesign without 
significant loss of secondary or tertiary structure (150, 151). 
Four-helix bundle protein scaffolds are well suited for the design of an electron 
transport chain.  Their elongated rod-like structure enforces a linear arrangement of the 
cofactors, which works in favor of charge separation, because it maximizes the distance 
between the electron donating and accepting ends of the maquette, thereby limiting intra-
protein recombination of electrons and holes.  Inter-protein collisional recombination is also 
restricted because cofactors are insulated within the protein frame, which prevents close 
contact between redox centers from different maquettes.  The medium between cofactors is a 
dry, nonpolar core that facilitates efficient electron transfer by ensuring a low reorganization 
energy despite being surrounded by aqueous solvent.  A coiled coil platform also allows for 
modularity of design.  Modifying one cofactor binding site to bind a different type of cofactor 
typically has minimal effects on the properties of the other cofactors and the overall maquette 
structure (124).  Distances between cofactors can be adjusted in quantized steps of 1 α-helical 
turn (about 5 Å) to maximize charge separation efficiency.  Furthermore, while addition of 
cofactors to a pre-existing globular protein would typically necessitate a difficult redesign, a 
helical bundle can often accommodate more cofactors by a simple extension of each helix (152), 
and increasing the length tends to stabilize the fold (153). 
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Some maquettes can bind iron tetrapyrroles and zinc tetrapyrroles with high affinity.  
Iron tetrapyrroles are stabilized by hexacoodinate ligation of the iron ion; they prefer two axial 
ligands, usually histidine.  Zinc tetrapyrroles, in contrast, prefer a pentacoodinate zinc ion that 
only requires one axial histidine (144).  The special advantage of a zinc tetrapyrrole is that, like 
chlorophyll in photosynthetic proteins, it can absorb light to enter a high-energy excited state 
that is a strong reductant.  Once oxidized, the zinc tetrapyrrole radical cation is a powerful 
oxidizing agent.  If cofactors are arranged favorably, as they are in photosystem II, light 
activation can lead to electron transfer and trapping of the charge separated state.  While 
maquettes that bind zinc and iron tetrapyrroles have been made to catalyze light-driven 
electron transfer (124), none can stabilize a charge-separated state for long enough to catalyze 
chemical reactions for solar energy conversion.  To do so efficiently would require at least three 
cofactors: an electron acceptor, a pigment, and an electron donor. 
 Unfortunately, no high-
resolution structures of 
tetrapyrrole binding maquettes 
have yet been reported in holo-
state, although apo-state 
structures of de novo proteins do 
exist (154-157).  Some 
tetrapyrrole binding maquettes 
from the Dutton laboratory have 
been shown to fold into an 
unusual mixed 
 
Figure 1.5: Four-helix bundle topologies 
Antiparallel (left, in green), and parallel/antiparallel (right, 
in red) helix threading topologies.  Helices are represented 
as cylinders with arrows pointing from N- to C-terminus.  
Antiparallel four-helix bundles are more common in 
nature. 
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parallel/antiparallel topology (Figure 1.5, right) rather than the more common antiparallel 
topology (Figure 1.5, left) (150, 154).  Heme binding is accompanied by a significant structural 
rearrangement in which the helices rotate to ligate the heme and bury some polar groups in the 
process (158).  Without high-resolution structures in the active holo-state, the structure-
function relationship remains uncertain, and it is unclear what mutations might lead to 
improved function.  This limits the effectiveness of the iterative redesign approach to maquette 
development, which is one of the prime selling points of the technique. 
 
1.2.2  Coiled coils 
In a low-energy conformation, an α-helix has approximately 3.6 residues per turn, but in 
coiled coils, α-helices twist together like a rope, creating a left-handed supercoil that lowers the 
periodicity of the right-handed α-helices to 3.5 residues per turn (150).  This high-affinity 
wrapping of the helices is driven by “knob-into-hole” interactions, first predicted by Francis 
Crick, in which amino acid side chains (the knobs) pack into spaces between side chains on 
adjacent helices (the holes) (159).  With only 3.5 amino acids per turn, a repeating unit is 
completed every two turns, or seven residues.  This means that α-helical folds can be stabilized 
by a binary pattern of polar and hydrophobic amino acids arranged into repeating heptads, as 
demonstrated by a large library of designed proteins that follow the heptad repeat pattern 
(160).  Following the convention set by McLachlan and Stewart (161), the seven positions in the 
heptad are designated a through g, where positions a and d are the most buried, e and g are 
interfacial, and b, c, and f are located on the exterior.  Natural coiled coils do not always follow 
these coiled coil guidelines perfectly.  Occasionally coiled coils have “stutters” or “skips” in the 
heptad pattern that can be compensated by local structural distortions; sometimes the 
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distinction between a coiled coils and other structures with helix-helix interactions cannot be 
made unambiguously (162, 163). 
A common example of a dimeric coiled coil found in nature is the leucine zipper, which 
contains highly-conserved leucines in most d-positions (164).  Leucine zippers provided an early 
platform for exploring the fundamental design rules that govern coiled coil structure.  
Mutagenesis studies on leucine zippers showed that the preference of a particular heptad 
repeat sequence to fold as a 2-, 3-, or 4-helix coiled coil is sometimes difficult to predict, as even 
volume-conserving mutations from Leu to Ile at a- and d-positions in leucine zippers can result 
in dramatic switches between oligomerization states or between native-like and molten globular 
states, as observed in the classic example of GCN4 (165).  For this reason, accurate prediction of 
coiled coil folding generally requires a broader consideration of inter-helical interactions in 
different possible structures.  In particular, a wider surface on each helix becomes buried in a 
four-helix bundle compared to a two-stranded coiled coil, which means that interfacial residues 
can play a key role in dictating the fold.  The role of interfacial residues is demonstrated in 
studies of various coiled coil mutants in which charged amino acids at e- and g-positions favor a 
two-stranded coiled coil, whereas nonpolar amino acids such as alanine at e- and g-positions 
stabilize four-helix bundles (166, 167). 
 
1.2.3  Layers of hydrophobic amino acids in the core 
 Complementary core packing is a hallmark of native-like, uniquely-structured proteins, 
and the hydrophobic effect is usually the most important driving force in protein folding (168).  
However, hydrophobic contacts can be difficult to design, and inadequate core packing can 
easily lead to a molten globular fold if there is not a large enough free energy gap between the 
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native and non-native folded states relative to thermal energy, kBT (138, 169).  In antiparallel 
four-helix bundles, core a- and d-position side chains can be thought of as forming “layers” 
where each layer consists of two a- and two d-position hydrophobic residues, with each helix  
contributing one residue to each layer (Figure 1.6) (170-172).  Complementarity of packing is 
maximized when each layer has roughly the same total volume so that helices are not pushed 
apart to create pockets that destabilize the protein by decreasing van der Waals contact and 
possibly even allowing water to 
penetrate into the core.  The 
crystal structure of the antiparallel 
four-helix bundle Rop provides a 
clear example of layers that has 
been used to guide de novo 
protein design (170, 171, 173, 
174).  When core d-positions are 
consistently large and core a-
positions are consistently small, a 
regular packing arrangement 
facilitates good van der Waals 
contact between hydrophobic side 
chains (168). 
Natural four-helix bundle proteins frequently have clearly segregated layers in the 
hydrophobic core.  Figure 1.7 shows the structures of the Lac repressor tetramerization domain 
(136), bacterioferritin (175), and cytochrome b (176).  Layers are shown as spheres with each 
 
Figure 1.6: Helical wheel diagram 
One heptad of an antiparallel four-helix bundle protein.  
The distance of an amino acid from the view is 
represented by the size of the heptad letter designation.  
Dotted lines represent hydrophobic interactions within a 
layer.  In helices, thick ribbons connect α-carbons, while 
thinner lines represent Cα-Cβ bonds.   Image rendered 
using The PyMOL Molecular Graphics System, Version 
1.7 Schrödinger, LLC. 
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layer colored differently to distinguish them.  The layers are sometimes more disorganized at 
the ends of the bundles where the four-helix bundle structure is breaking down, but in the 
center, the idea of layering can be a useful tool for thinking about core packing in four-helix 
bundles.  The corresponding green layers of a bacterioferritin-like four-helix bundle and a 
cytochrome b-like bundle design can be matched up to create an extended bundle that 
assembles two tetrapyrroles and a di-metal center with an associated tyrosine. 
 
 
 
 
 
  
Lac repressor 
tetramerization domain 
 
bacterioferritin monomer cytochrome b subunit of 
cytochrome bc1 
Figure 1.7: Layers in natural proteins 
Structure of the Lac repressor tetramerization domain (PDB ID: 1LBI) is shown at left (136).   
Bacterioferritin monomer is shown at middle with Mn(II) ions represented as mauve spheres 
in the center and tyrosine residues in yellow layers (PDB ID: 1BCF) (175).  Structure of 
cytochrome b subunit from cytochrome bc1 complex is shown at right with heme B cofactors 
represented as sticks (PDB ID: 1EZV) (176).  Core a- and d-position amino acid side chains are 
represented as spheres.  These residues segregate into layers which are distinguished by 
color.  Images rendered using The PyMOL Molecular Graphics System, Version 1.7 
Schrödinger, LLC. 
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Different studies have argued for the usefulness of a layering approach to four-helix 
bundle core design (168, 170-172, 177, 178).  One study by the Regan group showed that after 
substituting all eight layers of the Rop hydrophobic core with Ala in a-positions and Leu in d-
positions, respectively, the protein denaturation curves exhibited signs of native-like structure, 
and the mutant had a 27°C increase in the thermal stability over that of wild-type Rop (172).  In 
some cases, however, the intrinsic flexibility of leucine side chains can make a leucine-rich core 
dynamic, even if all the layers have the same size; it is often necessary to include some inflexible 
amino acids in the core such as aromatic and β-branching residues in addition to small or flexible 
amino acids in order to achieve a native-like structure (169).  In one example, a multi-structured 
heme-binding four-helix bundle maquette was used as a scaffold to investigate the effects of 
combinations of substitutions of four d-position Leu residues for Ile, Val, and Phe.  Six of the 
twenty mutants had a stable, unique structure as assayed by one-dimensional proton NMR, and 
some of these singularly-structured mutants were actually less stable than the original leucine-
rich precursor (151).  While not fail-safe, the layering method of hydrophobic core design offers 
a simple, intuitive method of building the core of a four-helix bundle. 
It should be noted that not all four-helix coiled coils are said to have discreet layers.  
Ferritin-like Alacoils such as the Lac repressor tetramerization domain (Figure 1.7, left), which 
have alanine residues in e-positions, have been described as having interdigitated a- and d-
positions, as measured by the relative positions of Cα atoms (179-181).  It has even been argued 
that the idea of layers in antiparallel four-helix bundles is faulty, because a- and d-positions 
rarely align exactly in antiparallel coiled coils (182).  However, the stringent requirement of 
exact alignment may be a red herring to the protein designer seeking to fill gaps in the core to 
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avoid destabilizing a maquette; the layering concept can still be applied even if layers appear 
slanted (Figure 1.7, middle).  A four-helix bundle should pack well as long as there is consistency 
in the total volumes of the layers and in the relative sizes of adjacent a- and d-position amino 
acids.  Layers give the designer a framework for predicting specific hydrophobic contacts in the 
core and the overall alignment of the helices.  As with any aspect of protein design, however, 
the designer must be conscientious of nuances of the sequence and structure that may 
confound attempts to control core packing; the layering approach will not necessarily trump all 
other determinants of core packing.  In this regard, properties of well-characterized natural 
proteins that are similar to the protein being designed can serve to guide the design process. 
 
1.2.4  Heme binding in natural four-helix bundles 
 Both the antiparallel four-helix bundle fold and the heme cofactor are highly abundant 
in nature, and there is no shortage of examples of heme-binding antiparallel four-helix bundles.  
The cytochrome b subunit of mitochondrial respiration protein cytochrome bc1 and the 
analogous photosynthetic protein cytochrome b6 from the cytochrome b6f complex are 
transmembrane antiparallel four-helix bundles that bind two hemes B (126, 127).  Other 
examples of heme B-binding antiparallel four-helix bundles include cytochrome b562 (128), 
succinate dehydrogenase (183), and bacterioferritin (175).  All of these four-helix bundle 
cytochromes are antiparallel and bind heme B so that the plane of the porphyrin ring is parallel 
to the g-g interface and cuts through the e-e interface.  This may be due to inherent structural 
differences between the e-e and g-g interfaces.  The Cα-to-Cβ bond of an amino acid in an e-
position points away from the hydrophobic core, while the Cα-to-Cβ bond in a g-position points 
into the core, making it easier for e-position amino acids to move out of the way of the bulky 
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heme cofactor to avoid steric clashing.  In addition, in all of these cases that use histidine to 
ligate the heme iron, the Nε atom of the imidazole ring is used to ligate the iron, probably 
because an iron-Nδ ligation may cause steric clashing between the porphyrin ring and the His Cβ 
atom or the helical backbone. 
 Of the four-helix bundle cytochromes mentioned above, cytochromes b and b6 are the 
most relevant to the artificial photosynthetic maquette that is the centerpiece of this 
dissertation.  This is because they each bind two B-type hemes non-covalently with an edge-to-
edge distance of about 12 Å (176, 184), which is close enough for electron transfer to occur but 
far enough to slow electron-hole recombination, and they have a designable, layered 
antiparallel fold that has already been reproduced in soluble proteins by several different 
groups, despite the fact that cytochromes b and b6 are transmembrane proteins (140, 141). 
A few details of the structure of cytochromes b and b6 appear to be very important to its 
electron transfer function.  Most importantly, bis-histidine ligation of the heme iron ion is used 
for high-affinity binding.  In addition, the four-helix bundle has binding pockets for the hemes 
carved out to allow space for the bulky heme cofactor (185, 186).  For each pair of ligating 
histidines, there is also a pair of universally conserved “notch” glycines that have been shown to 
be essential to high-affinity heme binding; even a conservative mutation of one of these glycine 
residues to alanine can strain the bis-histidine coordination of the heme and inactivate the 
cytochrome bc1 complex (187).  These His and Gly residues form the red layers in Figure 1.7 
(right panel).  Helical glycines are better tolerated in a membrane environment than in solution, 
but active site glycines have been shown to aid metal binding in di-metal-binding maquettes as 
well (188, 189).  Similarly, a maquette designed for anesthetic binding showed an increased 
affinity for halothane when four Leu residues surrounding the binding site were mutated to Ala 
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(190, 191).  Glycines may provide space and flexibility to accommodate subtle structural 
rearrangements induced by cofactor binding. 
Cytochromes b and b6 also have second-shell Ser and Thr residues that make hydrogen-
bonds to the heme-ligating His residues.  These second-shell Thr contacts have been reproduced 
previously in de novo-designed proteins (139).  The end layers (green in Figure 1.7, right panel) 
of cytochromes b and b6 contain conserved arginine amino acids that make hydrogen bonds 
with the propionate groups of heme B (126, 184). 
The core of the cytochrome b and b6 four helix bundle can be said to have five layers 
between and including the layers that each contain two heme-ligating histidines and two notch 
glycines (red layers in Figure 1.7, right panel).  The middle layer (yellow in Figure 1.7) is bulky, 
because it needs to fill the same volume as the layers that contain heme and two histidines; 
sequence alignments show that the middle layer usually contains exactly one phenylalanine and 
an assortment of mostly bulky hydrophobic residues that may include isoleucine, leucine, 
methionine, valine, and/or threonine.  Layers between the heme-ligating and middle layers 
(blue in Figure 1.7) have part of the heme projecting into them, so they tend to have smaller and 
more flexible amino acids such as alanine, proline, glutamine, leucine, valine, threonine, and 
methionine.  The presence of polar and helix-breaking amino acids may be more tolerable in a 
membrane than in solvent.  Therefore, a- and d-positions in a water-soluble maquette should 
avoid these residues with the exception of the notch glycines, which appear to be critical to the 
heme B affinity and electron transfer function of cytochromes b and b6. 
 
 
 
34 
 
1.2.5  The role of the apo-state in heme binding 
It is intuitive that a heme-binding protein should have hydrophobic core packing that 
complements the shape of the heme cofactor to produce a native-like holo-state, but it is also 
instructive to consider the structure of the apo-state in the absence of heme and how it might 
transition to the heme-bound holo-state.  Should an apo-hemoprotein be rigidly structured 
before the heme arrives, should folding be driven by heme binding, or is the apo-state structure 
irrelevant to heme binding?  Studies of natural hemoproteins in the apo-state shed light on the 
structural requirements of the apo-state of a high-affinity heme binding structure. 
One of the best-studied natural hemoproteins is myoglobin.  Apo-myoglobin has 
relatively low stability and in some ways resembles a molten globule, but it has ordered 
secondary structure as well as specific and stable tertiary interactions that show it is a native-
like globular protein (192).  However, apo-myoglobin does have a highly plastic apo-state 
structure, which has led to the suggestion that heme binding drives a final transition to a stable, 
highly-structured, native-like holo-state (193).  A similar native-like structure with folding 
intermediate-like properties has been observed in other apo-state B-type hemoproteins 
including apo-cytochrome P450 (194), apo-cytochrome b562 (195), and apo-cytochrome b5 (196).  
It should be noted, however, that proteins that bind heme transiently usually have more stable 
apo-state folds than proteins that bind heme permanently (197).  This may reflect a decreased 
pressure for high affinity heme binding and increased pressure for apo-protein resistance to 
aggregation and proteolysis in proteins that bind heme transiently.  It has been observed that 
natural hemoproteins in general are biased toward heme binding sites that have “low 
foldability” (198).  This pattern suggests that a heme-binding protein, which must accommodate 
the bulky hydrophobic porphyrin ring of heme, needs some degree of plasticity to allow the 
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entry of heme into a binding pocket.  Apo-protein flexibility lowers the enthalpic cost of heme 
binding by decreasing the number of protein-protein interactions that must be broken for heme 
to enter the binding site, but a partially pre-formed active site with native-like structure lowers 
the entropic cost of heme binding by lowering the conformational freedom of the apo-protein.  
In their study of cytochrome b5, Falzone et al. termed this the “partial fold option” to convey a 
balance of flexibility and native-like structure in the apo-protein that facilitates high-affinity 
heme binding (196). 
Some support for the partial fold option also comes from studies of de novo-designed 
hemoproteins.  For example, the HP-1 maquette binds two hemes B with high affinity 
(dissociation constants less than 20 nM).  HP-1 has a molten-globular apo-state but transitions 
to a structurally specific conformation upon the binding of heme B (154).  In contrast, a 
maquette with a very similar sequence that has a rigid, singularly-structured apo-state 
transitions to a molten globular state when heme binding disrupts core packing interactions, 
suggesting an advantage for hemoproteins that are flexible in the apo-state (199).  However, a 
heme maquette that is unfolded in the apo-state may not be ideal either.  A D2-symmetrical 
tetrameric heme maquette that was unfolded in the apo-state showed very slow heme binding 
that required hours to reach completion, and an unusually low extinction coefficient was 
reported for its Soret maximum, suggesting incomplete binding even after a day (141). 
 
1.2.6  Due Ferro series of maquettes 
A series of maquettes from the DeGrado and Lombardi groups and collaborators called 
Due Ferro proteins (200) were used to recapitulate functions of natural binuclear non-heme iron 
enzymes such as ferroxidase activity of bacterioferritin (201-205) and quinol oxidase activity of 
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alternative oxidase (132, 205, 206).  Numerous NMR and X-ray crystallographic structures of 
Due Ferro maquettes have shown that the maquettes fold very similarly to the natural proteins 
and bind various metal ions with high affinity including Mn(II), Fe(II), Fe(III), Co(II), Zn(II), and 
Cd(II) (188, 202, 206-211).  These natural and de novo four-helix bundle proteins ligate two 
metal ions in a deep water-filled cavity using two histidines, two bridging glutamates, and two 
axial glutamate residues.  The histidines ligate the metal ions using the Nδ atom and typically 
make second shell hydrogen bonds to aspartate residues using the Nε atom.  Tyrosines are often 
used to make second-shell hydrogen bonds to a bidentate axial glutamates (Figure 1.8). 
 
Figure 1.8: Canonical carboxylate-bridge diiron protein active site 
Bacterioferritin monomer (left) and close-up of the active site (right) (PDB ID: 1BCF) (175).  
Manganese(II) ions are represented as mauve spheres, and hydrogen bonds between Asp and 
His residues and between Glu and Tyr residues are represented by blue dotted lines.  Images 
rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
 
Just as notch glycines were found to be important for the function of cytochrome b, 
iterative redesigns of the Due Ferro series demonstrated that cofactor binding can be improved 
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by using active site glycine residues to make space for the cofactor.  DF1 was originally designed 
with a set of four leucine residues occluding the di-metal binding site, and it had to be 
denatured and refolded in the presence of metal ions before binding could take place (207, 
212).  In subsequent designs, these Leu residues were changed to smaller amino acids, 
progressively trading stability for increasing metal ion affinity and substrate access.  DF2, which 
had two of the Leu residues mutated to Ala, had high affinity for metal ions without the need for 
denaturation.  In addition, DF2 exhibited ferroxidase activity, whereas DF1 did not (204, 212).  In 
DF3, which had all four Leu residues changed to Gly, the affinity for Co(II) and Mn(II) was about 
two orders of magnitude higher than in DF2 (189), and DF3 was able to catalyze the oxidation of 
bulky phenol compounds (188). 
Glycine residues at the opening of the metal site cavity in DF3 also facilitated oxygen-
driven oxidation of substrate molecules including hydroquinones and anilines (188, 206, 213).  A 
recent study showed that a semiquinone could be stabilized by binding to a di-Zn(II) site in a Due 
Ferro variant that had two glycines and two alanines at the opening of the cavity.  Interestingly, 
hydrophobic interactions were identified as a critical driving force for the binding and 
stabilization of the semiquinone (214).  Despite the highly polar contents of the metal binding 
cavity, hydrophobic molecules are able to make stabilizing contacts with the glycine and alanine 
residues at the opening of the metal site.  The site is wide enough that it could conceivably 
accommodate a much larger molecule, such as a porphyrin. 
 
1.2.7  Negative design 
 An important aim of any protein design project is to make a protein with a singular, 
native-like conformation.  Negative design is necessary to widen the energy gap between the 
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intended design and alternative conformations, so that the protein cannot exist in multiple 
conformations at once.  In a four-helix bundle, the primary concern in that the threading of the 
helices, or the helix topology, could be arranged incorrectly; there are many ways for the helices 
to align in a four-helix bundle, and in the absence of negative design, they may have similar 
energies.  While it is true that some functions can be achieved in a protein that exchanges 
between multiple conformations, this is not the case for a reaction center maquette that must 
site-specifically assemble a di-metal center and two tetrapyrroles into an electron transport 
chain.  In a Due Ferro-type active site (177, 200, 207), any alternative helix threading topology 
other than the intended design would change the organization of metal-ligating histidines and 
glutamates such that metal affinity would be greatly reduced.  In the tetrapyrrole-binding 
section of a reaction center maquette, a reversal of the threading from left-turning antiparallel 
to right-turning antiparallel would not affect the geometry of ligation, but a parallel/antiparallel 
topology would leave a distorted binding cavity and the histidines would be in the wrong 
positions for stable tetrapyrrole ligation.  Furthermore, a maquette without a singular, native-
like conformation is not suited for high-resolution structure determination, so it would be 
difficult to verify that the protein folded as designed or to ascribe structural features to 
functional effects. 
We have at our disposal several tools to favor the target design including factors that 
can destabilize the unintended helix topology relative to the correctly folded state and factors 
that can stabilize the intended topology relative to the misfolded state.  For one thing, a single-
chain monomeric four-helix bundle would need to have inter-helical loops that are at least as 
long as a helix in order to have more than two helices with a parallel orientation.  Short loops 
obviate the possibility of a topology with all helices parallel or with three helices parallel and 
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one antiparallel.  Structured loops can be designed to favor a left- or right-turning topology, 
although loops usually have a weaker effect on topology than helix-helix interactions.  Another 
significant factor in determining helix topology is hydrophobic core packing.  Four-helix bundle 
stability is maximized when hydrophobic contact between helices is complementary, so a loss of 
complementarity in an alternative topology favors the intended design (170, 171). 
Perhaps the most easily controlled structural element that influences helix topology is 
inter-helical charge pairing interactions.  Early work on leucine zippers demonstrated the power 
of charge pairing in dictating coiled coil folding.  Mutagenesis and pH titrations on the 
heterodimeric leucine zipper Fos-Jun human oncoprotein showed that charge pairing e- and g-
positions destabilized the Fos and Jun homodimers while stabilizing the heterodimeric state 
(215).  A rigorous study of mutants of the homodimeric VBP leucine zipper showed that altered 
charge patterning at e- and g-positions could make VBP fold as a heterodimer of two mutants 
with complementary charges (166).  Charge patterning was soon leveraged to dictate folding in 
simple Rop-like antiparallel de novo four-helix bundle designs (170, 171), and later in more 
complicated functional antiparallel four-helix bundles.  In a set of tetrameric Due Ferro 
maquettes, the DeGrado group used charge pairing interactions at b-, c-, e-, and g-positions to 
specify heterotetrameric assembly of metal-binding maquettes.  When the component peptides 
were kept separate, they did not fold at neutral pH, but when the peptides were mixed together 
in the proper stoichiometries circular dichroism measurements showed high α-helical content 
(216, 217).  Similarly, charge pairing interactions at c-positions were used in a series of 
porphyrin array (PA) antiparallel four-helix bundle maquettes to help force the intended 
topology, and various methods demonstrated folding and function, but no high-resolution 
structures were obtained to verify the structure (139, 142, 152, 218). 
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1.2.8  Inter-helical loops 
The inter-helical loops of a four-helix bundle protein are usually among the most 
dynamic parts of the protein, but they can play a role in determining the structure.  A short loop 
can force the helices it connects to be antiparallel instead of parallel, and loops can have a 
significant influence on the overall stability of the bundle.   
A loop that is too long will decrease the stability of the four-helix bundle by raising the 
entropic cost of folding.  Indeed, a study on the helix-loop-helix Rop protein, which folds into a 
homodimeric antiparallel four-helix bundle, showed that when the native Asp-Ala loop was 
replaced by a polyglycine linker, increasing the number of glycines in the linker progressively 
lowered the melting temperature.  The mutant with 10 loop glycines denatured at a 
temperature 23°C lower than that of the mutant with a single glycine in the loop.  It was 
estimated that each loop glycine lowered the stability of Rop by 0.26 kcal/mol (219).  A loop that 
is very short, however, may sometimes cause misfolding or aggregation, as was observed in the 
α2B(P) maquette (220) and Rop variants with altered loops (221).  The latter study demonstrated 
that the wild-type homodimeric Rop could be converted to a monomeric four-helix bundle by 
adding polyglycine loops to connect the helices.  While a 3-glycine loop resulted in aggregation, 
the variant with 4 loop glycines was monomeric with comparable RNA substrate affinity and 
higher stability than the wild-type (221).  In a similar manner, the single-chain four-helix bundle 
maquette BT6 was developed from a homodimeric helix-loop-helix maquette by rearranging the 
loops.  In this case, 9-residue glycine-rich linkers were used to produce the single-chain BT6, 
which retained its affinity for heme and was expressible in E. coli (124). 
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The designed loops described above are all glycine-rich unstructured loops, which are 
usually sufficient to make stable, functional maquettes, but a structured loop can add stability to 
the protein.  However, the design of a stable loop in a four-helix bundle is difficult because it 
lacks a stable secondary structure, is highly exposed to solvent, and is located at the ends of the 
helices where the protein is most dynamic.  The DeGrado group has explored the use of loop 
structures that are found in natural proteins to connect the helices of four-helix bundles.  In the 
di-metal maquette DF2t, a structured loop was found to increase stability and expression yield 
(222), and a similar maquette, DF3, used a different loop conformation to confer even greater 
stability and solubility (188).  X-ray crystal and NMR structures demonstrated that the loops 
folded as designed.  While a structured loop sometimes can impart subtle improvements to a 
protein’s structure, unstructured loops are generally sufficient, because four-helix bundle 
folding and function is dictated primarily by the α-helices. 
 
1.2.9  Four-helix bundle length 
 Natural four-helix bundles usually have a length of about 15 to 24 residues per α-helix 
(223), but longer four-helix bundle proteins have been reported, and several natural 2-helix and 
3-helix coiled coils are considerably longer.  In 2008, a de novo-designed two-porphyrin array 
(2PA) four-helix bundle maquette with 34 residues per helix was lengthened by duplicating a 
three-heptad sequence (and introducing a total of five mutations per helix to ensure the correct 
charge pairing interactions) to make a four-porphyrin array (4PA) maquette with 55 residues per 
helix.  The extension of the helices raised the holo-state melting temperature by 24°C (139, 
152).  In a systematic study of four-helix bundle length and stability, a peptide sequence based 
on the Lac repressor tetramerization domain was extended from 21 to 28 to 35 amino acids, and 
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its four-helix bundle stability increased by approximately 16 kcal/mol for each heptad added 
(153).  The increased stabilization due to lengthening is an effect of the increased burial of 
hydrophobic surface area. 
 
1.2.10  Caps at helical termini 
 The termini of α-helices in four-helix bundles tend to fray, making them among the least 
stable parts of the protein (218, 224), which means that end caps can play a significant role in 
stability despite their small size.  For example, when a single 5-residue MTPEQ N-cap was added 
to the N-terminus of BT6, the apo-state melting temperature increased from 37 to about 45°C 
(124).  Similarly, when the tetrameric four-helix bundle maquette 4PA was given four SLEEA N-
caps and four FQKFQKYG C-caps, they increased the apo-state melting temperature by about 
57°C; the caps had a greater stabilizing effect than the lengthening of 2PA by three heptads to 
make 4PA (152). 
N- and C-termini are unstable because the absence of a continuing bundle leaves them 
solvent-exposed, and the absence of a connecting loop leaves their motion largely unrestricted.  
An analysis of N-caps in nature shows a significant preference for proline in the N-cap (225).  
This is because proline addresses both the solvent exposure and conformational freedom of 
helical termini: proline is the most water soluble of all natural amino acids, and it is constrained 
to an α-helical conformation (226).  In addition, the absence of a hydrogen-bond acceptor for N-
terminal backbone amine groups is not an issue for proline, because it has a pyrrolidine side 
chain in place of an N-H bond.  Outside of an N-cap, however, proline is a strong helix breaker 
because the pyrrolidine group blocks the preceding residue from adopting an α-helical 
conformation (226).  Unfortunately, an N-terminal proline presents a problem for TEV protease, 
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which is inhibited by a proline residue close to its site of cleavage (227).  N-caps in natural 
proteins also show a preference for Asn, Asp, Gly, and Ser residues immediately before the Pro 
(225, 228).  These residues can adopt non-helical conformations that can hydrogen bond 
backbone amines at the N-terminus of the helix (225).  In addition, natural N-caps frequently 
contain negatively charged residues, because these help stabilize the helix dipole moment which 
runs from N- to C- terminus, in the direction of backbone C=O bonds and against backbone N-H 
bonds.  In the same way, C-caps can stabilize helices by using positive charges to align the helix 
dipole (229).  However, C-caps do not have any other simple rules of thumb.  Natural proteins 
frequently use Gly at C-caps, but this is because they are often found in the more complicated 
Schellman and αL capping motifs (225, 226, 228).  While Gly residues are sometimes added to 
designed proteins at the C-termini (139, 207, 218), they may not affect stability unless residues 
around them cooperate to fold into specific capping motifs (228). 
 
1.2.11  Summary 
Taken together, the above considerations provide a framework for designing a four-
helix bundle maquette.  The most important tool available to a protein designer is an awareness 
of the literature that is relevant to the protein to be designed.  The structure and function of a 
protein is determined by a complex system of interactions, each of which may vary in strength 
depending on contextual details, and intuition alone cannot be relied upon as a robust predictor 
of structure; rational design requires guidance from empirical observations. 
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Chapter 2: Design and characterization of a reaction center 
maquette 
In order to stabilize a light-activated charge separated state, a working reaction center 
requires, at a minimum, an electron acceptor, a light-absorbing pigment molecule, and an 
electron donor.  Various cofactors can be used to satisfy these roles, and previous work in de 
novo protein design has produced helical bundle maquettes capable of assembling hemes (1-3), 
zinc tetrapyrroles (2, 4, 5), redox-active amino acids (6-8), and di-metal centers (9, 10), but no 
maquette has been made to assemble all of these cofactors into a single working scaffold.  Such 
a maquette would have to be larger and more complex than a typical maquette in order to 
assemble all of these cofactors.  Furthermore, a reaction center maquette has added 
constraints; cofactors must be recognized by their respective active sites and not bind to 
incorrect sites, and the inter-cofactor distances and local environments need to be tuned to 
enable light-driven electron transfer with rates appropriate for charge separation.  This chapter 
will describe the design and initial characterization of a working reaction center maquette.  
 
2.1 Crystallization trials with BT6, a multifunctional heme-binding maquette 
2.1.1: Structure and function of BT6 
 The de novo-designed four-helix bundle protein BT6, named after its designers Bruce 
Lichtenstein and Tammer Farid, is a heme binding maquette from the Dutton lab that is capable 
of multiple functions (2).  BT6 has demonstrated light-activated electron transfer functions 
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involving zinc porphyrins, zinc chlorins, flavins, and heme.  It is also capable of electron transfer 
to cytochrome c, energy transfer, and oxygen binding (2).   
 The light-driven electron transfer function of BT6 represents a first step toward a 
working reaction center.  The wild type form of BT6 has two bis-histidine heme binding sites, 
and mutation of one heme-ligating histidine amino acid to alanine in one of the heme sites 
renders that site unable to bind heme but still able to bind zinc tetrapyrroles.  Light absorption 
by the zinc tetrapyrrole (the pigment) creates a high-energy zinc tetrapyrrole excited state that 
reduces the heme electron acceptor.  Since there is no electron donor in BT6 to trap heme in 
the reduced state, the electron quickly tunnels back to the strongly oxidizing zinc tetrapyrrole 
radical cation and to regenerate the ground state.  If a sacrificial electron donor such as aniline is 
added to the solution, it can reduce the zinc tetrapyrrole radical cation before reduced heme 
does, which would trap the heme in the reduced state.  Since heme is bound to same protein as 
the zinc tetrapyrrole ~19 Å away, it usually outcompetes the aniline reaction, but over extended 
periods of continuous illumination and at high aniline concentrations, heme can be converted 
from the oxidized to the reduced form over several minutes, as shown in Figure 2.1 (2). 
 
Figure 2.1: Charge separation in BT6 
using a sacrificial electron donor 
A BT6 mutant with heme B and Zn 
protoporphyrin IX (ZnP) is able to drive 
heme reduction under illumination in 
the presence of aniline.  This is 
observed by a band shift in the 
ultraviolet/visible spectrum.  The light 
minus dark difference spectrum is 
identical to a reduced heme minus 
oxidized heme difference spectrum.  
Figure reproduced from Farid et al., 
2013 (2). 
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 BT6 is a four-helix bundle but does not appear to be a canonical coiled coil; a precursor 
of BT6 with a very similar sequence, L31M, was crystallized in the apo-state and showed very 
straight α-helices with a slight right-handed supercoil instead of the typical left-handed twist of 
normal coiled coils (11).  Also, the helices of BT6 and its precursors rotate to allow heme 
binding, which partially buries several glutamic acid residues, giving rise to an unusual, strained 
conformation (2, 12).  As a result, BT6 in the holo-state might be quite different from the 
previously solved apo-state structure of L31M (11).  No high-resolution structure of BT6 has 
been solved, but the many functions and unusual structural properties of BT6 make it a 
worthwhile target of structural studies. 
The sequence of BT6 is given below, with each helix on a new line and loops separated 
from helical sequences by a space.  Heme-ligating histidines are shown in red.  The sequences of 
all four helices are identical, as are all three flexible 9-residue glycine-rich loops (2): 
(N-terminus): GEIWKQHEDALQKFEEALNQFEDLKQL GGSGSGSGG                   
               EIWKQHEDALQKFEEALNQFEDLKQL GGSGSGSGG   
               EIWKQHEDALQKFEEALNQFEDLKQL GGSGSGSGG 
               EIWKQHEDALQKFEEALNQFEDLKQL  (C-terminus) 
 
2.1.1  Efforts to crystallize BT6 
BT6 has all the requirements for crystallographic structure determination.  It binds its 
heme B cofactors with high affinity (both heme dissociation constants are less than 2 nM), it is 
stable in the holo-state (with a melting temperature close to 80°C), and it has well-dispersed 
NMR peaks in the holo-state (2).  Unfortunately, its highly repetitive sequence makes structure 
determination by NMR extremely difficult.  Past attempts at crystallography have shown BT6 
and similar maquettes to be recalcitrant to crystallization, possibly because of the long, flexible 
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loops and the many charged surface amino acids that give the maquette an overall charge of 
about −16 at neutral pH. 
Here, another attempt at BT6 crystallization was made.  BT6 was expressed in E. coli 
with an N-terminal His6 tag and purified by Ni-NTA column chromatography.  This His6 tag was 
removed by TEV protease, and the TEV protease, His6 tag, and uncleaved maquette were 
removed with a second Ni-NTA column.  A size exclusion column yielded monomeric BT6 
protein, and after adding heme B, BT6 was ready for crystallization trials. 
Several months of crystallization trials eventually yielded small red crystals that were 
not suitable for diffraction.  A 500 μM BT6 stock solution was prepared in 10 mM MgCl2 with 10 
mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer at pH 7.5.  Small, 
irregular crystals were grown in hanging drop experiments at 4°C over well solutions of 50-600 
mM MgCl2 and ~28-34% w/v polyethylene glycol monomethyl ether with an average molecular 
weight of 2000 Da (PEGMME 2000).  Well solutions were not buffered, as several different 
buffers were found to disrupt crystal formation.  Shown below in Figure 2.2 is an example of the 
crystals observed.  This crystallization drop includes crystals of various morphologies including 
needles, semicircular plates, and roughly hexagonal plates.  Their red color shows that heme is 
present in the crystals.  Lengths of BT6 crystals rarely exceeded ~1 μm. 
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Figure 2.2: BT6 crystals 
not suitable for X-ray 
diffraction 
Crystals were 
photographed after 3 
weeks of growth at 4°C.  
Well solution was 300 
mM MgCl2, 32% w/v 
PEGMME 2000, and 1 
mM HCl to adjust the pH.  
The crystallization drop 
contained 2 μL BT6 stock 
solution and 2 μL well 
solution.  (Crystallization 
drop is labeled Tray B24, 
well D2). 
 
2.1.2  Improved crystal growth in a modified BT6, BT6_2sl 
 Crystallization is often inhibited by flexible protein domains.  The three long, 9-residue 
loops of BT6 are designed to be unstructured linkers.  This length is unlikely to be necessary, as 
previous work has shown that four-helix bundles rarely require more than four residues in inter-
helical loops for proper folding (13, 14).  For this reason, crystallization trials were attempted 
with a BT6 variant with shortened loops.  The middle loop of BT6 is believed to cross the bundle 
diagonally from helix 2 to helix 3, and may need to be longer; the second loop was left at 9 
residues.  The onerous task of site-directed mutagenesis in a maquette with such a repetitive 
sequence was tackled by fellow graduate student Joshua Mancini, who shortened loops 1 and 3 
to 5 residues.  The resulting sequence of BT6_2sl (also referred to as BT6sloop) is given below.  
The BT6_2sl sequence is identical to BT6, except for the two shortened loops. 
(N-terminus): GEIWKQHEDALQKFEEALNQFEDLKQL GGSGG                   
               EIWKQHEDALQKFEEALNQFEDLKQL GGSGSGSGG   
               EIWKQHEDALQKFEEALNQFEDLKQL GGSGG 
               EIWKQHEDALQKFEEALNQFEDLKQL  (C-terminus) 
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 A new round of crystallography with BT6_2sl following the same procedure as with BT6 
gave improved results, including X-ray diffraction to ~6-7 Å resolution using rotating copper 
anode X-ray generator (see section 7.5 of the appendix for details).  However, this resolution is 
not high enough to solve the crystal structure.  BT6_2sl crystals were grown using a 760 μM 
BT6_2sl stock solution in 10 mM MgCl2, 10 mM HEPES buffer at pH 7.5.  BT6_2sl crystals grew in 
similar conditions to BT6: hanging drops at 4°C over well solutions of 100-600 mM MgCl2 and 
~20-34% w/v PEGMME 2000.  Crystals grew with an unusual semicylindrical morphology and 
were embedded in films that formed on the surface of the drops or on the cover slides and were 
somewhat difficult to extract for X-ray diffraction.  Shown below in Figure 2.3 are two examples 
of BT6_2sl crystals that diffracted to ~6-7 Å resolution using a rotating copper anode X-ray 
source.  The spacing between reflections was consistent with an asymmetric unit similar to the 
expected dimensions of a BT6_2sl monomer.  However, many X-ray reflections appeared to be 
missing from the diffraction pattern, suggesting significant disorder in the crystals.  A full data 
set was not collected. 
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Figure 2.3: BT6_2sl crystals that diffract X-rays to 6-7 Å resolution 
Two examples of BT6_2sl crystals that diffracted to 6-7 Å resolution.  Before X-ray diffraction, 
crystals were dipped in a cryoprotectant similar to the well solution with increased PEGMME 
2000 and MgCl2 concentrations.  Left: Three-week old BT6_2sl crystals grown at 4°C over a 
well solution of 600 mM MgCl2 and 26% w/v PEGMME 2000.  Right: Two-year old BT6_2sl 
crystals grown at 4°C over a well solution of 400 mM MgCl2 and 23% w/v PEGMME 2000. 
 
2.1.3  Promising results from BT6_3sl crystallography  
 Given the impact that shortened loops made on crystal quality in BT6_2sl, it was 
hypothesized that shortening the second loop also would further improve the crystal 
morphology and diffraction quality.  Joshua Mancini used site-directed mutagenesis to shorten 
the second loop to create BT6_3sl, in which all three loops are shortened to five residues: 
(N-terminus): GEIWKQHEDALQKFEEALNQFEDLKQL GGSGG                   
               EIWKQHEDALQKFEEALNQFEDLKQL GGSGG   
               EIWKQHEDALQKFEEALNQFEDLKQL GGSGG 
               EIWKQHEDALQKFEEALNQFEDLKQL  (C-terminus) 
 
 BT6_3sl was expressed and purified using a similar procedure to BT6.  There was no sign 
of weakened affinity for heme B in BT6_3sl, and initial attempts at crystallographic structure 
determination have been pursued using a stock solution of 870 μM BT6_3sl with 10 mM MgCl2 
and 5 mM HEPES buffer at pH 7.5.  Like BT6, BT6_3sl crystals grew at 4°C over well solutions of 
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~24-30% w/v PEGMME 2000 and 100-600 mM MgCl2.  BT6_3sl growth was best when the 
crystallization drop had a pH of about 7.0, but crystal growth was disrupted by buffer, as with 
other BT6 variants.  BT6_3sl crystal morphology is greatly improved relative to BT6_2sl and BT6.  
While the crystals remain small (less than 10 μm in length), they tend to grow in the shapes of 
hexagonal prisms rather than thin semicylinders.  Crystals appeared within a day and continued 
growing for about 5 days.  Only one crystal so far has been mounted for X-ray diffraction, and it 
only diffracted to ~12 Å resolution, but there did not appear to be any missing reflections as 
there were with BT6_2sl.  The preliminary low resolution of BT6_3sl X-ray diffraction is probably 
limited by the small size of the crystals (~1-10 μm in length) rather than problems with disorder 
in the crystals.  Some examples of BT6_3sl crystals are shown in Figure 2.4. 
  
Figure 2.4: BT6_3sl crystals grow with improved morphology compared to BT6 and BT6_2sl 
Left: Five-month old BT6_3sl crystals grown at 4°C over a well solution of 300 mM MgCl2 and 
25.5% w/v PEGMME 2000. Right: Five-month old BT6_3sl crystals grown at 4°C over a well 
solution of 200 mM MgCl2 and 26% w/v PEGMME 2000. 
 
 While the crystal structure of BT6 has not yet been solved, the current results are very 
promising.  It is interesting to note that the crystallization conditions of BT6 are similar to the 
conditions used for crystallization of the apo-state of its precursor, the L31M maquette.  L31M 
crystals grew from well solutions with 30% w/v PEGMME 2000, similar to BT6.  However, the 
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L31M condition also had 100 mM HEPES buffer (which disrupts BT6 crystal growth), it did not 
contain MgCl2, and the crystals grew at 28°C instead of 4°C.  Still, it may be worthwhile to test 
the cryoprotectant that was favored for L31M (30% v/v PEG 550 and 30 mM HEPES buffer at pH 
7.4) (11).  Better crystals might also grow from the use of higher purity protein, such as that 
purified by high-performance liquid chromatography (HPLC).  Future work is likely to produce a 
high-resolution BT6_3sl structure that may elucidate the mechanisms of different functions in 
BT6. 
 
2.2 Design of the reaction center maquette MZH3 
 The trapping of a reduced heme state in BT6 is an important step toward developing an 
artificial reaction center maquette, but the ultimate goal is water oxidation and fuel generation.  
BT6 is not equipped to incorporate additional cofactor binding sites that will be necessary to 
achieve this function. 
A new maquette was designed to function as a simplified reaction center by 
incorporating electron donors, a pigment, and an electron acceptor.  The maquette was named 
MZH3 for the cofactors it binds: Metal, Zinc tetrapyrrole, and Heme.  The design of MZH3 makes 
use of the extensive literature on four-helix bundle design that has been built up since Regan 
and DeGrado made their first de novo four-helix bundle protein in 1988 (15).  MZH3 was 
designed to have an antiparallel topology, which is common to the natural carboxylate-bridged 
diiron and dimanganese family of proteins as well as cytochromes b and b6.  MZH3 is a 196-
amino acid protein with an extinction coefficient of 12,490 M-1cm-1 at 280 nm, a molecular 
weight of 22.5 kDa, and a theoretical isoelectric point at pH 5.5 in the apo-state (calculations 
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performed using ExPASy ProtParam online server) (16).  The sequence of MZH3 in its single-
letter amino acid code is: 
 
GSPELRQEHQQLAQEFQQLLQEIQQLGRELLKGELQGIKQLREASEKARNPEKKSVLQKILEDEEKHIELLETLQ
QTGQEAQQLLQELQQTGQELWQLGGSGGPELRQKHQQLAQKIQQLLQKHQQLGAKILEDEEKHIELLETILG
GSGGDELRELLKGELQGIKQYRELQQLGQKAQQLVQKLQQTGQKLWQLG 
 
 A more informative depiction of the sequence of MZH3 is given in Table 2.1.  The 
winding “snaked” sequence in the second row, which is written backwards in helices 2 and 4, 
shows which amino acids form layers together in the hydrophobic core. 
heptad 
positions 
(N)Forward: efgabcdefgabcdefgabcdefgabcdefgabcdefgabcdef        (C) 
(C)Reverse: gfedcbagfedcbagfedcbagfedcbagfedcbagfedcbagf        (N) 
MZH3 
“snaked” 
sequence 
(N-term) →GSPELRQEHQQLAQEFQQLLQEIQQLGRELLKGELQGIKQLREASEK ARN → (C) 
(C) ← GGSGG LQWLEQGTQQLEQLLQQAEQGTQQLTELLEIHKEEDELIKQLVSKKEP  ← (N)  
(N) →       PELRQKHQQLAQKIQQLLQKHQQLGAKILEDEEKHIELLETIL GGSGG → (C) 
(C-term) ← GLQWLKQGTQQLKQVLQQAKQGLQQLERYQKIGQLEGKLLERLED      ← (N) 
MZH3 N-to-
C forward 
sequence 
(N-term)  GSPELRQEHQQLAQEFQQLLQEIQQLGRELLKGELQGIKQLREASEK ARN   (C) 
(N)      PEKKSVLQKILEDEEKHIELLETLQQTGQEAQQLLQELQQTGQELWQL GGSGG (C) 
(N)         PELRQKHQQLAQKIQQLLQKHQQLGAKILEDEEKHIELLETIL GGSGG   (C) 
(N)          DELRELLKGELQGIKQYRELQQLGQKAQQLVQKLQQTGQKLWQLG (C-term) 
Table 2.1: Amino acid sequence of MZH3 
Coiled coil heptad positions a through g are denoted in the top row for both forward (N- to C-
terminus) and reverse (C- to N-terminus) sequences, and they are aligned with corresponding 
positions in the MZH3 amino acid sequences.  Residues highlighted yellow are a-position 
residues.  The MZH3 amino acid sequences have each helix written on a new line with loops 
separated from the helices by a space.  The N- and C-terminal ends of each helix are denoted 
by the letter in parentheses at either end of each helix, and “N-term” and “C-term” denote 
termini of the protein.  Green amino acids belong to the cytochrome b-like tetrapyrrole 
binding section of MZH3, whereas blue amino acids belong to the Due Ferro-like di-metal 
binding section of the protein.  In the MZH3 “snaked” sequence, helices 2 and 4 are written in 
reverse so that amino acids that are spatially close together in the folded protein are close 
together in the snaked sequence diagram.  Red boxes enclose layers of the hydrophobic core, 
each of which includes two a- and two d-position residues.  The N-to-C forward sequence is 
written conventionally, from the N-terminus to the C-terminus. 
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2.2.1  Use of the Due Ferro maquette sequences in MZH3 
 The electron donating section of the photosystem II reaction center has a Mn4Ca water 
oxidizing cluster and tyrosine Z, which transfer electrons to the pigment P680 when it becomes 
oxidized (17).  The design of MZH3 sought to reproduce this electron transfer pathway in a four-
helix bundle, and perhaps the most obvious template for such a design is the family of 
carboxylate-bridged diiron and dimanganese proteins that are diverse in function but similar in 
structure (18).  This scaffold was recreated in the Due Ferro series of maquettes created by the 
DeGrado and Lombardi groups and collaborators (9).  The carboxylate-bridged diiron fold usually 
includes one or two tyrosine amino acids that form hydrogen bonds with glutamates.  In some 
cases, such as bacterioferritin and ribonucleotide reductase, these tyrosines function as redox-
active cofactors (19, 20).  Given the success of the Due Ferro maquettes, the sequence of one of 
these proteins was used as the metal and tyrosine section of the protein with some adaptations. 
The Due Ferro section of MZH3 was based primarily on the sequence of DF3, a helix-
loop-helix dimeric 4-helix bundle maquette protein that can bind two metal ions and was 
originally used for ferroxidase and phenol oxidase activity (21, 22).  DF3 has higher affinity for 
metal ions than previous Due Ferro proteins, and its four active site glycines allow for a wide 
cavity that facilitates efficient entry and exit of substrate molecules and may allow space for a 
larger metal cluster to assemble, such as one close to the size of the oxygen evolving cluster of 
photosystem II.  However, these helical glycines make DF3 less stable than previous Due Ferro 
proteins.  The design of MZH3 compensates for this instability with its length and by using a 
single-chain monomeric rather than noncovalent dimeric folded state. 
To avoid undesirable side reactions, redox-active amino acids near the di-metal site 
were removed.  A single tyrosine was kept between the metal center and the pigment as an 
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intermediate electron donor, similar to tyrosine Z of photosystem II.  Two interfacial Trp 
residues were changed to Leu, one Tyr was changed to Glu, and one of the two active site 
second-shell Tyr residues was mutated to Leu (see Table 2.2).  A Tyr to Phe mutation might have 
been more conservative than Tyr to Leu, but studies involving the single-chain Due Ferro variant 
DFsc showed that the Y51F mutation resulted in sample heterogeneity and was not amenable to 
spectral analysis.  Instead, the Y51L mutation was selected as an alternative because Leu has a 
similar Stokes radius to Tyr; Y51L was useful for spectroscopy (23). 
 
heptad 
positions 
(N)Forward:     efgabcdefgabcdefgabcdefg           (C) 
(C)Reverse:     gfedcbagfedcbagfedcbagfe           (N) 
DF section 
of MZH3  
“snaked” 
sequence 
(N-term) →      ... RELLKGELQGIKQLREASEK ARN     → (C) 
(C) ←           ... TELLEIHKEEDELIKQLVSKKEP      ← (N)  
(N) →           ... AKILEDEEKHIELLETIL GGSGG     → (C) 
(C-term) ←      ... ERYQKIGQLEGKLLERLED          ← (N) 
DF3 
“snaked” 
sequence 
(N-term) →       DYLRELLKGELQGIKQYREALEY THN     → (C) 
(C-term) ←       GLITELWEIHKEEDELIKALVP          ← (N) 
(N) →            PVLAKILEDEEKHIEWLETILG     → (C-term) 
(C) ←       NHT YELAERYQKIGQLEGKLLERLYD     ← (N-term) 
DF2t 
“snaked” 
sequence 
(N-term) →      MDYLRELYKLEQQAMKLYREASEK ARN     → (C) 
(C-term) ←       GNITELWEIHKEEDELIKQLVSKKEP      ← (N) 
(N) →        PEKKSVLQKILEDEEKHIEWLETING     → (C-term) 
(C) ←       NRA KESAERYLKMAQQELKYLERLYDM    ← (N-term) 
Table 2.2: Comparison of the Due Ferro section of MZH3 to DF2t and DF3 sequences 
Residues written in orange line the active site and are thought to be important for metal 
binding affinity and catalysis (21).  Residues of MZH3 in red are found in neither DF2t nor DF3, 
and were selected in order to remove redox-active amino acids or to connect helices using a 
flexible linker.  Loops are separated from the helices by a space.  Residues highlighted yellow 
are in a-positions.  The termini of each helix are denoted by the letter in parentheses at either 
end of each helix.   
 
2.2.2  Tetrapyrrole binding section of MZH3 
 While Due Ferro maquettes are compatible with the envisioned structure and function 
of MZH3, no tetrapyrrole binding maquette precisely suits the needs for the tetrapyrrole section 
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of MZH3.  In addition, high-resolution structures of any maquette with tetrapyrroles bound do 
not exist, so the predicted structures have not been confirmed.  By designing a new tetrapyrrole 
binding section, inter-cofactor distances can be more precisely controlled, the structure can be 
tailored to help it join seamlessly to the Due Ferro section of the maquette, and important 
lessons learned from years of research on four-helix bundle sequence and structure that appear 
to have been neglected in some maquettes can be implemented in full force to build a uniquely-
structured high-affinity multi-cofactor binding protein. 
 Charge separation in an MZH3 tetrad should be optimized if the rate of electron transfer 
between the pigment and acceptor is slowed relative to the donor-to-pigment rate.  This can be 
accomplished by using a long pigment-acceptor distance and short donor-pigment distance.  If 
the pigment-acceptor distance is too long, however, the excited state of the zinc tetrapyrrole 
will decay before electron transfer can take place.  Cytochrome b from the bc1 complex, with its 
~12 Å distance between hemes (24), is close to optimal for the purposes of MZH3.  For this 
reason, general structural attributes of cytochrome b were reproduced in the MZH3 design.  The 
sequence of cytochrome b, however, would not work in a soluble maquette, because 
cytochrome b is a transmembrane four-helix bundle.  Cytochrome b has many nonpolar residues 
on its exterior, and helical propensities of amino acids are very different in nonpolar membrane 
environments; while glycines, prolines, and buried polar groups like glutamines and threonines 
are all tolerated quite well in a helical membrane protein, these residues would induce 
misfolding and aggregation in a water soluble maquette. 
Layers of core a- and d-position amino acids in MZH3 followed the general layering 
pattern of cytochrome b.  The design of MZH3 made use of the universally conserved heme-
ligating histidines and notch glycines of cytochrome b (24).  The histidines were placed at d-
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positions and the glycines at a-positions.  At the zinc tetrapyrrole site, one histidine was 
changed to isoleucine, since zinc tetrapyrroles have a pentacoordinate zinc ion and only one 
ligand is needed.  Isoleucine was the residue chosen for a similar role in a four-helix bundle 
maquette that bound a synthetic zinc porphyrin (25).  The d-position histidines were designed to 
make second shell hydrogen bonds to g-position threonines, as in cytochrome b.  A hydrogen 
bond between a porphyrin-ligating histidine and a threonine has been incorporated into a 
maquette previously, and electron paramagnetic resonance (EPR) measurements with and 
without the second shell threonine indicated that the hydrogen bond tilted the imidazole rings 
of the histidines (26).  Two a-position arginines were placed near the N-termini of helices 1 and 
3 in order to try to make salt bridging interactions with propionate groups as observed in 
cytochrome b and to prevent hydrophobic collapse of the apo-state of the acceptor site, which 
might inhibit cofactor binding. 
The three layers between the hemes of cytochrome b are subject to considerable 
variation across different species, but there are patterns in the total sizes of the layers (27).  The 
bulkiest amino acids are in the middle layer (yellow in Figure 2.5, left).  In the corresponding 
positions in MZH3, Phe and Ile were placed at the d-positions and Leu and Val were placed at 
the a-positions.  The intermediate layers between the middle and histidine layers (blue in Figure 
2.5, left) were composed of small and flexible Ala and Leu residues to accommodate the 
presence of part of the tetrapyrrole ring. 
73 
 
 
 
Figure 2.5: Layers in natural proteins 
Structure of cytochrome b subunit from 
cytochrome bc1 complex is shown at left 
with heme B cofactors represented as 
sticks (PDB ID: 1EZV) (24).  
Bacterioferritin monomer is shown at 
right with Mn(II) ions represented as 
mauve spheres in the center (PDB ID: 
1BCF) (28).  Core a- and d-position amino 
acid side chains are represented as 
spheres.  These residues segregate into 
layers which are distinguished by color.  
The basic idea of the MZH3 design is to 
merge a green layer from a cytochrome 
b-like structure and a green layer from a 
bacterioferritin-like structure to make a 
reaction center maquette.   Images 
rendered using The PyMOL Molecular 
Graphics System, Version 1.7 
Schrödinger, LLC. 
 
2.2.3  Helix-helix interfaces in MZH3 
 Designing MZH3 to have proper distances between adjacent helices (interface widths), 
is a serious concern in the joining of these two very different protein modules.  (Figure 2.6 
shows a helical wheel diagram of an antiparallel four-helix bundle). Natural carboxylate-bridged 
diiron proteins tend to have e-position alanines to stabilize narrow, tightly packed e-e interfaces 
to make the canonical ferritin-like Alacoil (18, 29).  In contrast, as described in the introduction, 
cytochrome b and other heme-binding antiparallel four-helix bundle proteins tend to bind heme 
so that the porphyrin ring lies parallel to the g-g interface and expands the e-e interface.  As a 
result, the exceptionally wide e-e interface in the tetrapyrrole section of MZH3 must transition 
to become very narrow in the bacterioferritin-like section of the maquette.  In addition, the g-g 
interface of carboxylate-bridged diiron proteins tends to be wide in order to accommodate the 
entry and departure of substrate and product molecules (18).  Crystal structures of cytochrome  
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b show a slightly narrower g-g 
interface than is observed in diiron 
proteins (24).  Some tetrapyrrole 
binding maquettes in the past 
have used a Rop-like Alacoil fold 
with alanines in g-positions to 
narrow the g-g interface (26, 30, 
31). 
In this way, the 
geometries of the cytochrome b-
like and bacterioferritin-like four-
helix bundles appear to be at odds 
with each other; if too much strain 
is exerted by one module onto the 
other, cofactor binding in one module could affect the structure of the other.  One advantage of 
using a Due Ferro sequence for the metal binding section of MZH3 is that its narrow e-e 
interface is unusually wide compared to most natural diiron and dimanganese proteins, and its 
wide g-g interface is unusually narrow compared to the natural proteins (32).  In order to 
prevent a conflict between the tetrapyrrole and metal sections of the protein, the Rop-like 
Alacoil fold of earlier porphyrin binding maquettes (26, 30, 31) was rejected in favor of a wider 
g-g interface.  To this end, the amino acid for most of the g-positions in the tetrapyrrole section 
of MZH3 was leucine.  (The exceptions were the second shell threonines that were meant to 
make hydrogen bonds to histidines).  Mutations of e-position interfacial alanines to leucines in 
 
Figure 2.6: Helical wheel diagram of one heptad of an 
antiparallel four-helix bundle protein 
The distance of an amino acid from the view is 
represented by the size of the heptad letter designation.  
Dotted lines represent hydrophobic interactions within a 
layer.  In helices, thick ribbons connect α-carbons, while 
thinner lines represent Cα-Cβ bonds.   Image rendered 
using The PyMOL Molecular Graphics System, Version 
1.7 Schrödinger, LLC. 
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the Lac repressor tetramerization domain have been predicted to force helices to rotate and 
move apart to accommodate the increased side chain volume (33).  In addition, interfacial 
leucines are significantly more stabilizing than alanines (29, 33).  Using g-position leucines in 
MZH3 allows for the expansion of the g-g interface to prevent strain in the transition between 
the tetrapyrrole and metal binding sections of MZH3. 
Another way to prevent strain between the modules might be to ensure flexibility in the 
helices where the two modules meet.  The pigment binding site already has two a-position 
glycine residues in the same layer as the histidine because of the similar notch glycine positions 
in cytochrome b, but it was given two more a-position glycines, G27 and G128, in the layer 
adjacent to the histidine layer nearest the metal binding module.  This further expands the zinc 
tetrapyrrole binding pocket, which is at risk of hydrophobic collapse that could prevent binding 
of the pigment.  Gylcine residues G27 and G128 were also intended to increase the flexibility to 
allow a seamless transition from one module to the next. 
 
2.2.4  Inter-helical loops in MZH3 
 In MZH3, the joining of a Due Ferro protein to a tetrapyrrole-binding protein required 
careful consideration of loop placement.  On the electron acceptor end of MZH3, some solvent 
access is required to solubilize the propionate groups of protoporphyrin IX derivatives like heme 
B, and flexibility in the apo-state is believed to facilitate entry of the large, bulky tetrapyrrole 
cofactor into the binding cleft (34-36).  In contrast, the DF3-like di-metal site of MZH3 is 
destabilized by four α-helical glycine residues and a water-filled active site containing four 
charged glutamates.  In fact, the stability of DF3 was poor enough that it required the design of 
its own structured loop (21).  For these reasons, the heme-binding end of MZH3 was chosen as 
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the end with N- and C-termini, and the DF end was given two loops in order to increase its 
stability (see Table 2.1).  One of these loops came from DF2t (37), because the DF3 loop contains 
a solvent-exposed histidine, which may be capable of ligating metallo-tetrapyrroles (38) and 
thereby complicating characterization of MZH3.  Similarly, the redesign of bacterioferritin for 
zinc chlorin binding called for the removal of surface histidines to avoid unintentional cofactor 
ligation (39).  The metal site was chosen to be DF3-like because of the high metal binding affinity 
of DF3, but some parts of the sequence beyond the loop and active site regions differed 
between DF2t and DF3.  Amino acids that were close to the loop were chosen to be DF2t-like, 
because loop stability depends on the overall structure of the protein (40).  The other loop on 
the DF end is simply a flexible linker.  This Gly-Gly-Ser-Gly-Gly linker unites the DF maquette into 
a single chain, as was done similarly in Rop and BT6 (2, 14).  An identical linker was used on the 
heme-binding end of MZH3.  A length of 5 residues was chosen for the glycine-rich linkers in 
order to guarantee sufficient length to prevent misfolding but also ensure high stability. 
 
2.2.5  Inter-helical charge pairing interactions 
 The helical topology in Due Ferro proteins appears to be dictated by the sum of many 
interactions throughout the bundle including complementarity of core packing, inter-helical 
hydrogen bonds, and short, structured loops (37, 41).  In MZH3, most core layers of the 
tetrapyrrole binding section are symmetrical, meaning that these hydrophobic contacts would 
not select for the left-turning antiparallel topology over the right-turning antiparallel topology.  
In addition, two of the loops in MZH3 are unstructured and cannot determine the topology.  
Interfacial g-position leucine pairing would strongly favor the antiparallel fold over the four 
other possible topologies that are all mixed parallel/antiparallel folds, but the right-turning 
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antiparallel topology would have the same leucine-leucine interactions as the left (see Figure 
2.7).  In order to help constrain the topology, charge pairing interactions were included in c-
positions, as has been done previously in maquettes to dictate the topology (26, 42).  Each helix 
in MZH3 included three charged c-position amino acids to pair with its adjacent helix across the 
g-g interface.  Helices 1 and 2 were given c-position glutamates and helices 3 and 4 were given 
lysines, as depicted in Figure 2.7.  As a result, each of the five alternative helix threading 
topologies that are possible given the short loops have helix-helix interactions that destabilize 
them relative to the intended helix topology.  In order to prevent the c-position charged 
residues from being steered away from their intended hydrogen bonding partners, b- and f-
position surface-exposed residues were made uncharged polar amino acids.  There is really only 
one polar, uncharged amino acid with a reasonably high helical propensity, and that is glutamine 
(43).  The decision to include many glutamine residues on the exterior of MZH3 along with c-
position charged residues gives it an exterior that is very similar to the porphyrin array 
maquettes from the DeGrado group (25, 26, 44). 
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Figure 2.7: Negative design of MZH3 
Possible four-helix bundle conformations are viewed from the heme-binding end.  The helix 
number of each helix is given along with which end (N- or C-terminus) is facing the viewer.  
Thick black arcs represent connecting inter-helical loops on side facing viewer, and thin black 
dotted arcs represent inter-helical loops on far end of maquette.  The circled + and – symbols 
stand for charged c-position lysine and glutamate residues, respectively.  Green dotted lines 
represent charge pairing interactions, and large red X’s represent charge clashes.  Small red 
X’s symbolize that the leucine zipper-like interaction of g-position leucines is disrupted. 
 
 This careful approach to the design of a four-helix bundle leans heavily upon specific 
examples of natural and de novo designed proteins in the literature.  Can the many disparate 
lessons learned from all of these studies be integrated into a single design of a new protein?  Or 
does each protein have such important nuances in its structure that takeaway messages from 
studies of other proteins cannot be relied upon to produce general rules for four-helix bundle 
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design?  In order to evaluate the effectiveness this approach, the next section will describe the 
expression and routine characterization of MZH3.  
 
2.3 Routine characterization of MZH3 
 In order to determine whether the design of MZH3 succeeded in creating a stable, 
folded protein maquette with the intended functions, MZH3 was subjected to a battery of 
routine tests.  These included size exclusion chromatography to check the oligomeric state, 
ultraviolet/visible spectroscopy to measure cofactor binding, circular dichroism to test the 
stability, and redox titration to measure midpoint potentials.  Methods for each technique are 
described in the appendix. 
 
2.3.1  Size exclusion chromatography 
 Size exclusion chromatography (SEC) was used to determine the oligomerization state of 
MZH3.  A mixture of monomeric and oligomeric MZH3 was observed after overexpression in E. 
coli, purification by Ni-NTA affinity chromatography, and cleavage of the His6 tag by TEV 
protease (Figure 2.8, panel A).  Addition of stoichiometric heme B or 4-fold excess ZnSO4 to 
MZH3 injectant solution was not found to significantly affect the elution profile (data not 
shown).  Monomeric and oligomeric MZH3 were collected and stored at 4°C overnight.  To 
determine whether MZH3 monomers and oligomers rapidly interconvert, the samples were 
injected onto the SEC column again the next day (Figure 2.8, panels C and D).  The 
chromatograms show that monomers remained monomeric and oligomers remained 
oligomeric.  Oligomers can be converted to monomers by denaturing with 6.5 M GdnHCl and 
refolding by dilution. 
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 To verify that the putative oligomeric MZH3 eluates were composed of MZH3 and not a 
higher molecular weight contaminant, samples from SEC fractions (labeled at the bottom of 
Figure 2.8A) were run in an SDS-PAGE gel, which denatures proteins so that they run as 
  
 
  
Figure 2.8: Size exclusion chromatography elution profiles of MZH3 
(A) Chromatogram for initial SEC injection, with fraction numbers given at bottom.   Fractions 
were collected separately and stored overnight at 4°C.  (B) SDS-PAGE gel on SEC eluates from 
panel (A).  Molecular weights of ladder bands are given at left in kDa.  Well numbers given at 
the top of each well correspond to fraction numbers from SEC chromatogram in panel (A).  
After 1 day, (C) monomeric fraction was injected again, followed by (D) oligomeric fraction.  
Blue, red, and pink lines represent absorbance at indicated wavelengths vs. elution volume 
(mL).  Running buffer was 50 mM NaCl, 10 mM MOPS buffer, pH 7.   
(C) (D) 
dimers 
trimers 
Larger 
oligomers 
monomers 
monomers 
dimers 
trimers 
larger 
oligomers 
(A) (B) 
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monomers (Figure 2.8B).  SDS-PAGE showed that a single band at ~22 kDa was present in all SEC 
fractions that had light-absorbing eluates, demonstrating that MZH3 (which has a molecular 
weight of 22.5 kDa) was present in each elution peak of the SEC column.  No other significant 
bands were observed in SDS-PAGE. 
MZH3 was designed to have a rod-like cylindrical shape with a diameter of about 2 nm 
and a length of about 7 nm, but roughly spherical globular proteins were used to standardize 
the size exclusion column.  Given that SEC columns separate proteins based on Stokes radius 
rather than molecular weight (45), the rod-like shape of MZH3 is expected to decrease its 
elution volume relative to spherical proteins of the same molecular weight.  This effect is 
observed for monomeric, dimeric, and trimeric states of MZH3, as shown in Figure 2.9. 
 
2.3.2  Ultraviolet/visible spectroscopy 
 Tetrapyrroles are strong absorbers of ultraviolet and visible light, and their absorption 
spectra are sensitive to their environments.  Ligation of the central metal ion of a 
 
Figure 2.9: Size exclusion 
chromatography calibration 
curves 
Blue: calibration curve for 
the XK 16/70 column (GE 
Healthcare Life Sciences) 
packed with 110 mL of 
Superdex 75 prep grade gel 
filtration medium (GE 
Healthcare Life Sciences).  
Red: MZH3 peak positions 
on same column for 
monomers, dimers, and 
trimers.  Running buffer was 
50 mM NaCl, 10 mM MOPS 
buffer, pH 7.5. 
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metallotetrapyrrole by ligating amino acids such as histidine can trigger a pronounced band shift 
that can be used to monitor binding by ultraviolet/visible spectroscopy (UV/vis). 
 Overexpression of MZH3 in E. coli 
results in a red cell pellet, suggesting that 
MZH3 overexpression increases heme B 
biosynthesis.  The red color of the sample 
persists during purification of MZH3 by 
Ni-NTA column chromatography, His-tag 
cleavage by TEV protease, and SEC.  After 
purification, MZH3 is found to contain 
approximately 0.1 equivalents of heme B 
per mole of MZH3, as estimated from the UV/vis spectra (Figure 2.10).  When necessary, heme 
can be removed by high-performance liquid chromatography (HPLC) or by denaturation and 
washing with 2-butanone (46). 
 In the spectroscopic titrations presented below, cofactor solutions were titrated into 
protein solutions.  Absorbance values at a selected wavelength were fitted to Equation 2.1, a 
one-site binding equation that relates the cofactor concentration c (the independent variable), 
absorbance A (the dependent variable), and four parameters: the total protein concentration P, 
the extinction coefficient of the cofactor bound to the protein εb, the extinction coefficient of 
the unbound cofactor εu, and the dissociation constant KD: 
𝐴 = 𝑐 ∙ 𝜀𝑢 +
(𝜀𝑏 − 𝜀𝑢) ∙ [(𝐾𝐷 + 𝑃 + 𝑐) − √(𝐾𝐷 + 𝑃 + 𝑐)2 − 4 ∙ 𝑃 ∙ 𝑐]
2
 
Equation 2.1 
 
 
 
Figure 2.10: Heme binding by MZH3 in vivo 
Spectrum of MZH3 after overexpression and 
purification, but before addition of heme B.  The 
peak at 280 nm is due to absorbance of Trp and 
Tyr residues, and the peak at 415 nm is the Soret 
band of heme B.  Conditions: 150mM NaCl, 6 mM 
phosphate buffer, pH 7.4. 
83 
 
2.3.3  UV/vis spectroscopy: Acceptor site 
 High-affinity binding of ferric heme B by MZH3 was demonstrated by UV/vis titration.  
The absorbance spectrum of MZH3 in complex with ferric heme has a Soret band at 415 nm with 
an extinction coefficient of 115,000 M−1cm−1 and broad Q bands at about 534 nm and 566 nm.  
This is similar to the yeast cytochrome b absorbance features which include a Soret band at 416 
nm with an extinction coefficient of about 120,000 M−1cm−1 (47).  Heme B is not soluble in 
aqueous solutions, so the unbound heme B spectrum is easily distinguished from the bound 
spectrum.  Unbound heme B has broadened bands with significantly decreased extinction 
coefficients at the peaks.  Fitting the absorbance of the Soret band at 415 nm vs. heme B 
concentration to Equation 2.1 gives a dissociation constant of less than 10 nM, which is near the 
resolution limit for the procedure (see Figure 2.11).  This ferric heme B dissociation constant is 
very close to that of the natural soluble four-helix bundle hemoprotein cytochrome b562, which 
is estimated at about 9 nM (48), although some other natural hemoproteins have much higher 
affinities (35). 
 
Figure 2.11: Heme B 
binding titration 
UV/vis binding titration 
of ferric heme B into 1.2 
µM MZH3.  The 
structure of heme is 
shown at upper left and 
the spectrum at 0.8 
equivalents of heme B 
per MZH3 is shown at 
beneath the curve.  The 
schematic at right shows 
where heme B is 
expected to bind.  
Conditions: 10 mM 
Na2HPO4, 15 mM NaCl, 
pH 7. 
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A measurement of the reduced, ferrous heme B spectrum was made by adding 
dithionite to a solution of MZH3 with ferric heme B (Figure 2.12).  The dithionite absorbance 
peak centered at 319 nm may interfere with the estimation of the Soret extinction coefficient in 
the reduced state, but it is about 160,000 M−1cm−1 at 430 nm. 
 
Replacement of the iron ion of heme B with cobalt gives cobalt protoporphyrin IX 
(CoPPIX), which is stable to oxygen in the Co(III) (cobaltic) state.  CoPPIX is interesting as a 
potential electron acceptor because reduced cobalt tetrapyrroles are capable of proton 
reduction (49, 50).  Co(III)PPIX does not have the pronounced spectral difference between the 
bound and unbound states that heme B has in aqueous solutions, partly because CoPPIX is more 
soluble.  As a result, fitting the absorbance of the Soret band vs. CoPPIX concentration is 
difficult, because the curve is almost a straight line.  However, the absorbance difference 
between 426 and 419 nm vs. CoPPIX concentration has a much sharper change in slope around 
1.0 equivalent of cofactor per protein, allowing curve fitting with Equation 2.1 (see Figure 2.13).  
 
Figure 2.12: Heme B 
spectra in MZH3 
Ferric heme B (red) and 
ferrous heme B (blue) 
spectra in MZH3.  
Ferrous spectrum was 
prepared by reduction 
with dithionite 
compared.  Peak at 319 
nm is due to excess 
dithionite.  Conditions: 8 
μM MZH3 with 1 
equivalent of heme B, 
15mM NaCl, 10mM 
phosphate buffer, pH7. 
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The result of this fit was a dissociation constant of approximately 250 nM and an extinction 
coefficient of 220,000 M−1cm−1 for the Soret band at 426 nm in the MZH3-bound state.  The 
estimated extinction coefficient of the Soret maximum for unbound Co(III)PPIX was 190,000 
M−1cm−1, in agreement with previous work that found a value of 170,000 M−1cm−1 under similar 
conditions (49).  The dissociation constant of 250 nM of MZH3 for Co(III)PPIX is about 25 times 
weaker than it is for heme B, but 35-fold stronger than the Co(III)PPIX affinity of cytochrome b562 
of 8.9 µM (49). 
 
Another iron tetrapyrrole with a structure similar to heme B is Fe(III) 2,4-diacetyl 
deuteroporphyrin IX (Fe-DADPIX), and it binds to MZH3 with a KD of less than 10 nM, similar to 
heme B (Figure 2.14).  Fe-DADPIX is similar in structure to heme B, but it has a higher 
electrochemical midpoint potential and red-shifted absorption bands relative to heme B.  Its 
Soret maximum in MZH3 is about 90,000 M−1cm−1 at 431 nm. 
 
 
Figure 2.13: CoPPIX 
binding titration to MZH3 
UV/vis binding titration of 
Co(III)PPIX into 0.9 µM 
MZH3.  The structure of 
Co(III)PPIX is shown above 
the curve and the 
spectrum at 0.8 
equivalents of Co(III)PPIX 
per MZH3 is shown 
beneath the curve.  
Schematic of where 
CoPPIX is expected to bind 
is shown at right.  
Conditions: 10 mM MOPS, 
50 mM NaCl, pH 7. 
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Figure 2.14: Ferric DADPIX 
binding titration with 
MZH3 
UV/vis binding titration of 
Fe(III)-DADPIX into 4.4 µM 
MZH3.  The structure of 
Fe(III)-DADPIX is shown at 
upper left and the 
spectrum at 0.8 
equivalents of Fe(III)-
DADPIX per MZH3 is 
shown above the curve.  
Schematic of where Fe-
DADPIX is expected to 
bind is shown at right.  
Conditions: 50 mM NaCl, 
20 mM phosphate buffer, 
pH 7. 
 
A fourth possible electron acceptor, Fe(III) 5,10,15-tri-(p-carboxyphenyl) corrole 
(provided by Nicholas Roach from the laboratory of David Officer and referred to as PM56) 
showed no evidence of binding to MZH3 (see Table 2.3). 
These UV/vis titrations are consistent with high-affinity bis-histidine ligation of iron and 
cobalt tetrapyrroles, and the 1:1 binding stoichiometry indicates that only one site in MZH3 is 
involved in ligation of these electron accepting cofactors.  Of four cofactors tested, three bind 
tightly.  The MZH3 electron acceptor site shows some discrimination between cofactors, but its 
ability to ligate different cofactors suggests a degree of plasticity in the binding site.  This is 
similar to natural heme B proteins which can frequently bind cofactors slightly different from 
heme B (49).  It is likely that many other iron and cobalt tetrapyrroles will bind to the acceptor 
site, and, as shown in the next section, some zinc tetrapyrroles will bind to this site as well, 
although they are intended for the mono-histidine pigment site. 
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Cofactor Heme B Fe-DADPIX CoPPIX PM56 
KD < 10 nM < 10 nM ~250 nM None detected 
Soret λ 415 nm 431 nm 426 nm N/A 
Soret εb 115,000M−1cm−1 90,000 M−1cm−1 220,000 M−1cm−1 N/A 
Table 2.3: Summary of properties of tetrapyrroles tested for binding to MZH3 acceptor site 
Structures, dissociation constants (KD), Soret band wavelengths in the bound state (Soret λ), 
and Soret extinction coefficients in the bound state (Soret εb) are given. 
 
2.3.4  UV/vis spectroscopy: Pigment site 
 Zinc tetrapyrroles are useful as pigments for light-driven electron transfer, because they 
can absorb light to enter a high-energy, reducing, photo-excited state similar to chlorophyll in 
natural reaction centers (2, 38, 39).  The iron ion of iron tetrapyrroles prefers a hexacoordinate 
geometry, but zinc tetrapyrroles are stable with the zinc ion in a pentacoordinate geometry.  
This means that zinc tetrapyrroles can bind with high affinity to a binding pocket that has only 
one histidine (such as the pigment site of MZH3), but they could also bind to a pocket with two 
histidines (such as the electron acceptor site of MZH3).  For this reason, it was necessary to first 
add an electron accepting cofactor such as heme B prior to zinc tetrapyrrole titrations of MZH3 
in order to prevent the electron acceptor site from binding the zinc tetrapyrrole. 
To demonstrate the necessity of an electron acceptor to block binding of the pigment to 
the acceptor site, a zinc Newkome porphyrin (ZnNP, provided by Tatiana Esipova in the 
laboratory of Sergei Vinogradov) was titrated into an MZH3 solution (Figure 2.15: ZnNP titration 
into MZH3).  A band shift indicated binding of the ZnNP to MZH3.  Using Equation 2.1, the 
binding stoichiometry appeared to be roughly 3.75 ZnNP molecules per protein.  Cofactors at 
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different sites in the protein could have slightly different spectra, but this method can still give a 
rough estimate of binding affinities, assuming the spectra are similar.  The dissociation constant 
was estimated at about 20 nM. 
 
 This titration was repeated in the presence of 1.0 equivalent of heme B per MZH3 
protein (Figure 2.16).  The dissociation constant for ZnNP was estimated at about 70 nM, and 
the binding stoichiometry appeared to be 1:1, suggesting that ZnNP binds to the pigment site 
and nowhere else in the protein when heme B is present. 
 
Figure 2.15: ZnNP titration 
into MZH3 
UV/vis binding titration of 
ZnNP into 0.51 µM MZH3 in 
the absence of an electron 
acceptor cofactor.  The 
structure of ZnNP and the 
spectrum at 0.8 equivalents 
of ZnNP per MZH3 are 
shown beneath the curve.  
Schematic of where ZnNP is 
expected to bind is shown at 
right.  Conditions: 15 mM 
NaCl, 10 mM phosphate 
buffer, pH 7. 
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 Other titrations were performed with heme B and other zinc tetrapyrroles.  Of special 
interest was Zn 5-phenyl-15-(p-carboxyphenyl) porphyrin (ZnPCP), which bound with a 1:1 
stoichiometry and dissociation constant of <10 nM at pH 6.5 in the presence of 1.0 equivalent of 
heme B and 1.5 mM ZnCl2 (Figure 2.17).  ZnPCP was subsequently used for crystallography and 
transient absorption spectroscopy experiments. 
 
Figure 2.16: Binding titration of 
ZnNP into MZH3/Heme 
UV/vis binding titration of ZnNP 
into 1.0 µM MZH3 in the 
presence of 1.0 equivalent of 
heme B per protein.  The 
structure of ZnNP and the 
spectrum at 0.8 equivalents of 
ZnNP per MZH3 are shown 
beneath the curve.  The dotted 
line is the initial spectrum with 
heme B, before addition of ZnNP.  
Schematic of where ZnNP is 
expected to bind is shown at 
right.  Conditions: 15 mM NaCl, 
10 mM phosphate buffer, pH 7. 
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 Synthetic zinc tetrapyrroles were prepared by collaborators following methods 
described previously (5, 51).  The zinc porphyrins ZnNP, ZnPCP, TE312, and TE394, TE400, and 
TE400b were synthesized by Tatiana Esipova in the laboratory of Sergei Vinogradov following 
methods described previously.  NR117 was provided by Nicholas Roach and the laboratory of 
David Officer.  The zinc chlorins SE370 and SE375 were synthesized in the laboratory of Jonathan 
Lindsey.  Other tetrapyrroles were purchased from Frontier Scientific.  A list of zinc tetrapyrroles 
that bind MZH3 with high affinity when an acceptor cofactor is present is shown in Table 2.4, 
and those with low affinity are shown in Table 2.5. 
 
 
 
 
Figure 2.17: ZnPCP titration 
into MZH3/Heme/Zn(II) 
UV/vis binding titration of 
ZnPCP into 1.2 µM MZH3 in 
the presence of 1.0 
equivalent of heme B per 
protein.  The structure of 
ZnPCP is shown above the 
curve, and the spectrum at 
0.8 equivalents of ZnPCP per 
MZH3 is shown beneath the 
curve.  The dotted line is the 
initial spectrum with heme B, 
before addition of ZnPCP.  
Schematic of where ZnPCP is 
expected to bind is shown at 
right.  Conditions: 15 mM 
NaCl, 1.5 mM ZnCl2, 10 mM 
PIPES buffer, pH 6.5. 
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Pigment 
name 
Pigment structure Acceptor 
cofactor 
Metal Stochio-
metry 
Binding 
ZnNP 
 
none − ~3.75 ~20 nM 
average 
Heme B − 1 ~70 nM 
CoPPIX − 1 ~50 nM 
Heme B Co(II) 1 ~50 nM 
ZnPCP 
 
Heme B Zn(II) 1 < 10 nM 
SE370 
 
Heme B − 1 ~30 nM 
SE375 
 
Heme B − 1 ~70 nM 
NR117 
 
Heme B − incon- 
clusive 
~30 nM 
ZnC 
 
Heme B − incon- 
clusive 
~100 nM 
Heme B Co(II) 1 ~200-500 
nM 
TE312 
 
Heme B Zn(II) n.d. band shift 
observed, 
KD was not 
measured 
TE394 
 
Heme B − n.d. band shift 
observed, 
KD was not 
measured 
Table 2.4: Zinc tetrapyrroles that bind to MZH3/Heme with high affinity 
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Pigment 
name 
Pigment structure Acceptor 
cofactor 
Metal Stochio-
metry 
Binding 
ZnPPIX 
 
Heme B 
 
Zn(II) 1 ~2 µM 
ZnMPIX 
 
Heme B − 0 not 
detected 
ZnCe6 
 
Heme B − 0 not 
detected 
TE400 
 
Heme B − 0 not 
detected 
TE400b 
 
Heme B − 0 not 
detected 
ZnTCP 
 
Heme B − incon-
clusive 
~5 µM 
ZnTPP 
 
Heme B − 0 not 
detected 
ZnDPDP 
 
Heme B − 0 not 
detected 
Table 2.5: Zinc tetrapyrroles that do not bind to MZH3/Heme with high affinity 
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 The tests of zinc tetrapyrrole affinity for the MZH3 pigment site summarized in Table 2.4 
and Table 2.5 reveal a pattern of selectivity for zinc tetrapyrroles with particular structural 
attributes.  Consideration of the potential for steric clashes and burial of polar groups can help 
predict what zinc tetrapyrrole structures will bind to the pigment site of MZH3.  The pigment 
binding cavity in the center of the maquette is a deep, narrow slit that stretches across the 
width of the four-helix bundle and is lined with tightly packed hydrophobic residues in layers 
above and below the ligating histidine.  It cannot expand enough to accommodate the bulk of 
meso-tetraphenyl porphyrins (ZnTCP, ZnTPP, and ZnDPDP), and tetrapyrroles with carboxylate 
groups too close to the tetrapyrrole ring may be prevented from binding because the histidine 
cannot ligate the zinc ion without burying those negative charges (ZnPPIX, ZnMPIX, ZnCe6, 
TE400, and TE400b).  This issue of charge burial is believed to have prevented binding of heme B 
and ZnPPIX to porphyrin-binding four-helix bundle maquettes that had similarly hydrophobic 
binding sites (25, 26, 31).  The most successful zinc tetrapyrrole designs have two phenyl groups 
on opposite sides of the tetrapyrrole ring and lack bulky, inflexible substituents at the 10 and 20 
meso positions that are present in the low-affinity tetraphenyl ZnTCP, ZnTPP, and ZnDPDP 
porphyrins.  This narrower shape of the 5,15-diphenyl porphyrin better complements the shape 
of the binding cleft.  The successful zinc tetrapyrroles also typically have polar groups in para 
positions on the phenyl rings.  These polar groups might not increase the stability of the MZH3-
zinc tetrapyrrole interaction, but they are likely to destabilize aggregates of zinc tetrapyrroles 
that might otherwise sequester the cofactor and prevent binding to MZH3, as is likely the case 
for the somewhat lower affinity ZnC, which has low solubility in aqueous solutions.   
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2.3.5  UV/vis spectroscopy: Donor site 
Unlike tetrapyrroles, transition metal dications in proteins are weak absorbers of visible 
light and are not usually suitable for UV/vis spectroscopic titrations.  A Co(II) ion bound to a 
protein has a maximum extinction coefficient of about one thousandth that of a typical 
tetrapyrrole, but this is still significantly greater than the absorbance of most other transition 
metals.  Co(II) also has the advantage of having an absorbance spectrum that is highly sensitive 
to its coordination number, allowing UV/vis titrations to yield information on both binding 
affinity and ligation state.  Extinction coefficients for Co(II) typically range from approximately 
10-20 M−1cm−1 for 4-coordinate, 100-150 M−1cm−1 for 5-coordinate, and 400-600 M−1cm−1 for 6-
coordinate complexes (52). 
Co(II) binding to MZH3 was tested by a UV/vis titration of Co(NO3)2 into a solution of 34 
µM MZH3 in a 10 cm (Figure 2.18).  The result was a stoichiometry of two Co(II) ions per protein 
with an extinction coefficient of 90 M−1cm−1 per Co(II) ion at 545 nm and an average dissociation 
constant of about 3.3 μM at pH 7.3.  For comparison, DF3 has a Co(II) extinction coefficient of 98 
M−1cm−1 at 548 nm and an average dissociation constant of about 240 nM at pH 7 (22).  Another 
Due Ferro maquette, DFsc, has an extinction coefficient of 136 M−1cm−1 at 550 nm and an 
average dissociation constant of about 160 μM at pH 6 (53).  The natural diiron protein 
bacterioferritin has an extinction coefficient of 155 M−1cm−1 at 548 nm and an average 
dissociation constant of about 10 μM in the absence of heme B at pH 7.1 (54).  The Co(II) 
affinities are similar to Mn(II) affinities in most Due Ferro maquettes (22, 40, 55).  The Co(II) 
titration shows that MZH3 has a penta-coordinate binding site similar to the Co(II) binding 
properties of other di-metal proteins. 
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2.3.6  Ferroxidase activity 
Natural diiron proteins and the Due Ferro series of de novo proteins catalyze ferroxidase 
activity, wherein a diferrous center reacts with oxygen to produce an oxo-bridged diferric site 
with a characteristic ligand-to-metal charge transfer (LMCT) band around 300 nm.  As expected, 
MZH3 catalyzes this reaction as well.  Figure 2.19 shows the absorbance at 300 nm of an 
anaerobic sample of 30 μM MZH3 in complex with stoichiometric iron chloride.  At time t=0, the 
anaerobic sample was exposed to ambient oxygen, triggering a rapid conversion to the differic 
species with a lifetime of roughly 3.6 minutes for the transition.  The inset spectra show the rise 
of the LMCT band with time.  The extinction coefficient for the diferric state at 300 nm is 3400 
M−1cm−1, which agrees with the values for DF2 and bacterioferritin of 3240 M−1cm−1 and 3380 
M−1cm−1, respectively (55, 56).  Iron oxidation in MZH3 is reversible, as it is in DF3 (21).  
Reduction of MZH3-Fe(III)2 by dithionite eliminated the LMCT band and subsequent air oxidation 
regenerated it. 
 
Figure 2.18: Co(II) 
binding titration with 
MZH3. 
UV/vis binding titration 
of Co(NO3)2 into 33.7 
µM MZH3 in 10 cm path 
length cuvette.  The 
spectrum at 1.8 
equivalents of Co(II) per 
MZH3 is shown beneath 
the curve.  Schematic of 
where Co(II) is expected 
to bind is shown at 
right.  Conditions: 150 
mM KCl, 100 mM MOPS 
buffer, pH 7.3. 
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In DF3, ferroxidase activity appears to give rise to a tyrosinate-Fe(III) ligation, as 
evidenced by a putative tyrosinate-to-Fe(III) LMCT transition with an extinction coefficient of 
1,200 M−1cm−1 at 500 nm (22).  In contrast, MZH3 lacks a distinct absorbance feature in this 
region and has only a 200 M−1cm−1 extinction coefficient at 500 nm, probably due to the broad 
absorbance of the oxo-to-Fe(III) charge transfer band or a small amount of Rayleigh scattering.  
The absence of a tyrosinate-Fe(III) in MZH3 may be because one of the tyrosine residues is 
replaced with leucine and because the increased stability of MZH3 prevents the structural 
rearrangement that would allow the other tyrosine to ligate the iron. 
 
2.3.7  Circular dichroism to assay secondary structure 
At 25°C under low salt conditions at pH 7, the mean molar ellipticity per residue at 222 
nm, [θMMR]222, of apo-MZH3 was −29,000 deg cm2 dmol−1 res−1 (see Figure 2.20 and Table 2.6).  
The shape of the curve and the intensity of [θMMR]222 are consistent with high α-helical content 
(57).  In addition, the ratio of [θMMR]222/[θMMR]208 of 1.09 is high, which is consistent with a coiled 
coil structure (4, 58-60).  The addition of 33 µM MnCl2 to 15.2 µM MZH3 (~2 molar equivalents 
of MnCl2 per MZH3 protein) increased the magnitude of [θMMR]222 and the ratio of  
 
Figure 2.19: Ferroxidase 
activity of MZH3. 
Exposure to ambient 
oxygen at time t=0 lead 
to rapid increase in LMCT 
band with lifetime of ~3.6 
minutes.  Conditions: 30 
μM MZH3, 60 μM FeCl2, 
1500 mM KCl, 50 mM 
MOPS buffer, pH 7.3. 
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 [θMMR]222/[θMMR]208, while the 
addition of 1 molar equivalent of 
heme B to 20.3 µM MZH3 
lowered the magnitude of 
[θMMR]222 and the ratio of 
[θMMR]222/[θMMR]208 (see Table 2.6).  
Heme binding has a similar effect 
on [θMMR]222 in DDH2, a truncated 
version of MZH3 that binds two hemes B and lacks a metal binding site, as discussed in detail in 
section 2.4.  This suggests that the decrease of [θMMR]222 is caused by the effect of heme on 
nearby helices rather than a long-range effect on the metal-binding section of the protein. 
The effect of heme B binding in MZH3 appears to be a decrease in helicity and an 
increase in thermal stability.  While it is common for the melting temperature to increase upon 
heme binding, the decrease in [θMMR]222 sets MZH3 apart from the behavior of other helical 
porphyrin-binding proteins.  As described in the introduction, natural hemoproteins are usually 
unstable in the apo-state, and finish folding once heme is bound (34, 35).  Designed porphyrin-
binding proteins follow this pattern as well, showing increased ellipticity at 222 nm (26, 31, 61-
63).  For example, myoglobin has an apo-state [θMMR]222 that is only 70% of the magnitude in the 
holo-state (64, 65).  In one exception, an iron porphyrin-binding maquette with a highly stable 
apo-state (similar to MZH3) showed a small decrease in [θMMR]222 upon porphyrin binding, but 
the authors attributed this to transitions of the synthetic porphyrin itself, rather than helical 
content (44).  The decrease in [θMMR]222 upon heme binding by MZH3 cannot be attributed to 
dichroic absorption of the heme B cofactor itself, as its contribution to the CD signal at 222 nm is  
Cofactor 
added to 
MZH3 
[θMMR]222 (deg cm2 
dmol−1 res−1) 
[θMMR]222/
[θMMR]208 
TM (°C) 
Apo −29,000 1.09 82 
1 eq. heme B −19,400 1.04 94 
2 eq. Mn(II) −31,900 1.12 >100 
3 eq. Ca(II) n.d. 1.11 90 
Table 2.6: MZH3 circular dichroism measurements 
All samples contained 15 mM NaCl and 10 mM NaH2PO4 
at pH 7.  MZH3 concentration for each sample were 16.8 
μM (apo), 15.2 μM (MnCl2), 20.3 μM (Heme), and ~16 μM 
(CaCl2). 
98 
 
negligible (57, 66, 67).  The 
total fraction of residues that 
have a helical conformation 
accounts for much of the 
observed value of [θMMR]222, 
but [θMMR]222 is also influenced 
by subtle variations of α-
helical structure such as 
lengths of the helices, 
dynamical motion of the 
protein, and the precise 
conformation of helical 
residues (68).  It is not 
inconceivable, then, that heme 
binding influences the 
structure of MZH3 in such a 
way that [θMMR]222 decreases 
significantly, but the total helix 
content remains similar to the 
apo-state.  However, the loss 
of ellipticity upon heme binding is consistent with a disruption of core packing by heme binding, 
which might mean that heme affinity could be further improved by reengineering the heme site 
to make it less stable in the apo-state so that MZH3 is more like natural apo-hemoproteins. 
  
 
Figure 2.20: Circular dichroism measurements of MZH3 
A: Far UV CD spectra at 25°C.  B: Melting curves estimated 
from [θMMR]222 signal.  Black curves at apo-MZH3, blue curves 
are have two equivalents of MnCl2 per protein, red curves 
have one equivalent of heme B per protein, and orange 
curve is 3 equivalents of CaCl2 per protein.  All samples 
contained 15 mM NaCl and 10 mM NaH2PO4 at pH 7. 
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The decrease in [θMMR]222 could be explained if estimates of extinction coefficients were 
inaccurate, since the apo-MZH3 and heme-MZH3 concentrations were estimated by measuring 
different absorption features.  However, the extinction coefficient for the heme B Soret band at 
415 nm was determined from UV/vis titrations in which MZH3 concentration was determined 
from Trp and Tyr absorbance at 280 nm.  These titrations showed a heme B stoichiometry of 
precisely 1.0, demonstrating consistency between concentration estimates based on the two 
absorption features.  In addition, an error in extinction coefficients would not explain the 
significant decrease in [θMMR]222/[θMMR]208 ratio that results from heme binding. 
 Melting curves demonstrate that Mn(II) binds to MZH3 more tightly than Ca(II), which is 
expected from typical stabilities of Mn(II) and Ca(II) complexes (69).  It is surprising that Mn(II) 
binding has a significantly greater stabilizing effect on MZH3 than the binding of heme B.  
Cytochrome b562, which has a ferric heme B affinity similar to MZH3, increases in stability by ~15 
kJ mol−1 upon binding of ferric heme B (35, 70).  In DF3, Zn(II) binding stabilizes the protein by 
43.5 kJ mol−1, but Mn(II) only increases the stability by 12.1 kJ mol−1 (22).  This is consistent with 
the Irving-Williams series, which predicts metal complex stabilities to follow the trend Mn(II) < 
Fe(II) < Co(II) < Ni(II) < Cu(II) > Zn(II), where Zn(II) affinities are generally high and close to Cu(II) 
(69).  Given the similarities between MZH3 and these proteins, it should follow that heme B is 
more stabilizing than Mn(II), but the thermal melts show that the reverse is true.  The 
pronounced difference between the stabilities of MZH3-Mn(II)2 and MZH3-heme B could be due 
to an unexpected high Mn(II) affinity, but it is more likely that in the apo-state of MZH3, the Due 
Ferro section of the protein is less stable than the heme binding section.  This would mean that 
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the stabilizing effect of heme B is applied primarily to a region of the maquette that is already 
stable, while Mn(II) increases the helicity of a more dynamic part of MZH3. 
 
2.3.8  Circular dichroism in Soret region to assay exciton coupling 
 If a chromophore is either chiral, covalently bonded to a chiral center, or located in an 
asymmetric environment, then it is optically active and capable of producing a CD signal at 
wavelengths where normal absorption occurs.  CD signals come from the interaction between 
transition dipoles of a chromophore and other transition dipoles in the molecule.  If two 
chromophore transitions are close to degenerate, excitation of one chromophore can be 
delocalized across both chromophores through exciton coupling, creating a sigmoidal CD signal 
centered at the absorption maximum of the transition (71).  Exciton coupling has been observed 
between the hemes of cytochrome b (47, 72) and cytochrome bd (73) and between 
bacteriochlorophylls of the bacterial light-harvesting antenna complex LH2 (74, 75).  The 
phenomenon has been used in de novo proteins that bind two synthetic metalloporphyrins in 
order to determine whether the porphyrins bind in a cooperative manner (31). 
CD spectra in the Soret region of MZH3 in complexes with heme B and ZnNP 
demonstrate that both ZnNP and Heme B are bound to MZH3 at the same time.  Figure 2.21A 
shows weak CD signals when only one heme B or only one ZnNP is bound to the protein.  Based 
on comparison to spectra of myoglobin and hemoglobin, these signals may be due to coupled 
oscillator interactions between the porphyrin and aromatic amino acids, the polypeptide 
backbone, or alkyl side chains (76).  In contrast, Figure 2.21B shows that the addition of both 
heme and ZnNP or two ZnNP molecules results in CD signals more than an order of magnitude 
larger than the signal due to heme by itself, and about double the magnitude of the ZnNP by 
101 
 
itself.  Such an amplification of the CD signal is expected for exciton coupling between two 
porphyrins with similar excitation energies bound close together in the same protein (72, 73).   
 
 
Figure 2.21: Exciton coupling effects of MZH3 with heme B and ZnNP by circular dichroism 
(A) MZH3 spectra with only one porphyrin.  Red trace: 5.2 μM MZH3 with 1 equivalent of 
ferric heme B per bundle, 1 cm path length.  Blue trace: 5.2 μM MZH3 with 1 eq. ferrous 
heme (reduced with sodium dithionite), 1 cm path length.  Green trace: 23 μM MZH3 with 19 
μM ZnNP (0.83 eq.), 0.1 cm path length.  Orange trace: 31 μM ZnNP, no protein, 0.1 cm path 
length.  (B) MZH3 spectra with two porphyrins.  Red trace: 33 μM MZH3 with 1.0 eq. ferric 
heme and 1.0 eq ZnNP, 0.1 cm path length.  Blue trace: 33 μM MZH3 with 1.0 eq. ferrous 
heme (reduced by sodium dithionite) and 1.0 eq ZnNP, 0.1 cm path length.  Green trace: 23 
μM MZH3 with 42 μM ZnNP (1.83 eq.), 0.1 cm path length.  All data sets were collected in 15 
mM NaCl, 10 mM phosphate buffer, pH 7.  
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Since the heme Soret bands at 415 nm in the oxidized state and 430 nm in the reduced 
state are very close to the ZnNP Soret band at about 423 nm, there is significant exciton 
coupling, giving rise to the observed intense CD bands.  Indeed, the expected ~25-45° dihedral 
angle between the bound porphyrin planes at the two sites will tend to enhance CD excitonic 
coupling signals (72). 
 
2.3.9  Heme B Redox titration 
 A rate of electron transfer depends partly on the driving force of the reaction, which is 
determined from the difference between the midpoint potentials of the cofactors involved in 
the reaction.  The midpoint potential of a cofactor is the potential at which half of it is oxidized 
and half is reduced.  The Nernst equation can be used to relate the midpoint potential of a redox 
center Em, the potential of the solution measured with the standard hydrogen electrode Eh, the 
number of electrons transferred in the reaction n, the ratio of the concentrations of oxidized to 
reduced cofactor [ox]/[red], the universal gas constant R, temperature T, and Faraday’s constant 
F (77):  
𝐸ℎ = 𝐸𝑚 +
𝑅𝑇
𝑛𝐹
∙ 𝑙𝑛 (
[𝑜𝑥]
[𝑟𝑒𝑑]
) 
Equation 2.2 
 
At room temperature, this equation reduces to following, where Eh and Em are in volts: 
𝐸ℎ = 𝐸𝑚 +
0.059
𝑛
∙ 𝑙𝑜𝑔 (
[𝑜𝑥]
[𝑟𝑒𝑑]
) 
Equation 2.3 
 
A redox titration was used to determine the midpoint potential of heme B in MZH3 at 
pH 7 following procedures described previously (77, 78).  Details are given in the Appendix.  The 
relative concentrations of oxidized and reduced heme were monitored by UV/vis spectroscopy 
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of the Q-band region of the heme absorption spectrum.  Increases in the absorbance difference 
between 560 nm and 545 nm compared to the initial oxidized spectrum were proportional to 
the total concentration of reduced heme, allowing absorbance changes to be fitted to the 
Nernst equation (Figure 2.22).  The reducing and oxidizing curves were fitted with Em values of 
−184 mV and −168 mV, respectively, which are the same within error, so no significant 
hysteresis is apparent.  The fitted n values were both within 7% of 1.0, consistent with the 
expected one-electron transition from ferric to ferrous heme B. 
 
Figure 2.22: Redox titration 
of heme B bound to MZH3 
Titration was done at pH 
7.0 in reducing (black) and 
oxidizing (red) directions.  
Inset: absorbance spectra 
of Q band region of MZH3-
heme B in reduced (blue) 
and oxidized (red) states. 
 
 This midpoint potential of -180 mV for heme B in MZH3 is not unusual for a four-helix 
bundle maquette.  Midpoints of bis-histidine-ligated heme B in maquettes have ranged from 
−260 mV to −150 mV (79).  Generally, potentials are higher when the heme is more buried.  
 
2.4 DDH2: A truncated version of MZH3 that binds two hemes 
MZH3 is essentially the joining of a well-described di-metal binding de novo maquette, 
Due Ferro, to a newly-designed and uncharacterized cytochrome b-like maquette that binds two 
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metallotetrapyrroles.  Because the cytochrome b-like section of MZH3 has not been studied as 
an independent protein previously, it is difficult to compare it to other successful di-heme four-
helix bundle maquettes such as BT6 (2), a di-heme binding homotetramer (62), a cytochrome b-
like template-assembled synthetic protein (TASP) (61), a series of porphyrin array (PA) proteins 
developed by the DeGrado group (25, 26, 31), and combinatorially designed heme proteins from 
the Hecht group (80). 
To ascertain whether the cytochrome b-like section of MZH3 remains functional in the 
absence of the di-metal Due Ferro section, a shortened di-heme maquette based on the 
sequence of MZH3, DDH2 (“Diagonal Di-Heme”), was expressed in E. coli with an N-terminal His6 
tag and TEV cleavage site.  DDH2 is as similar in sequence to MZH3 as possible, except at the 
ends of the helices where DDH2 has helix caps and loops in place of helices that continue 
through the Due Ferro section of the protein.  In addition, the pigment site of MZH3 becomes a 
second heme binding site in DDH2.  Two a-position glycines in MZH3 were change to alanines, 
because the helices are expected to be relatively flexible in that region of DDH2.  DDH2 is 135 
amino acids long with a molecular weight of 14.99 kDa in the apo-state, an extinction coefficient 
of 11,000 M−1cm−1 at 280 nm due to two tryptophan residues, and a theoretical isoelectric point 
of 6.1, as estimated using the ExPASy ProtParam server (81).  The sequence of DDH2 is given in 
below: 
 
GGSPELRQEHQQLAQEFQQLLQEHQQLARELGGSGGDPAEELQQTGQEAQQLLQELQQTGQELWQLGGS
GGPELRQKHQQLAQKIQQLLQKHQQLARKLGGSGGDPAEKLQQTGQKAQQLVQKLQQTGQKLWQLG 
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A more informative layout of the sequence of DDH2 for comparison to the original 
MZH3 sequence is given in Table 2.7: 
heptad 
positions 
(N)Forward: efgabcdefgabcdefgabcdefgabcdefgabcdefgabcdef        (C) 
(C)Reverse: gfedcbagfedcbagfedcbagfedcbagfedcbagfedcbagf        (N) 
MZH3 
“snaked” 
sequence 
(N-term) →GSPELRQEHQQLAQEFQQLLQEIQQLGRELLKGELQGIKQLREASEK ARN → (C) 
(C) ← GGSGG LQWLEQGTQQLEQLLQQAEQGTQQLTELLEIHKEEDELIKQLVSKKEP  ← (N)  
(N) →       PELRQKHQQLAQKIQQLLQKHQQLGAKILEDEEKHIELLETIL GGSGG → (C) 
(C-term) ← GLQWLKQGTQQLKQVLQQAKQGLQQLERYQKIGQLEGKLLERLED      ← (N) 
DDH2 
“snaked” 
sequence 
(N-term)→GGSPELRQEHQQLAQEFQQLLQEHQQLAREL  GGSGG               → (C) 
(C) ← GGSGG LQWLEQGTQQLEQLLQQAEQGTQQLEEAPD                    ← (N) 
(N) →       PELRQKHQQLAQKIQQLLQKHQQLARKL  GGSGG               → (C) 
(C-term) ← GLQWLKQGTQQLKQVLQQAKQGTQQLKEAPD                    ← (N) 
Table 2.7: Amino acid sequence of DDH2 compared to MZH3 
The differences between DDH2 and MZH3 are shown in bold in the DDH2 sequence, and the 
added capping sequences of DDH2 are underlined.  Coiled coil heptad positions a through g 
are denoted in the top row for both forward (N- to C-terminus) and reverse (C- to N-terminus) 
sequences.  Residues highlighted yellow are a-position residues.  Red boxes enclose layers of 
the hydrophobic core, each of which includes two a- and two d-position residues.  The amino 
acid sequences have each helix written on a new line with loops separated from the helices by 
a space.  In the “snaked” sequences, helices 2 and 4 are written in reverse so that amino acids 
that are spatially close together in the folded protein are close together in the snaked 
sequence diagram.  The N- and C-terminal ends of each helix are denoted by the letter in 
parentheses at either end of each helix, and “N-term” and “C-term” denote termini of the 
protein.  Green amino acids belong to the cytochrome b-like tetrapyrrole binding section of 
MZH3, and blue amino acids belong to the Due Ferro-like di-metal binding section of the 
protein.   
 
2.4.1  Size exclusion chromatography 
 Size exclusion chromatography was used to assay the oligomerization state of DDH2.  
Unlike MZH3, only a single peak was detected for DDH2, consistent with a monomeric 15 kDa 
protein (Figure 2.23).  The elution peak for DDH2 puts it between the lines for the globular 
protein standards and the rod-shaped MZH3 protein (Figure 2.23, inset).  This is consistent with 
the shortened rod-like shape of DDH2 compared to MZH3. 
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Figure 2.23: Size exclusion chromatography elution profile of DDH2 
The blue line is the absorbance of the sample at 280 nm vs. elution volume.  Inset: Plot of log 
molecular weight against elution volume for DDH2 (black), globular protein standards (blue), 
and MZH3 (red). 
 
2.4.2  Ultraviolet/visible spectroscopy of DDH2 with heme B 
Overexpression of DDH2 in E. coli produced red cell pellets, as with MZH3, and after 
purification, DDH2 appeared to have roughly ~0.25 equivalents of ferric heme B per DDH2 
protein (or ~0.13 equivalents of heme B per binding site).  DDH2 was purified by HPLC to remove 
heme B that was bound during expression.  After purification by size exclusion chromatography, 
a ferric heme B binding titration was performed at pH 7.5 with 0.5 μM DDH2, as shown in Figure 
2.24.  The stoichiometry was two hemes B per DDH2 protein, as expected.  The dissociation 
constant was similar to MZH3; both maquettes bind heme B with a dissociation constant of 
about 10 nM or less.  The extinction coefficient for the Soret peak in DDH2 was 120,000 
M−1cm−1, which is similar to the value for MZH3 of 115,000 M−1cm−1. 
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Figure 2.24: Heme 
titration into DDH2 
UV/vis binding titration 
of ferric heme B into 0.5 
µM DDH2.  Inset: 
Spectrum at 0.8 
equivalents of heme B 
per MZH3.  Conditions: 
50 mM NaCl, 10 mM 
MOPS buffer, pH 7.5. 
 
2.4.3  Circular dichroism of DDH2 with heme B 
 DDH2 is highly α-helical, as demonstrated by circular dichroism (CD) spectra in Figure 
2.25, top.  The mean molar ellipticity per residue at 222 nm, [θMMR]222, in the apo-state is 
−27,900 deg cm2 dmol−1 res−1.  This ellipticity decreases progressively with the addition of heme 
B to −21,100 deg cm2 dmol−1 res−1 when two hemes are bound.  In addition, heme binding 
decreases the ratio of [θMMR] at 222 nm to 208 nm from 1.11 in the apo-state to 0.97 in the holo-
state.  This is similar to the behavior of MZH3 when it binds heme.  DDH2 also exhibits relatively 
high thermal stability, as shown in Figure 2.25, bottom.  The midpoint of unfolding in the apo-
state occurs at about 71°C, which is about 11°C lower than the melting temperature of MZH3.  
This decreased stability is not surprising given the shortened length of DDH2 and smaller 
hydrophobic core.  Like MZH3, heme binding has a stabilizing effect on the thermal unfolding 
curve, despite the decrease in [θMMR]222. 
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 Exciton coupling between hemes B in DDH2 is observed by CD, as shown in Figure 2.26.  
The addition of less than one equivalent of heme B per DDH2 protein results in a weak exciton 
coupling signal near the heme Soret (blue and green traces in Figure 2.26, top).  However, when 
more than one heme B per protein is added, a pronounced exciton coupling signal is observed.  
In Figure 2.26, top, the trace with 0.47 hemes per protein (blue) overlaps with the trace with 
0.91 hemes per protein (green), but the trace with 1.37 hemes per protein (black) has a distinct 
spectrum, which is increased with 2.0 hemes per protein (red).  (The mean molar ellipticity is 
given per heme, not per protein).  If we assume that the heme CD signal in the 2.0 hemes per 
protein spectrum (red) represents the CD spectrum for any heme in a protein with a second 
 
Figure 2.25: Far UV circular 
dichroism spectroscopy of DDH2 
Used 0.1 cm path length cuvette.  
Black curves: 32 μM apo-DDH2.  
Blue curves: 18.2 μM DDH2 with 
0.47 equivalents of heme B per 
protein.  Green curves: 20.9 μM 
DDH2 with 0.91 equivalents of 
heme.  Red curves: 18.3 μM DDH2 
with 2.0 equivalents of heme. Top: 
Far UV CD spectra of DDH2.  
Bottom: Thermal denaturation of 
DDH2.  Fraction folded is estimated 
by the decreased in measured by 
mean molar ellipticity at 222 nm 
relative to the ellipticity at 2°C. 
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heme, and the 0.91 hemes per protein spectrum (green) represents the CD spectrum for heme 
by itself in DDH2, we can predict the spectrum for 1.37 hemes per protein; at 1.37 hemes, 54% 
of the heme is in a protein where there is a second heme, and 46% is in a protein by itself.  The 
grey dotted line represents this calculated spectrum, and it overlaps with the measured 1.37 
hemes spectrum in black.  It follows that heme binds to DDH2 anti-cooperatively; a second 
heme B does not bind to DDH2 until all of the protein has one heme B bound already.  In Figure 
2.26, bottom, the 0.47 equivalents (blue) and 2.0 equivalents (red) spectra were reduced with 
dithionite (dotted lines) and compared to the oxidized spectra.  The red-shift and increased 
magnitude of exciton coupling are consistent with heme B reduction. 
 
Figure 2.26: Exciton coupling 
between hemes B in DDH2 
Measured in 1 cm path length 
cuvette.  Blue curves: 18.2 μM 
DDH2 with 0.47 equivalents of 
heme B per protein.  Green 
curves: 9.4 μM DDH2 with 0.91 
equivalents of heme.  Black 
curves: 6.6 μM DDH2 with 1.37 
equivalents of heme.  Red curves: 
18.3 μM DDH2 with 2.0 
equivalents of heme.  Top: Grey 
dotted line: calculated spectrum 
of 1.37 equivalents of heme B, 
based on spectra from 2.0 and 
0.91 heme per protein spectra.  
Bottom: Red and blue dotted 
lines: heme B reduced with 
dithionite. 
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2.4.4  Significance of DDH2 
 DDH2 has properties that are very similar to the porphyrin binding section of MZH3.  
DDH2 has high affinity for heme B, binds heme B in vivo, is stable, and shows the same decrease 
in ellipticity at 222 nm upon binding heme.  Therefore, the removal of the Due Ferro section of 
MZH3 does not significantly perturb the structure or heme-binding function of the tetrapyrrole-
binding section of MZH3; both the tetrapyrrole-binding and Due Ferro sections of MZH3 can 
function as a standalone maquettes.  In effect, MZH3 can be regarded as the joining of two 
separate functional proteins into a single fold.  DDH2 is a viable candidate for the testing of 
other functions performed by BT6 including electron transfer, energy transfer, and oxygen 
binding (2). 
However, it should be noted that these experiments cannot prove that DDH2 folds as 
the intended left-turning antiparallel four-helix bundle and not the right-turning antiparallel 
structure; it remains possible that the Due Ferro section of MZH3 might help select for the 
correct helical topology or that charge pairing interactions in DDH2 do not sufficiently widen the 
energy gap between the right- and left-turning folds.  Future studies of DDH2 should involve 
high resolution structure determination by NMR or crystallography to test the hypothesis that 
DDH2 folds as designed. 
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Chapter 3: Structure of a reaction center maquette 
 No high-resolution structure of a de novo-designed protein has been reported in 
complex with heme B or any other tetrapyrrole.  High-resolution structures do exist for small 
peptides that are covalently linked to a tetrapyrrole cofactor (1, 2), modified natural proteins 
with bound tetrapyrroles (3), and apo-states of de novo proteins that are capable of binding 
tetrapyrroles (4-7).  This conspicuous absence is not for lack of effort, as structural 
characterization of designed proteins is generally pursued with purpose; experimentally-derived 
structures of de novo-designed proteins have the power to validate design methods, guide 
future designs, reveal structure-function relationships, and help explain the significance of 
structural elements of natural proteins. 
3.1 Crystallographic structure determination of MZH3 
Given the past difficulties in structural characterization of tetrapyrrole maquettes, 
crystallography of MZH3 in complex with heme B and zinc 5-phenyl,15-(p-carboxyphenyl) 
porphyrin (ZnPCP) was pursued with caution, initially.  However, it was soon found that MZH3 
crystallizes readily, with some limitations, in different space groups and unit cells with different 
cofactors and under various conditions.  The very first crystal tray of MZH3 that was set to 
optimize results from an initial screen yielded heme-containing red crystals shown in Figure 3.1 
that diffracted to 1.45 Å at the National Synchrotron Light Source (NSLS) at Brookhaven National 
Laboratory. 
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MZH3 samples that were subjected to 
HPLC and lyophilization prior to SEC showed no 
attenuation in crystal quality.  MZH3 samples of 
only ~90% purity as estimated from SDS-PAGE 
gels were often easy to crystallize with heme 
and metal ions, but samples of MZH3 with a 
zinc tetrapyrrole were much more difficult to 
grow, and sometimes required seeding with 
crystals that did not contain a zinc tetrapyrrole.  
UV/vis spectroscopy and the quality of crystal 
growth and diffraction suggested that careful 
addition of 1.0 equivalent of low-solubility electron acceptor and pigment tetrapyrroles per 
maquette was necessary to prevent tetrapyrrole aggregates from sequestering cofactors and 
lowering occupancy of the acceptor and pigment binding sites.  See the appendix for details 
concerning crystallography methods. 
 Three different crystallization conditions were used to solve high-resolution structures 
of MZH3, and a fourth condition was identified that provided only small, thin crystals that were 
not suitable for diffraction.  These conditions and the ranges across which crystal growth was 
observed are shown in Table 3.1.  Most crystal structures came from crystallization conditions 
CC-1 and CC-2, which have pH less than or equal 5.0, but crystals were also observed at pH as 
high 6.1 in CC-3.  Lest it be surmised that MZH3 is only singularly structured at low pH, CC-4 was 
included in Table 3.1 to show that MZH3 crystals at higher pH have been observed, suggesting 
that MZH3 remains uniquely structured across a wide pH range. 
 
Figure 3.1: Crystals of MZH3 with heme B 
These crystals were grown with heme B and 
Zn(II) in the first optimization tray and 
diffracted to 1.45 Å resolution for crystal 
structure CS-D (Table 3.2). 
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Eight crystal structures of MZH3 are reported in this chapter, and they are listed in Table 
3.2.  Each of these structures contributes unique information about the assembly of cofactors.  
The first MZH3 structure was CS-A, which was solved by multi-wavelength anomalous dispersion 
(MAD) using the X-ray absorption of the three zinc ions (two from the metal site and one from 
the zinc tetrapyrrole) to create the phase shift and anomalous dispersion.  All of the subsequent 
structures were solved by using molecular replacement starting from previously solved 
structures.  Diffraction data for crystal structures CS-A and CS-D were collected using 
synchrotron radiation at the National Synchrotron Light Source.  All others were collected using 
an in-house rotating copper anode X-ray generator at the University of Pennsylvania.  Details of 
the methods and statistics for each crystal are given in the appendix. 
 
Name Salt buffer pH precipitant Notes 
CC-1 2.2 – 4.0 M 
NaCl 
100 mM 
Na 
acetate 
3.2 – 5.0 – One metal ion is located in 
unintended position, ligated 
by His138 Nε atom instead of 
Nδ.  Can grow with or without 
ZnPCP.  Requires heme and 
metal dications. 
CC-2 40 – 120 mM 
CdCl2 
100 mM 
Na 
acetate 
4.0 – 4.9 18 – 30% 
PEG 400 –
20,000 
Crystals did not grow with 
ZnPCP.  Can grow with or 
without heme B.  Cd(II) is 
unavoidable in metal site. 
CC-3 1 – 1.5 M Li2SO4 
0.5M (NH4)2SO4 
100 mM 
Na3citrate 
5.6 – 6.1 – Crystals grew with heme B 
and Zn(II) or Mn(II).   
CC-4 10 – 200 mM 
Na/K tartrate or 
Na3citrate 
various 
buffers 
6.8 – 9.5 24 – 40% 
PEG 200 – 
PEG 400 
Crystals grew in presence of 
heme B, ZnPCP, and Zn(II). No 
diffraction-quality crystals 
grown 
Table 3.1: Crystallization conditions used to grow MZH3 crystals 
Details of the crystallization conditions for each crystal are given in the appendix.  PEG is 
polyethylene glycol; the number beside it is the average molecular weight of PEG used. 
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Name Condition Resolution Acceptor Pigment Metal Notes 
CS-A CC-1 2.0 Å Heme B ZnPCP 2 Zn(II)  used for MAD phasing 
 Zn(II) on wrong side of 
H138 
 pH 4.5 
CS-B CC-1 2.02 Å Heme B ZnPCP 3 Mn(II)  Tyr in two rotamers 
 Mn(II) on both sides of 
H138 
 pH 4.9 
CS-C CC-1 2.10 Å Heme B ZnPCP 2 Mn(II)  Tyr in unintended rotamer 
 extra ZnPCP 
 Mn(II) on wrong side of 
H138 
 pH 4.8 
CS-D CC-1 1.45 Å Heme B – 2 Zn(II)  Zn(II) on wrong side of 
H138 
 pH 4.5 
CS-E CC-3 1.90 Å Heme B – 2 Mn(II)  one low-occupancy Mn(II) 
 pH 5.9 
CS-F CC-2 2.01 Å Heme B – 2 Cd(II)  pH 4.2 
CS-G CC-2 1.78 Å – – 2 Cd(II)  Cd(II) bound to acceptor 
site 
 pH 4.4 
CS-H CC-2 2.02 Å Heme B – 2 Cd(II)  L71H mutant with His-Tyr 
hydrogen bond 
 pH 4.6 
Table 3.2: List of MZH3 crystal structures 
Details of the crystallization conditions for each crystal are given in the appendix. 
 
3.2 Overall structure of MZH3 
 As designed, MZH3 folds as a four-helix coiled coil (Figure 3.2).  All eight structures are 
similar overall and largely consistent with the design.  Helices begin and end at the intended 
positions, a- and d-position amino acids are directed into the core, each helix is oriented 
antiparallel to its two adjacent neighboring helices to form e-e and g-g interfaces, the bundle 
has the intended left turning topology, and, with some exceptions that will be described in 
subsequent sections, cofactors bind to intended sites in accordance with the design. 
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Figure 3.2: Crystal structure of MZH3 in holo-state. 
Structure CS-B with backbone amino acids is traced 
by cartoon helices and loops.  Mn(II) ions are 
portrayed as mauve spheres and tetrapyrroles as 
sticks.  (A) Axial view of MZH3 from the electron 
donating end shows canonical left-handed 
superhelix.  Structured loop is at upper right and a 
dynamic glycine-rich loop is at lower left.  (B) Lateral 
view of MZH3 shows correct placement of heme B in 
electron acceptor site (top), ZnPCP in pigment site 
(middle), and tyrosine with two Mn(II) ions in 
electron donor site (bottom).  Images rendered using 
The PyMOL Molecular Graphics System, Version 1.7 
Schrödinger, LLC. 
 
3.2.1  MZH3 is a coiled coil 
Coiled coil structural parameters of MZH3 were evaluated by the programs SOCKET (8), 
TWISTER (9), and CCCP (10).  These programs assess the structure of a coiled coil by taking 
atomic coordinates from a PDB file as input and searching for knob-into-hole interactions and/or 
determining the Crick parameters, a set of parameters that can be used to define the amino acid 
backbone coordinates in an idealized coiled coil (11, 12).  Using the coordinates of CS-B as a 
prototypical MZH3 structure, all three programs find that MZH3 is a canonical coiled coil with a 
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left-handed superhelix.  In addition, the heptad abcdefg positions of helical amino acids in MZH3 
designated by the programs agree with the abcdefg assignments intended by design.  For a set 
of coordinates that included only the residues between and including the core a-d-a-d layers at 
either end of the MZH3 bundle, CCCP calculated an average of 3.51 residues per turn (canonical 
coiled coils have 3.5 residues per turn) and a 0.968 Å RMSD deviation from an idealized coiled 
coil structure.  SOCKET identified extensive knob-into-hole interactions involving a, d, e, and g 
positions across each helix.  SOCKET also calculated the average pairwise helix crossing angle 
between adjacent helices to be 19.9°; idealized coiled coils with left-handed supercoils tend to 
have crossing angles near 20° (13).  This analysis shows that the secondary and tertiary structure 
of MZH3 is consistent with the design. 
 
3.2.2  Layers in the hydrophobic core 
 MZH3 forms layers in the hydrophobic core that are consistent with the design.  Each 
helix contributes two heptad a- and two d-positions to each layer to make groups of four amino 
acids each that are roughly aligned in the same plane.  This validates the original design 
approach of connecting the set of layers from a di-heme protein such as cytochrome b to the set 
of layers from a diiron protein such as bacterioferritin to form a long string of layers in an 
extended four-helix bundle.  The left panel in Figure 3.3, shows how the a-d-a-d layers of 
cytochrome b and bacterioferritin were essentially strung together to make the core of MZH3.  
While the exact identities of each core a- and d-position are not copied from nature, the total 
size of the amino acid side chains and cofactors in each layer is kept consistent throughout the 
length of the holo-state bundle, with small exceptions to aid cofactor binding and function.  The 
right panel of Figure 3.3 shows the simplified cartoon backbones and cofactors of cytochrome b 
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and bacterioferritin to show how MZH3 retains structural properties of both a transmembrane 
hemoprotein and a water soluble diiron protein.  When connected, they create a metal-
tyrosine-pigment-electron acceptor tetrad that should be competent for light-activated electron 
transfer and the trapping of a charge-separated state. 
  
Figure 3.3: Seamless connection of MZH3 cofactor binding modules facilitated by layers  
Left: layering of the hydrophobic core in MZH3 (CS-B) is similar to that of a cytochrome b-like 
protein joined to a bacterioferritin-like protein.  The four-helix bundle on the top left is a 
crystal structure of cytochrome b (14).  The bottom left bundle is a crystal structure of 
bacterioferritin (15).  Layers of a-d-a-d positions are shown as spheres.  Colors of layers in 
MZH3 match up with layers in cytochrome b and bacterioferritin, as indicated by arrows.  
Right: Cartoon of MZH3 with cofactors (green, structure CS-B) is shown alongside cytochrome 
b in cyan (16), and bacterioferritin in magenta (17).  Cofactors are labeled A for electron 
acceptor, P for pigment, Y for tyrosine, and M for di-metal center.  Images rendered using The 
PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
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3.2.3  Inter-helical charge patterning interactions 
Charge patterning interactions between c-position glutamates and lysines in the 
tetrapyrrole-binding section of MZH3 did not result in stable salt-bridging hydrogen bonds.  In 
some crystal structures, some of the distances between lysine nitrogens and glutamate oxygens 
are close enough for hydrogen bonding, but these flexible, solvent-exposed side chains tend to 
have relatively high temperature factors, indicating that hydrogen bonding interactions are 
transient.  It may be that the g-g interfaces in MZH3 are too wide for persistent hydrogen 
bonding between c-position residues.  In addition, the high ionic strengths of the three 
crystallization conditions may shield the charges to some extent and destabilize surface-exposed 
polar contacts.  Despite the lack of stable salt bridges, the cumulative effect of all of the inter-
helical electrostatic interactions may be involved in determining the topology. 
 
3.2.4  Inter-helical loops 
 The structures of the inter-helical loops in MZH3 follow the design (Figure 3.4).  The 
structured turn between helices 1 and 2 in MZH3 forms the same set of hydrogen bonds as the 
Due Ferro protein DF2t, which has the same loop sequence (18).  This structured loop has 
backbone temperature factors that are similar to backbone temperature factors within the 
helices, indicating that the loop is stable and that the hydrogen bonding pattern in the turn 
persists.  In contrast, the N- and C-termini and glycine-rich loops in MZH3 are dynamic. 
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The overall structure of MZH3 is consistent with the design.  The following sections will 
examine specific interactions at cofactor binding sites to validate or challenge design methods 
and consider possible effects on function. 
 
3.3 Electron acceptor site 
3.3.1  Heme B binding site agrees with design 
 Heme B was selected as the electron acceptor in all crystallography experiments, except 
in crystal structure CS-G, which lacks an electron acceptor.  All heme-containing structures show 
that the acceptor site histidine residues ligate the ferric ion of heme B with Nε atoms, the 
propionate groups of the heme are directed away from the hydrophobic core and are partially 
 
 
Figure 3.4: Structured loop in MZH3 and DF2t 
The structured turn in MZH3 that connects helices 1 and 2 (above left, 
from structure CS-D) closely matches the conformation of the turn in 
DF2t (above right, PDB ID: 1MFT) (18).  Yellow dotted lines represent 
hydrogen bonds between side chains and backbone atoms.  Right: 
backbone atoms in CS-D represented by temperature factor from low 
(blue, narrow tube), to medium (white), to high (red, wide tube).  As 
expected, the most dynamic parts are the N- and C- termini and glycine-
rich loops.  The structured loop (bottom, rear) has temperature factors 
similar to the center of the bundle.  Images rendered using The PyMOL 
Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
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exposed to solvent, and the porphyrin ring is secured into a well-defined conformation with low 
temperature factors (Figure 3.5).  This fixed heme conformation is surprising, because no facet 
of the design was consciously included to prevent free rotation of the porphyrin ring about the 
histidine-iron ligands while keeping propionate groups solvent exposed.   
 
 
Figure 3.5: Heme B has well-defined conformation in MZH3 
Crystal structure CS-D at 1.45 Å resolution shows heme B with well-
defined conformation.  (A) An (Fobs, φcalc) electron density map 
contoured at 1.8 σ of electron acceptor site with bis-histidine ligated 
heme B.  Helix 2 is cut away for better view of heme.  (B) Full length 
lateral view of CS-D shows heme B in acceptor site at top and two 
Zn(II) ions in metal site.  Images rendered using The PyMOL Molecular 
Graphics System, Version 1.7 Schrödinger, LLC. 
 
All of the crystal structures with heme in the electron acceptor site exhibit the intended 
second-shell inter-helical hydrogen bonds between the Nδ atoms of the heme-ligating histidines 
and the threonine hydroxyl groups (Figure 3.6).  The lengths of the hydrogen bonds range from 
about 2.6 to 3.1 Å.  Helices 1 and 3, which bear heme-ligating histidines are pushed outward to 
make room for the histidine-iron ligation, while helices 2 and 4, which contain notch glycines, 
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make close contact with heme.  The Cα atoms of the notch glycines (shown as green spheres in 
Figure 3.6) are within van der Waals contact of the heme. 
 
Figure 3.6: Heme B 
binding site and 2nd 
shell threonines 
Axial view of crystal 
structure CS-D from 
electron acceptor end.  
Blue dotted lines 
represent hydrogen 
bonds between 
threonine residues and 
ligating histidines.  
Glycine residues (with 
Cα as green spheres) 
make close van der 
Waals contact with 
heme (translucent 
spheres). 
Image rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
 
3.3.2  Multiple heme conformations in the acceptor site 
Despite the low temperature factors of heme B in MZH3, different conformations are 
observed in the crystal structures.  A close-up view of the isolated electron density map of the 
heme B from crystal structure CS-D at 1.45 Å shows that the diffraction data is consistent with 
heme B in either of two orientations related by a 180° rotation that switches the positions of the 
vinyl groups (Figure 3.7).  A similar lack of conformational specificity with regard to the vinyl 
groups is observed in cytochrome b5, neuroglobin, and others (19, 20), but some proteins 
display selectivity for one orientation.  Protein contacts at the heme edge are generally not well 
conserved, suggesting that this 180° flipping of the heme has little effect on function (21). 
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Figure 3.7: Heme flipping in MZH3 
Left: Two possible orientations of heme B 
superimposed in structure CS-D (Fobs, φcalc) 
map contoured at 1.8 σ.  One orientation 
has heme vinyl methylene groups colored 
yellow, the other magenta.  Top right: 
Heme B has asymmetric arrangement of 
vinyl and methyl groups in pyrrole β-
positions. 
Image rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
 
 While the positions of the vinyl groups of heme B are sometimes in a mixture of states, 
heme B is otherwise fixed in natural proteins.  In MZH3, mutation of leucine 71 to histidine in 
crystal structure CS-H led to a 90° rotation of the heme porphyrin ring relative to the wild type 
structure, putting the propionate groups between helices 3 and 4 instead of between 1 and 2 
(Figure 3.8).  The MZH3-L71H mutant will be discussed in more detail in section 3.6. 
  
Figure 3.8: Heme B rotation by 
90° in MZH3-L71H mutant 
Heme B is rotated in crystal 
structure CS-F (left) relative to 
CS-H (right).  Both crystals were 
grown in condition CC-2 with 
heme B and Cd(II), but CS-H has 
L71H mutation.  Space groups 
were C2 for CS-F and P21 for 
CS-H.  Helices 1, 2, 3, and 4 are 
colored blue, green, yellow, 
and red, respectively. 
Images rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
 
128 
 
3.3.3  Influence of arginine and tryptophan residues on heme binding in MZH3 
Arginine residues in cytochrome b 
make stable salt bridging hydrogen bonds 
with the propionate groups of heme B.  In 
MZH3, two d-position arginines were placed 
one turn N-terminal to the heme-ligating 
histidines in an effort to reproduce this 
interaction.  Crystal structures indicate that 
these arginines do not make stable hydrogen 
bonds with heme propionate groups.  The low 
pH of most of the crystal structures might 
inhibit salt bridging interactions by 
protonating the propionate groups.  In 
structure CS-E at pH 5.9, the arginine nitrogen 
to propionate oxygen distance is 2.8 Å, close 
enough for hydrogen bonding, but elevated temperature factors suggest that these interactions 
are transient (Figure 3.9).  Nevertheless, d-position arginines may serve to prevent hydrophobic 
collapse of the electron acceptor site in the apo-state to make the site accessible for cofactor 
binding, attract the heme B cofactor (which has an overall charge of −1 in the ferric state at 
neutral pH), stabilize the propionate groups by electrostatic interactions, and raise the midpoint 
potential of the electron acceptor.  Calculations performed by Dirk Auman using multi-
conformer continuum electrostatics (MCCE) (22, 23) indicate that despite the conformational 
freedom of the two arginine residues, they each raise the heme B midpoint potential by ~16 mV 
 
Figure 3.9: Heme-arginine interaction in 
MZH3 
MZH3 crystal structure CS-E at pH 5.9 shows 
heme propionate-arginine interaction.  Heme 
B and arginine side chains are represented as 
sticks.  Atoms are colored by temperature 
factors from low (blue) to medium (white) to 
high (red).  Temperature factors suggest 
propionate-arginine hydrogen bond is 
unstable.  Image rendered using The PyMOL 
Molecular Graphics System, Version 1.7 
Schrödinger, LLC. 
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to a predicted midpoint of -192 mV (personal communication).  This is consistent with the −180 
mV measurement at pH 7 by redox titration (Figure 2.22). 
MZH3 has two tryptophan residues in interfacial e-positions next to the electron 
acceptor site that were included mainly as spectroscopic probes for concentration 
measurements.  They are located very close to the dynamic C-termini of helices 2 and 4, and 
their conformations vary widely in different crystal structures.  However, most of the MZH3 
crystal structures have one tryptophan residue within about 4 Å of the heme cofactor, possibly 
forming stabilizing T-stacking interactions.  The second tryptophan side chain appears to be very 
close to the propionate groups of heme, which is a potentially destabilizing interaction.  Despite 
their proximity to the heme, the effect of the tryptophan residues on heme binding is 
ambiguous. 
 
3.3.4  Structural similarity between heme sites of MZH3 and cytochrome b  
The MZH3 crystal structures that contain heme B reveal remarkable structural 
similarities with cytochrome b despite negligible sequence similarity (Figure 3.10).  As intended 
by design, MZH3 shows similar interface widths, hydrophobic core packing, rotameric states of 
heme-ligating histidines, and second shell histidine-threonine hydrogen bonds.  Furthermore, 
the orientation of the maquette heme relative to the superhelical bundle axis is conspicuously 
similar to that observed in cytochrome b, suggesting that the particular conformation of heme 
in cytochrome b is not precisely controlled for any functional purpose, but rather is an accident 
of the structural constraints demanded by this protein fold. 
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Figure 3.10: Structural similarity between MZH3 and cytochrome b 
Despite low sequence similarity, MZH3 and cytochrome b bind heme B with very similar 
conformations.  Left: MZH3 crystal structure CS-D.  Right: cytochrome b crystal structure, PDB 
ID: 2A06 (16).  Images rendered using The PyMOL Molecular Graphics System, Version 1.7 
Schrödinger, LLC. 
 
3.3.5  Apo-state of the acceptor site 
Binding of heme B appeared to improve crystal growth in most cases, but crystallization 
condition CC-2 containing ~35 mM CdCl2 was able to facilitate MZH3 crystal growth from a 
sample that lacked an electron acceptor cofactor.  Because MZH3 expresses with some heme 
already bound, extra purification steps were required including HPLC purification to remove 
heme, lyophilization to remove acetonitrile, resuspension in GdnHCl to solubilize the lyophilized 
powder, and dilution to refold the protein.  After SEC, the crystallization trays were set, and the 
resulting structure, CS-G, diffracted to 1.78 Å using a rotating copper anode X-ray tube. 
In CS-G and other crystal structures that came from crystallization condition CC-2, 
several Cd(II) ions are bound to the surface of MZH3, and some of them mediate crystal 
contacts.  In CS-G, one of the resolved Cd(II) ions is ligated by the two histidines in the electron 
acceptor site.  The Cd(II) takes on a tetrahedral geometry with two coordinated water molecules 
and the two histidines ligating with Nε atoms (Figure 3.11).  Because of the tetrahedral geometry 
of the Cd(II) ion, the histidines cannot have the same rotameric state as they do when ligating 
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heme.  Instead, His110 has its imidazole ring flipped, disrupting the second-shell hydrogen-bond 
to Thr91. 
 
Figure 3.11: MZH3 structure 
without electron acceptor 
MZH3 conformation is similar 
with heme B or Cd(II) in acceptor 
site.  Left: crystal structure CS-D 
has bis-histidine ligated heme B 
and second shell His-Thr 
hydrogen bonds.  Right: structure 
CS-G lacks an electron acceptor, 
but a Cd(II) ion is coordinated by 
the two histidine residues.  One 
His-Thr hydrogen bond remains 
intact, but the other is broken.  
Images rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
 
 In comparing the structures of MZH3 with and without heme, it is important to 
remember that the Cd(II) ion in the acceptor site may serve to stabilize the site.  As described in 
the introduction, natural hemoproteins typically have significant conformational variability in 
heme binding sites in the apo-state, and the binding of heme stabilizes secondary and tertiary 
structure.  In contrast, the structures of MZH3 with heme and with Cd(II) in the acceptor site 
have relatively subtle differences.  They have essentially identical helix content, and the only 
significant difference between their tertiary structures is a modest expansion of e-e interface 
through which the porphyrin ring lies.  As shown in Figure 3.12, the most notable changes seem 
to be in side chain rotamers.  The two tryptophan residues next to the acceptor site, W96 and 
W193, are fully or partially buried in the absence of heme, but heme binding displaces them into 
more solvent-exposed conformations.  Gln residues in e-positions and two d-position Leu 
residues also change conformation to accommodate the steric bulk of the heme cofactor. 
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Figure 3.12: Conformational changes associated with heme binding in MZH3 
Heme binding in MZH3 triggers a slight expansion of the e-e interface as well as rotameric 
changes in the side chains of Trp96, Trp193, Arg6, Arg107, Gln10, Gln111, Leu88, and Leu185.  
Some of these changes, particularly the removal of the tryptophans from the core, might 
weaken heme affinity.  Left: MZH3 crystal structure CS-D.  Right: MZH3 crystal structure CS-G.  
Images rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
 
The electron acceptor site probably does not bind metal ions at lower concentrations, 
and it is possible that the bis-histidine-ligated Cd(II) ion affects the structure.  Even with Cd(II) 
contributing to stability, it is still surprising that the acceptor site is so structured without heme; 
the hydrophobic core in this part of the protein includes two d-position arginines, two a-position 
glycines, and two d-position histidines, all of which should be strongly destabilizing.  It may be 
that interfacial interactions between g-position leucines and electrostatic interactions between 
c-position glutamates and lysines are the most stabilizing forces in the vicinity of the apo-state 
acceptor site. 
 
3.4 Pigment site 
3.4.1  Apo-state of the pigment site 
 Given the importance of apo-state flexibility for heme binding sites, it was deemed 
important to create ample space for the binding of a zinc tetrapyrrole at the pigment site of 
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MZH3.  The pigment site lies in the center of the four-helix bundle, where the protein should be 
the most stable, and if the pigment site succumbs to hydrophobic collapse in the apo-state, the 
inherent inflexibility of the helices in this section of the bundle would prevent entry of the zinc 
tetrapyrrole.  For this reason, MZH3 design included a-d-a-d layers of bulky hydrophobic amino 
acids adjacent to the pigment site and four helical a-position glycines in the pigment site in 
order to create a cavity into which a zinc tetrapyrrole could penetrate. 
Figure 3.13 shows that in 
the absence of a pigment 
cofactor, the helices are indeed 
held apart to create a pore in the 
center of the bundle.  The 
highest resolution crystal 
structures that lack a zinc 
tetrapyrrole, CS-D and CS-G, 
have four well-resolved water 
molecules in the pigment site.  
These four waters are found in 
the same positions regardless of differences in the crystallization condition or whether heme B 
is present.  The fact that water is able to penetrate into the pigment site means that a proper 
binding cavity has been created for the zinc tetrapyrrole. 
 The presence of water in the hydrophobic core is usually strongly destabilizing.  
However, circular dichroism showed that in the absence of cofactors, MZH3 is highly α-helical 
and has a high melting temperature of 82°C.  Given that apo-MZH3 has poor hydrophobic core 
 
Figure 3.13: MZH3 structure without pigment 
The MZH3 pigment site contains four structured water 
molecules when zinc tetrapyrrole is absent.  Crystal 
structure CS-G is shown here with the four buried waters 
shown as red spheres and the zinc tetrapyrrole-ligating 
histidine and intended second-shell threonine shown in 
red.  Part of helix 2 is cut away for better view of pigment 
site.  Image rendered using The PyMOL Molecular 
Graphics System, Version 1.7 Schrödinger, LLC. 
134 
 
packing in the acceptor site, water in core at the pigment site, water and four negatively 
charged glutamate residues in the core at the metal site, and a total of ten helical glycine 
residues at mostly a- and d-positions, its high stability cannot be attributed to packing of a-d-a-d 
layers alone.  Interfacial hydrophobic contacts and possibly inter-helical charge pairing 
interactions may provide much of the driving force for folding of MZH3. 
Figure 3.13 also shows that the pigment site histidine residue H124 and an interfacial 
threonine T77 (both shown in red) are not in rotameric states that would allow a hydrogen bond 
to form.  These residues were designed to make a hydrogen bond when the zinc tetrapyrrole is 
bound, and with their Cα atoms 5.9 Å apart in CS-G, they appear to be close enough to make a 
hydrogen bond if their rotamers changed. 
 
3.4.2  Holo-state of the pigment site 
All three crystal structures that contain a pigment molecule, CS-A, CS-B, and CS-C, used 
Zn 5-(p-carboxyphenyl)-15-phenyl porphyrin (ZnPCP), which was kindly provided by Tatiana 
Esipova in the laboratory of Sergei Vinogradov.  As shown in Figure 2.17, ZnPCP binds with a 
dissociation constant of <10 nM.  These three structures also had heme B and either Zn(II) or 
Mn(II) as the metal ion.  Zn(II) has the advantage of being able to form strong ligands, as 
predicted by the Irving-Williams series (24), and zinc was useful for MAD phasing in concert with 
the zinc ion of ZnPCP to solve the crystal structure CS-A. 
The pigment binding site of CS-A is shown in Figure 3.14.  The ZnPCP molecule in CS-A is 
resolved in the pigment site with a conformation that is largely consistent with the design.  The 
phenyl groups protrude through the e-e interfaces on either side of the protein, as expected.  
Similar to heme B, the ZnPCP molecule is tilted in the binding site so that two of the pyrrole 
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nitrogens are closer to the central superhelical axis of MZH3 than the other two.  ZnPCP has 
higher temperature factors and less well-defined electron density than the heme B, which 
suggests sub-stoichiometric occupancy of the pigment site or increased conformational 
variability compared to heme B. 
Like the ZnPCP cofactor itself, the ZnPCP-ligating His124 has poorly-defined electron 
density, and its rotameric state is ambiguous.  It is not clear whether His124 ligates ZnPCP with 
the Nδ or Nε imidazole nitrogen, possibly because partial occupancy of the ZnPCP may result in 
the histidine having multiple conformations that complicate its electron density.  The pigment 
site was designed for ligation of the zinc ion of ZnPCP by the histidine Nε, and this conformation 
is consistent with the (Fobs, φcalc) electron density map of CS-A (Figure 3.14), but not conclusive.  
In the conformation that has the Nε atom as the ZnPCP ligand, the His124 Nδ is 2.7 Å from the 
second shell Thr77 oxygen, forming a putative hydrogen bond, as designed. 
The ZnPCP molecule has one carboxylate group in the para-position on one of the 
phenyl groups.  The temperature factors of this carboxylate group are high, but the electron 
density map is more consistent with the carboxylate being in the e-e interface between helices 3 
and 4 than between helices 1 and 2 (Figure 3.14).  This could be because the charge-pairing c-
position amino acids in the porphyrin-binding section of MZH3 are distributed so that helices 3 
and 4 are positively charged and helices 1 and 2 are negatively charged, creating a dipole 
moment that may cause the preference in ZnPCP orientation.   
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In contrast to the heme in MZH3, the structure of the pigment site with its ZnPCP 
deviates slightly from the structure of cytochrome b.  ZnPCP does not bind with its porphyrin 
ring in the same orientation relative to the helical bundle axis as the hemes of cytochrome b, 
possibly because the bulky phenyl groups would clash with the hydrophobic core of the 
maquette.  Also, the metal-to-metal distance in MZH3 is about ~1 Å longer than in cytochrome 
b, probably because the four glycine residues in the core near the pigment binding cavity in 
MZH3 create a pocket that causes the ZnPCP to shift away from the electron acceptor.  Whereas 
heme is ligated by two histidines, ZnPCP is ligated by only one histidine, giving it more 
conformational freedom to adapt to the shape of the binding cleft.   
  
Figure 3.14: CS-A pigment site with ZnPCP 
The cofactor Zn 5-(p-carboxyphenyl)-15-
phenyl porphyrin (ZnPCP) (lower right) binds 
to the pigment site of MZH3 in crystal 
structure CS-A (upper right).  An (Fobs, φcalc) 
electron density map of CS-A contoured at 1.0 
σ (upper left) shows the electron density of 
the ZnPCP in the pigment site.  Blue dotted 
line shows second shell histidine-threonine 
hydrogen bond. 
 
 
Images rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
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3.4.3  ZnPCP can bind to an unexpected site in MZH3 
The (Fobs, φcalc) electron density map of crystal structure CS-A has an unusually large 
peak of 3.0 σ located at the opening of the metal-binding cavity.  (For comparison, the peak for 
the zinc ion of ZnPCP in the pigment site is 9.5 σ).  The peak of 3.0 σ is located between the 
carbonyl oxygen atoms of helical glycines G33 and G160, which line the opening to the metal 
binding cavity.  The center of the peak is 2.9 Å from the carbonyl oxygen of G160 and 3.6 Å from 
the oxygen of G33.  A chloride ion at this position would clash with the nearby partial negative 
charge of the glycine carbonyl oxygens.  The peak was deemed unlikely to represent a free 
metal ion because carbonyl oxygens are not strong ligands, and the crystallization drop only had 
a stoichiometric concentration of ZnCl2.  The 3.0 σ peak is surrounded by a coplanar arc of 
diffuse electron density on one side, not unlike a metal ion surrounded by a partially-resolved 
tetrapyrrole ring.  If this electron density does come from a tetrapyrrole, the occupancy of that 
tetrapyrrole would be very low, so the peaks in this region were assigned to water molecules 
instead. 
 Crystal structure CS-A (Figure 3.14) was solved with zinc ions in the metal site for MAD 
phasing with the zinc of the ZnPCP cofactor, but Zn(II) is redox-inactive and not useful as an 
electron donor in a reaction center maquette.  The most promising metal ion for use in an 
oxygen evolution catalyst is manganese, because of its relevance to photosystem II, rich redox 
chemistry, known capacity for oxygen evolution, and abundance (25).  For this reason, 
additional crystal structures of MZH3 with heme B and ZnPCP were grown with Mn(II) to 
produce structures CS-B and CS-C.  Unlike the crystals from CS-A which grew spontaneously, 
growth of crystals for CS-B and CS-C structures required seeding with crystals that contained 
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heme B and Mn(II) but not ZnPCP.  All pigment-containing structures came from crystallization 
condition CC-1.  Efforts to grow crystals with ZnPCP in conditions CC-2 and CC-3 resulted in 
crystal structures that lacked the pigment; evidently, the ZnPCP cofactor dissociated from MZH3 
before crystallization. 
 In crystal structure CS-C, the temperature factors and the shape of the electron density 
for the ZnPCP cofactor in the pigment site were improved compared to structure CS-A (Figure 
3.15).  In CS-C, the overall conformation of ZnPCP in the pigment site is in good agreement with 
the structures of CS-A and CS-B.  The carboxylate group of ZnPCP is between helices 3 and 4 for 
all three structures, which supports the hypothesis that the ZnPCP orientation is influenced by a 
dipole moment created by charged c-position residues.  The conformation of the ZnPCP-ligating 
histidine H124 appears to be more consistent with ligation of the zinc by the Nδ atom than the 
Nε atom.  This is unusual 
because natural heme-
binding proteins 
overwhelmingly favor 
heme ligation by histidine 
Nε atoms over Nδ atoms.  
Despite the flipping of the 
imidazole ring, there 
remains a 2.8 Å hydrogen 
bond between the H124 
Nε atom and the hydroxyl 
oxygen of T77. 
 
Figure 3.15: CS-C pigment site with ZnPCP 
ZnPCP in MZH3 pigment binding site in crystal structure CS-C has 
lower B-factors than CS-A, suggesting increased occupancy of 
ZnPCP.  An (Fobs, φcalc) electron density map contoured at 1.0 σ 
corroborates ZnPCP conformation in CS-A, but His124 in CS-C 
appears to fit electron density better when ligating ZnPCP with 
Nδ.  Image rendered using The PyMOL Molecular Graphics 
System, Version 1.7 Schrödinger, LLC. 
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Crystal structure CS-C has a clearly-resolved second ZnPCP molecule at the opening of 
the metal site cavity in the same position as the tetrapyrrole-like features observed in CS-A 
(Figure 3.16).  In the (Fobs, φcalc) map of CS-C, the electron density peak heights for the zinc ion in 
the pigment site and the metal cavity are 12.8 σ and 6.7 σ respectively, compared to 9.5 σ and 
3.0 σ in CS-A.  In CS-C, the G160 carbonyl oxygen appears to interact with the zinc ion which is 
2.9 Å away, and the distance between the zinc and G33 carbonyl oxygen is 3.7 Å.  The porphyrin 
ring of ZnPCP makes van der Waals contact with all four of the glycine residues that line the 
opening of the metal binding cavity, G33, G37, G160, and G164.  The pyrrole group of the 
porphyrin ring furthest from the porphyrin-binding section of the protein packs against the side 
chains of residues L41 and L157.  The p-carboxyphenyl group of ZnPCP projects out of the 
protein into the solvent and is not resolved at all.  The other phenyl group projects into the core 
of MZH3 and displaces the tyrosine 168 side chain so that Y168 rotates outward into a partially 
solvent-exposed interfacial position, pushing Gln172 into a strained conformation.  The phenyl 
group makes hydrophobic contacts with side chains of L30, L71, I131, and Y168. 
The binding of ZnPCP to the metal site is reminiscent of work done on Due Ferro 
proteins that has shown quinone molecules binding to the metal cavity for redox reactions with 
iron ions (26).  While interesting in its own rite, the ZnPCP binding at the metal cavity presents a 
problem for light-driven electron transfer studies, because it changes the rotameric state of 
tyrosine 168, which changes the distances between cofactors and therefore electron transfer 
rates, impedes binding of metal ions and potential substrates to the metal site, and may 
participate in light-activated redox chemistry that would interfere with charge separation.  All 
three ZnPCP-containing structures, CS-A, CS-B, and CS-C, have some evidence of this metal 
cavity ZnPCP, but it is clearest in CS-C and nearly undetectable in CS-A. 
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Figure 3.16: Extra ZnPCP at opening of metal binding site cavity 
ZnPCP is well-resolved in an unintended site at the opening of the metal binding cavity in 
crystal structure CS-C, but not CS-A.  (A) (Fobs, φcalc) map of CS-C contoured at 1.0 σ shows 
electron density of ZnPCP at opening of metal-binding cavity.  Dotted blue line shows 
proximity of G160 carbonyl oxygen to zinc ion of ZnPCP.  Solvent-exposed p-carboxyphenyl of 
ZnPCP is not resolved.  Part of helix 4 is cut away for better view.  (B) (Fobs, φcalc) map of CS-C 
at 1.0 σ contour level showing the two ZnPCP cofactors in yellow and the change in Tyr168 
rotamer with ZnPCP binding to metal cavity.  Tyr168 of structure CS-A, shown in cyan, would 
clash with ZnPCP phenyl group if it did not adopt interfacial conformation observed in CS-C.  
Part of helix 1 is removed.  (C) CS-C interfacial Tyr168 side chain rotamer avoids steric clash 
with ZnPCP phenyl group.  Gln172 (top right) in strained conformation avoids steric clash with 
Tyr168.  (D) CS-A Tyr168 side chain is located in the core in the absence of ZnPCP at metal 
cavity, and Gln172 adopts relaxed conformation.  Images rendered using The PyMOL 
Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
 
The crystal structures indicate that ZnPCP binds with higher affinity to the intended 
pigment site than the metal cavity.  In all three structures, the electron density of the zinc ion of 
ZnPCP at the pigment site is significantly higher than the zinc ion of ZnPCP at the metal cavity.  
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All three crystal structures grew from crystallization condition CC-1 well solutions with pH 
between 4.5 and 4.9, and this may disfavor binding to the pigment site, which involves 
coordination by histidine 124.  His124 is likely to be protonated in this pH range the absence of 
ZnPCP, because the solution pKa of histidine is about 6.4, and His124 is surrounded by water in 
the apo-state (see Figure 3.13).  Acidic conditions have been observed to weaken histidine-
metalloporphyrin interactions in maquettes previously (27).  In contrast, the ZnPCP at the metal 
cavity is not contingent upon ligation by any protonatable groups, suggesting that acidic 
conditions would favor ZnPCP binding to the metal cavity over the pigment site.  Despite the low 
pH, however, the electron density maps clearly show more density for ZnPCP at the pigment 
site, and this disparity may be higher at neutral pH. 
The unexpected binding of ZnPCP to the metal cavity likely cannot be reproduced in 
other zinc tetrapyrroles that bind to MZH3 with high affinity.  Table 2.4 shows that SE375, 
NR117, TE312, and TE394 have different substituents on the porphyrin ring, and they would not 
be able to make the same interactions that ZnPCP makes at the metal cavity.  NR117, for 
example, has two p-carboxyphenyl groups which would not easily be buried in the core to pack 
against L30, L71, and I131 as ZnPCP does.  TE312 and TE394 have benzyl substituents fused to 
two of the pyrrole units, and these are likely to clash with glutamate residues in the metal 
binding site and core leucine residues L30 or L157 on either side of the opening to the metal 
binding cavity.  In SE375, an alkyne group connects the porphyrin ring to a phenyl group, and 
this long, inflexible substituent would create severe steric clashes if the porphyrin ring were 
lodged at the opening of the metal cluster as it is in CS-C.  Despite these potential clashes at the 
metal binding cavity, SE375, NR117, TE312, and TE394 all bind to MZH3 with high affinity, 
suggesting that the intended pigment binding site is the preferred site for zinc tetrapyrroles. 
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3.5 Metal-binding site 
3.5.1  Di-metal site structure consistent with design 
All MZH3 crystals grown in crystallization conditions CC-2 and CC-3 had metal binding 
sites that closely match the design.  Histidines H67 and H138 ligate the metal ions with Nδ atoms 
and make second-shell hydrogen bonds with Nε atoms to aspartates D134 and D63, respectively.  
Glutamates E34 and E161 make bidentate axial ligands with the metal ions, while E64 and E135 
make bridging ligands to connect the two metal ions.  In one exception, the Mn(II)2 site of CS-E 
has a low-occupancy Mn(II) in the site closest to the tyrosine, and E34 appears to be out of 
place.  This crystal was grown with a slightly sub-stoichiometric amount of MnCl2, which may not 
have been enough to fill the metal sites, given the relatively weak affinity of Mn(II) compared to 
other metals (28).  In the highest resolution structure that came from CC-2 or CC-3, CS-G, a 
bridging μ-aqua or μ-hydroxo ligand is resolved between the two cadmium ions.  Crystal 
structures CS-F and CS-H, which both have Cd(II) and heme B, look very similar to the CS-G 
structure, which has only Cd(II).  In all three structures containing CdCl2, the Cd(II) ions are 3.6 Å 
apart.  In the Mn(II) structure CS-E, the distance between the ions is 5.5 Å.  This change is likely 
due to the lengthening of the ligands between the Mn(II) ions and the amino acid ligands 
compared to Cd(II).  Figure 3.17 shows an election density map of the metal site in CS-G and the 
overall structure. 
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Figure 3.17: Cd(II) 
bound to MZH3 
Crystal structure CS-G 
shows high-affinity 
metal binding.  Left: 
(Fobs, φcalc) map 
contoured at 1.0 σ 
with part of helix 3 cut 
away.  Cd(II) ions are 
shown as grey 
spheres.  Right: 
overall fold of MZH3 
in CS-G.   
Images rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
 
The metal binding site of MZH3 in crystals from crystallization conditions CC-2 and CC-3 
are very similar to the metal site of bacterioferritin.  As an example, structure CS-G is shown in a 
side-by-side comparison with bacterioferritin in Figure 3.18.   
 
Figure 3.18: Comparison of MZH3 to bacterioferritin 
Metal binding site of crystal structure CS-G with Cd(II) (left) closely matches the structure of 
the natural diiron protein bacterioferritin with Mn(II) (right).  Side chain rotamers of first shell 
histidines and glutamates and second-shell asparates and tyrosine are nearly identical in the 
two structures.  Bacterioferritin structure comes from PDB ID: 1BFR (17).  Images rendered 
using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
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3.5.2  Di-metal site structure with metal in unintended position 
 In contrast to structures 
from crystallization conditions CC-2 
and CC-3, all structures from 
condition CC-1, including CS-A, CS-
B, CS-C, and CS-D, had a misplaced 
metal ion on the outside of the 
metal binding site and 
corresponding lowered or absent 
occupancy of a metal in the 
intended site on the interior of the 
protein (Figure 3.19).  The 
unexpected external metal ion was 
coordinated in a tetrahedral 
geometry by active site residue H138, a water molecule, and the two aspartates, D63 and D134, 
which were intended to be second shell contacts to the histidines.  H138 is designed to ligate a 
metal ion in the interior of the protein using the Nδ atom, and in structures from condition CC-1, 
H138 retains the conformation it was intended to have, but ligates the external metal ion using 
its Nε atom.  The (Fobs, φcalc) electron density maps from condition CC-1 structures show that the 
external metal has very strong scattering intensity that is higher than that of the internal metal 
at the site nearest the porphyrin binding section of MZH3. 
Structures CS-A and CS-D contained Zn(II), a metal that commonly adopts a tetrahedral 
geometry, but Mn(II) is rarely stable in this geometry (29).  Crystals of MZH3 with Mn(II), heme  
 
Figure 3.19: Unintended metal binding site 
Crystal structure CS-D exemplifies the external metal 
binding site from crystallization condition CC-1 
structures.  While the Zn(II) ion nearest the porphyrin-
binding section of the protein is ligated correctly, the 
far site is empty and an external Zn(II) coordinates the 
active site His138 and second shell residues D63 and 
D134.  Image rendered using The PyMOL Molecular 
Graphics System, Version 1.7 Schrödinger, LLC. 
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 B, and ZnPCP were 
grown in condition CC-1 
with the expectation that 
Mn(II) would not be able 
to bind to the external 
site because it would 
have to be tetrahedral.  
Instead, structures CS-B 
and CS-C showed that 
Mn(II) did, in fact, bind 
with a tetrahedral 
geometry to the unusual 
external metal site (Figure 3.20).  In structure CS-C, which had 2 mM MnCl2 in the protein stock 
solution (about 3 equivalents of MnCl2 per protein), only two metal ions were observed with 
one in the internal site close to the porphyrin section of the protein and one in the external site, 
similar to the Zn(II) structures CS-A and CS-D.  In crystal structure CS-B, however, ~35 mM MnCl2 
was added in an attempt to fill the intended metal binding site.  The result was electron density 
consistent with a Mn(II) ion on both sides of His138, suggesting that either His 138 was ligating 
two Mn(II) ions at once or that there was a mixture of states of Mn(II) binding.  The (Fobs, φcalc) 
map showed the internal and external Mn(II) ions ligated by His138 had peaks of 3.7 σ and 4.8 σ, 
respectively. 
The metal binding site of structures from condition CC-1 may not be an accurate 
representation of the metal binding site of MZH3 in solution.  The CC-1 metal site structure is 
 
Figure 3.20: Metal binding 
with extra Mn(II) and ZnPCP 
Crystal structure of CS-B 
with three Mn(II) ions.  
His138 is shown ligating 
internal Mn(II) with Nδ and 
external Mn(II) with Nε.  
Tyr168 adopts two 
rotamers, presumably 
because of partial 
occupancy of ZnPCP at 
metal binding cavity.  
Tyr168 in core would clash 
with ZnPCP, so it moves to 
the interfacial rotamer 
when ZnPCP is present.  
Image rendered using The 
PyMOL Molecular Graphics 
System, Version 1.7 
Schrödinger, LLC. 
146 
 
not consistent with structures from the other two crystallization conditions, which suggests that 
the external metal ion may be an artifact of crystal packing.  This external metal ion is not 
observed in any structure reported for Due Ferro proteins, and UV/vis titration of Co(NO3)2 into 
an MZH3 solution produced a spectrum and extinction coefficients for MZH3-Co(II) that are 
consistent with pentacoordinate ligation and not tetrahedral ligation, similar to Due Ferro 
proteins (Figure 2.18) (28, 30, 31).  As a result, structures from crystallization conditions CC-2 
and CC-3 are presumed to be more reliable representations of the mode of metal binding by 
MZH3 in solution at neutral pH. 
 
3.6 Leu71His mutation and His-Tyr hydrogen bond 
 The redox active tyrosine Z of Photosystem II has a hydrogen bonding interaction with a 
histidine side chain (32).  The histidine is necessary for rapid proton transfer to and from 
tyrosine Z to enable efficient oxidation and reduction of the tyrosine side chain.  In order to 
reproduce this effect in MZH3, Leu71 was mutated to histidine to make MZH3-L71H.  The MZH3-
L71H mutant was crystallized in the cadmium-containing condition CC-2 with heme B in the 
electron acceptor site.  Figure 3.21 (bottom) shows that a hydrogen bond forms in MZH3-L71H 
with a length of 2.6 Å between the His71 Nε atom and the Tyr168 oxygen.  This relatively short 
distance is consistent with a stable hydrogen bond.  The L71H mutation does not seem to affect 
binding of the Cd(II) ions. 
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Figure 3.21: Histidine-tyrosine 
hydrogen bond in MZH3-L71H 
mutant 
Electron density (Fobs, φcalc) maps 
of crystal structures CS-D (top) and 
CS-H (bottom) contoured at 
1.0 σ.  Blue dotted line in L71H 
mutant, structure CS-H, shows that 
a hydrogen bond forms between 
H71 and Y168, as designed.  Image 
rendered using The PyMOL 
Molecular Graphics System, 
Version 1.7 Schrödinger, LLC. 
 
 The length of the hydrogen bond in MZH3-L71H shown in Figure 3.21 appears to be 
typical of a strong hydrogen bond, but not unusually strong.  In contrast, the hydrogen bond in 
photosystem II between tyrosine Z and a histidine has special characteristics.  It has a 2.5 Å 
donor-acceptor distance, and analysis of the 1.9 Å crystal structure suggests that the proton is 
shared equally between the tyrosine and the histidine, facilitating rapid proton coupled electron 
transfer reactions of the tyrosine (32, 33).  The MZH3-L71H hydrogen bond, with a length of 2.6 
Å, probably does not have these special features, but can still act as a probe to explore the role 
of hydrogen bonding in tyrosine electron transfer kinetics. 
 As noted above in Figure 3.8, the heme B of L71H is rotated by 90° relative to the wild 
type MZH3 structures so that the propionate groups project out of the core in a different 
direction.  It is not obvious why L71H would cause such a conformational change on the other 
end of the protein.  The change could be due to differences in crystal contacts; one of the heme 
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propionate groups in the L71H structure appears to be involved in a 3.3 Å inter-protein 
hydrogen bond with Gln7 from a neighboring protein.  However, all six heme-containing wild 
type MZH3 structures from all three crystallization conditions in different states of cofactor 
assembly have the same heme conformation.  In addition, dogged attempts to crystallize MZH3-
L71H in crystallization condition CC-1 produced only long needle-like crystals that were not 
useful for diffraction.  Wild type MZH3 crystal structures from CC-1 have a heme propionate 
inter-protein hydrogen bond with Lys32 with a length of 2.8 Å (as measured in CS-D), and 
crystals did not grow in CC-1 without heme B.  While wild type MZH3 crystallized readily in CC-1, 
the needle-like crystals of L71H were difficult to grow.  It is likely, therefore, that a subtle shift in 
core packing created by the L71H mutation is translated up the helices to the electron acceptor 
site, causing a different heme B conformation.  The fact that such a subtle shift could tip the 
balance to favor a different heme conformation is not surprising given the symmetry of the 
heme binding site and the fact that no design element was consciously included to favor one 
orientation over the other.  What is surprising is that all of the wild type structures have a 
consistent heme orientation with the propionate groups in the same position. 
 
3.7 Summary 
 X-ray crystal structures of MZH3 from 1.45 to 2.10 Å resolution show that the overall 
structure of MZH3 closely matches the design; the maquette folds as a left-turning antiparallel 
four-helix coiled coil, with heptad a- and d-positions forming layers in the hydrophobic core.  
The protein retains its fold in the absence of a pigment or electron acceptor, despite the 
penetration of solvent into the hydrophobic core.  The apo-state stability may be the result of 
stabilizing interactions between interfacial g-position leucines.  Stable inter-helical salt bridging 
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interactions were not observed in these crystal structures, but charge pairing interactions might 
still play an important role in determining helix topology. 
 Heme B and metal ions bind to the correct sites with structures very similar to natural 
proteins cytochrome b and bacterioferritin, respectively, despite the absence of sequence 
identity between these proteins.  Heme and metal ions are coordinated exactly as intended by 
design, complete with second-shell hydrogen bonding interactions.  In crystallization condition 
CC-1, ZnPCP is shown to bind to the pigment site, and is ligated by the intended histidine 124.  
The rotameric state of His124 when it ligates ZnPCP is not resolved conclusively, but it appears 
to make the intended second-shell hydrogen bond to Thr77.  Unexpected details emerged from 
crystals grown in CC-1, including the improper binding of a tetrahedral metal ion to the exterior 
of MZH3 and the unintended binding of ZnPCP to the opening of the metal binding cavity.  The 
exterior metal was not present in other crystallization conditions, and only a single ZnPCP is 
observed to bind to MZH3 by UV/vis spectroscopy.  These results suggest that crystal packing 
may have distorted the metal site of MZH3 in condition CC-1 and given rise to these unexpected 
results. 
 There is room for improvement of the sequence of MZH3.  Some glutamine residues in 
the vicinity of tetrapyrrole binding sites appear to be pushed into strained rotameric states by 
the binding of the cofactor.  In addition, two tryptophan residues are buried in the apo-state 
and must be solvated to allow heme binding.  Mutation of some of these amino acids to smaller 
residues may increase the binding affinity of the tetrapyrroles.  It may also be wise to change 
the metal binding site so that metals and ZnPCP cannot bind to unintended sites in the manner 
of crystals grown in condition CC-1, even though these anomalies appear to be artifacts of 
crystal packing.  Redesign should be approached with caution, however, as increasing the 
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stability of the holo-state might also increase the stability of the apo-state, which could have the 
effect of slowing the binding rate or weakening cofactor affinity.  Even without enhancements, 
however, these crystal structures show that MZH3 has an architecture consistent with the 
design, with cofactors positioned appropriately for long-lived light-activated charge separation.  
The next chapter will use transient absorption spectroscopy to investigate whether MZH3 can in 
fact function as a reaction center maquette. 
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Chapter 4: Light-driven electron transfer in a reaction center 
maquette 
 The long-term goal of this project is to convert solar energy to fuel, and this means the 
energy of a light-activated charge separated state must be converted into chemical energy by 
oxidizing one substrate (such as water to make oxygen) and reducing another (such as protons 
to make hydrogen fuel).  Such chemical reactions are usually much slower than the charge 
separating electron transfer reactions, because they need time for the comparatively slow 
making and breaking of chemical bonds.  Previous work has demonstrated the use of de novo-
designed protein maquettes to create light-activatable electron transfer dyads, in which a 
pigment molecule photo-reduces an electron acceptor (1-3).  Dyads can be useful in 
investigating the parameters that affect electron transfer, but they are not equipped to trap a 
long-lived charge separated state, because the electron on the reduced electron acceptor 
quickly recombines with the hole on the oxidized pigment.  In order to stabilize the charge 
separated state, a third cofactor, an electron donor, must be introduced to increase the distance 
between the electron and the hole in order to allow a charge separated state to persist for long 
enough for chemical reactions to make fuel.  The electron donor should be placed close to the 
pigment so that oxidation of the donor can outcompete the electron-hole recombination that 
would quench the electrical potential energy of the charge separated state.  In photosystem II, a 
long string of electron donors and acceptors gives the reaction center a quantum yield for 
producing product O2 and reduced plastoquinone of up to 95% in favorable light conditions (4, 
5).  Here, MZH3 makes use of a redox-active triad to trap a long-lived charge separated state. 
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4.1 Electron transfer background 
4.1.1  A kinetic model of electron transfer in MZH3 
MZH3 was designed for tetrad activity involving an iron or cobalt porphyrin, a zinc 
tetrapyrrole, a tyrosine side chain, and two metal ions.  Here, the discussion will focus on 
development of a triad, and a charge separating tetrad will be a future aim.  A comparison of the 
electron transfer pathways of a light-activatable dyad and triad in MZH3 is shown in Figure 4.1.  
A dyad can be prepared by making an MZH3 mutant that lacks a tyrosine or by inhibiting 
tyrosine oxidation in the wild type MZH3.  A model such as this can be used to predict how a 
system will progress after the pigment absorbs light to enter the excited state. 
 
Figure 4.1: Model of electron transfer pathway in dyad and triad versions of MZH3 
Cofactor A is the electron acceptor, P is the pigment, and D is an electron donor, such as a 
tyrosine side chain.  CS is a charge separation, and CR is a charge recombination. 
 
Figure 4.1 makes use of a few assumptions.  For example, the singlet excited state of the 
zinc porphyrin is not relevant, because it goes through intersystem crossing to the triplet state 
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before electron transfer.  In addition, the triplet excited state does not relax to the ground state, 
the A-P+ state does not return to the excited triplet state of the zinc porphyrin, and the A-D+ 
state in the triad case does not return directly to the ground state.  These assumptions are valid 
because competing reactions are significantly faster than these reactions, so they do not play a 
significant role in the electron transfer pathway of the system. 
Using Figure 4.1, a set of equations can be written to describe how the concentration of 
each state of the system changes with time after light absorption.  For example, in the triad 
case, the rate of change of the concentration of the excited state, d[E]/dt, depends only on the 
concentration of the excited state, [E], and the rate constant for its conversion to the A-P+ state, 
kCS1, as shown below: 
𝑑[𝐸]
𝑑𝑡
= −𝑘CS1[𝐸]  
Table 4.1 gives the rate of change of each state of the triad system.  From this 
information, a system of equations can be compiled to describe how the triad system evolves 
after absorption of a photon. 
 [E] [A-P+] [A-D+] [G] 
𝑑[𝐸]
𝑑𝑡
  −𝑘CS1 0 0 0 
𝑑[A−P+ ]
𝑑𝑡
  +𝑘CS1 −𝑘CR1 − 𝑘CS2 +𝑘CS2 0 
𝑑[A−D+ ]
𝑑𝑡
  0 +𝑘CS2 −𝑘CR2 0 
𝑑[𝐺]
𝑑𝑡
  0 +𝑘CR1 0 0 
Table 4.1: Rates of change of each state of the MZH3 triad system  
The rate of change of the concentration of each state given on the left of each row is equal to 
each rate constant in that row times its corresponding concentration at the top of the 
column.  The names of each state and rate constant are taken from Figure 4.1.  E is the 
excited state and G is the ground state.  CS is charge separation and CR is charge 
recombination.  The rate constants kCS1, kCS2, kCR1 and kCR2 represent the transitions labeled 1st 
CS, 2nd CS, 1st CR, and 2nd CR, respectively, in Figure 4.1. 
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 When the triad system is photo-activated at time t = 0, the entire system is in the 
excited state, E, so the occupancy of [E] is 1.0.  With this starting condition and the equations 
from Table 4.1, the relative occupancies of each state can be determined at any time t after light 
absorption in terms of the electron transfer rate constants given in Table 4.1.  If we can make 
accurate estimates of these rate constants, then we can accurately predict how the system will 
change with time after light absorption. 
 
4.1.2  Parameters that govern electron transfer rates 
MZH3 was designed to arrange its cofactors in a way that could manipulate light-
activated electron transfer rates to maximize the yield and lifetime of charge separation.  
Prediction of electron transfer rates was guided by an empirical approximation of Marcus theory 
sometimes referred to as the Moser-Dutton ruler, shown below in Equation 4.1 (6-8).  In this 
equation, kET is the rate constant for electron transfer from one redox center to another in s-1, R 
is the distance between them measured in Å, ΔG is the driving force of the reaction in eV, and λ 
is the reorganization energy in eV. 
 
 The most important variable that influences electron transfer rates is the distance 
between the redox centers, R; for every 1.6 Å change in distance, the rate of electron transfer 
changes by an order of magnitude.  Crystal structures of MZH3 with heme B, ZnPCP, and Mn(II) 
give the distances between cofactors.  The R values relevant to electron transfer rates in 
Equation 4.1 are measured by the distance of closest approach between the two redox centers 
(6, 7).  The edge-to-edge distance between the porphyrin rings of pigment ZnPCP and acceptor 
log(𝑘𝐸𝑇) = 15 − 0.6𝑅 − 3.1 ∙
(∆𝐺 + 𝜆)2
𝜆
 
Equation 4.1 
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heme B, RPA, is 13.0 to 13.1 Å in the crystal structures that contained both cofactors.  Vinyl and 
methyl groups of the heme B cofactors are assumed not to be part of the redox-active center 
and are therefore ignored in this distance measurement.  The edge-to-edge distance between 
tyrosine 168 and the pigment ZnPCP, RYP, is 5.0 to 5.1 Å in crystal structures CS-A and CS-B when 
tyrosine is in the intended conformation.  The RYP distance is reduced to 3.4 to 3.5 Å in crystal 
structures CS-B and CS-C when the tyrosine has moved to an interfacial conformation to 
accommodate the binding of ZnPCP to the metal binding cavity, but this conformation may not 
be relevant to these electron transfer studies.  The distance between tyrosine 168 and the 
nearest metal, RMY, appears to vary by metal ion.  Structures containing Cd(II) have a 4.7 Å RCdY 
distance, Zn(II) structures have a 3.7 to 4.0 Å RZnY distance, and Mn(II) structures have a 3.2 to 
3.5 Å RMnY distance.  If the tyrosine is not an active participant in photo-oxidation of bound metal 
ions, then the distance between the metal and the pigment, RMP, becomes important.  This 
distance ranges from 9.6 to 10.1 Å in crystal structures that contain ZnPCP and Mn(II) or Zn(II). 
 The second most important variable in calculating electron transfer rates is the driving 
force for electron transfer, ΔG, which is calculated from the difference in midpoint potentials of 
the redox centers involved in electron transfer.  Redox titration provided a midpoint potential 
for heme B in MZH3 in the absence of ZnPCP of -180 mV vs. SHE (Figure 2.22).  Zinc porphyrins 
in the excited state tend to be powerful reducing agents.  The excited singlet state of the ZnPCP 
used for these experiments has a lifetime on the order of nanoseconds, which is too short for 
electron transfer to heme in MZH3.  However, ZnPCP bound to MZH3 undergoes relatively 
efficient intersystem crossing to a triplet excited state that persists for milliseconds before 
phosphorescing (9).  For this reason, it is assumed that the heme B in MZH3 transient absorption 
experiments is reduced only by the triplet excited state of the zinc porphyrin, and the singlet 
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state is not relevant to these electron transfer studies.  Spectroelectrochemical titration and 
phosphorescence measurements of ZnPCP in MZH3 by Zhenyu Zhao gave potentials of 0.91 V 
for the [ZnPCP•+/ZnPCP0] redox couple and −0.69 V for [ZnPCP•+/3ZnPCP*] (9). 
 The midpoint potential of tyrosine in MZH3 has not been measured.  Tyrosine 
potentials depend upon the protonation states and the mechanism of the electron transfer or 
proton-coupled electron transfer (PCET) of the redox reaction.  Tyrosine has a pKa of about 10.2 
in solution, and at high pH, it can exist partly in the neutral protonated form and partly as the 
deprotonated tyrosinate species (10).  Oxidation of tyrosine in MZH3 should be treated as the 
oxidation of a mixture of these two components, as opposed to the oxidation of a single 
tyrosine species with a pH-dependent driving force for electron transfer (11).  Oxidation of 
protonated tyrosine leads to an unstable radical cation that has a pKa of −2 (12).  If tyrosine 
oxidation proceeds by electron transfer followed by proton transfer (an ET-PT mechanism), then 
protonated tyrosine will have a high midpoint potential of ~1.34 V, because the radical cation 
product of the reaction is so unstable (13).  In contrast, oxidation of the negatively charged 
tyrosinate anion forms the neutral tyrosyl radical that is much more stable than the radical 
cation, giving the Tyr-O−/Tyr-O• redox couple a lower midpoint potential of about 0.72 V, based 
on work by the laboratory of Cecilia Tommos (14).  However, other mechanisms such as 
concerted proton-electron transfer (CPET) are observed in photosystem II redox active tyrosines 
and various phenols from model systems (15-19).  The potentials of these CPET reactions 
depend on the nature of the proton acceptor, among other environmental details. 
Unfortunately, reorganization energy, λ, is very difficult to measure.  The reorganization 
energy for electron tunneling within the hydrophobic core of proteins is typically around 0.7 eV, 
but inter-protein electron transfer, which usually involves tunneling through solvent, has a 
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reorganization energy closer to about 1.3 
eV (6).  An intermediate reorganization 
energy of 1.2 eV may be most appropriate 
for electron transfer rate calculations in 
MZH3, because some cofactors are 
solvent-exposed while others are buried.  
A summary of the measured and predicted 
electron transfer parameters is given in 
Table 4.2.  Figure 4.2 illustrates these 
parameters and applies them to the kinetic model described in section 4.1.1. 
 
RPA 13.1 Å 
RYP 5.0 Å 
RMY 3.7 Å 
RMP 9.6 Å 
Em, [Fe(II)-Heme B/Fe(III)-Heme B] -0.18 V 
Em, [3ZnPCP*/ZnPCP•+] −0.69 V 
Em, [ZnPCP0/ZnPCP•+] 0.91 V 
Em, [Tyr-OH/Tyr-OH•+] ~1.34 V 
Em, [Tyr-O−/Tyr-O•] ~0.72 V 
λ ~1.2 eV 
Table 4.2: Summary of parameters that 
determine electron transfer rates in MZH3 
Parameters listed with a tilde (~) are estimates, 
and the other values have been measured 
experimentally.  Midpoint potentials are vs. SHE. 
  
Figure 4.2: Electron transfer predictions in MZH3 
Left: MZH3 crystal structure CS-B shows inter-cofactor distances, and energy diagrams show 
midpoint potentials and corresponding driving forces for electron transfer.  Right: Once a 
photon is absorbed, the progression of the dyad and triad systems can be predicted using the 
Moser-Dutton ruler (Equation 4.1) and the parameters listed on the left and in Table 4.2.  Red 
traces: Occupancy of the excited state.  Orange trace: Occupancy of A-P+.  Green trace: 
Occupancy of A-D+.  Blue traces: Occupancy of the ground state.  The triad case assumes a 
deprotonated tyrosinate in the starting condition. 
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4.2 Transient absorption 
Tetrapyrroles like heme B and ZnPCP are strong absorbers of visible light, and their 
UV/vis absorbance spectra are highly sensitive to changes in their electronic state.  This makes 
them amenable to characterization by transient absorption spectroscopy, in which a sample is 
photo-excited by a short pulse of bright light, and a measurement of the absorbance is made 
after a series of set time delays to track changes in electronic states.  Here, transient absorption 
is used to examine light-driven electron transfer rates and yields of charge separated states in 
MZH3. 
 
4.2.1  Transient absorption experimental approach 
Here, a transient absorption setup was used that included a 2 ns excitation pulse of 532 
nm light from an Nd:YAG laser directed toward one end of a 1 mL, 1 cm path length quartz 
cuvette containing a sample of interest; the other end of the sample was not exposed to the 
laser light.  After a time delay, the excitation pulse was followed by emission of white light from 
a Xe flash lamp as a probe beam to determine absorbance spectra of the sample that was kept 
in the dark and the sample that was exposed to the excitation pulse.  A monochromator 
separated the light by wavelength, and a PiMax CCD detector recorded the spectra.  The dark 
reference spectrum was subtracted from the photoexcited sample spectrum for data analysis.  
After each measurement, a magnetic stir bar stirred the sample.  Sets of 50 spectra per time 
point were recorded from about 350 nm to 650 nm at time points from 1 μs to up to 10 s after 
the laser pulse.  The gate width of the Xe flash lamp for the experiments described here ranged 
from 600 ns to 1 μs to maximize the signal-to-noise ratio, but the limit of the time resolution for 
161 
 
this setup is about 30 ns.  Transient absorption samples were held at 20°C using a Peltier 
temperature controller.  Figure 4.3 illustrates the transient absorption setup.   
 
Figure 4.3: Schematic of setup for transient absorption experiments 
An excitation flash of 532 nm laser light is absorbed by pigment cofactor in one part of the 
cuvette, while the other part remains dark.  After a variable time delay t, the Xe flash lamp 
emits a probe beam to measure the absorbance spectra of the photo-excited sample and dark 
sample at time t.  A monochromator separates light by wavelength and a PiMax CCD detector 
collects the absorbance spectra.  The light minus dark difference spectrum shows the redox 
states of light-absorbing cofactors. 
 
To avoid redox reactions with oxygen, all transient absorption experiments reported 
here were done with samples that were sealed in a quartz cuvette and thoroughly purged with 
argon purified through an oxygen-scrubbing gas train as described previously (20).  Argon 
purging was continued during the experiment.  Exposure to ambient oxygen resulted in gradual 
attenuation of transient absorption signals and an increased rate of photo-degradation of the 
sample, consistent with production of reactive oxygen species from the zinc porphyrin excited 
triplet state.  Under anaerobic conditions, absorbance spectra at time t = 1 μs after the laser 
flash were measured at the beginning and end of each experiment, and the magnitude of the 
ZnPCP Soret bleach in the final measurement at 1 μs was usually within 5-10% of the first. 
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Transient absorption experiments with MZH3 sought to track two signals with time: one 
from the conversion of the ground state of ZnPCP to the excited triplet state 3ZnPCP* and one 
from ferric Fe(III)-heme B reduction to ferrous Fe(II)-heme.  The difference absorption spectra 
corresponding to these transitions are shown in Figure 4.4.  The ZnPCP•+ radical cation species 
was not observed, presumably because it had a short lifetime and its spectrum is similar to 
3ZnPCP* in the measured wavelength range.  Oxidized tyrosyl radicals have a weak absorbance, 
measured at 2,750 M−1cm−1 at 408 nm in a three-helix bundle maquette (14), but this signal was 
not resolved in experiments described here, probably because the tyrosyl radical absorbance is 
too low and it overlaps with larger absorbance signals from the other cofactors. 
 
 
 
Figure 4.4: Redox difference spectra relevant to transient absorption experiments 
Green: 3ZnPCP* minus ground state of ZnPCP in MZH3-Y168L mutant at pH 7.5, 1 μs after 
flashing with 532 nm light.  Extinction coefficients are rough estimates based on the ground 
state spectrum.  Black: Fe(II)-heme minus Fe(III)-heme difference spectrum in MZH3 wild 
type at pH 7.  Fe(II)-heme spectrum was prepared by reducing the Fe(III)-heme sample with 
excess dithionite, which may cause slight overestimate of Fe(II)-heme extinction coefficients.  
Inset: Spectra of ZnPCP ground state (green), Fe(III)-heme (red), and Fe(II)-heme (blue) bound 
to MZH3.  The ZnPCP spectrum was measured in MZH3 that also contained heme; the heme 
spectrum was subtracted out. 
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4.2.2  Monad and Dyad in MZH3 
 The first step was to reproduce light-activated electron transfer dyad results involving 
zinc tetrapyrroles and heme B that were demonstrated previously in de novo four-helix bundle 
maquettes (1).  To confirm electron transfer between the two cofactors of a dyad, the behavior 
of the dyad must be compared to a monad (a pigment by itself), in order to determine the effect 
of the electron acceptor.  This is because the P+A− state (Figure 4.1) is transient in the dyad and 
is difficult to observe directly.   
A monad maquette was prepared by adding zinc Newkome porphyrin (ZnNP) to MZH3 
at pH 7.3 in the absence of any other cofactor, and the lifetime of the triplet excited state was 
measured by transient absorption.  The lifetime of 3ZnNP* is similar to 3ZnPCP*.  All other 
transient absorption experiments presented in this chapter use ZnPCP as the pigment.  The 
addition of ZnNP to an MZH3 protein that lacks an electron acceptor might allow the ZnNP to 
bind preferentially to the acceptor site or to a mixture of both the pigment and acceptor sites.  
This is not a concern, because the decay rate of the triplet excited state is not expected to be 
sensitive to the relatively modest differences between the environments of the pigment and 
acceptor sites.  The recovery of the ground state spectrum was estimated by the absorbance of 
the Soret band at 423 nm.  Fitting to a single exponential fit gave an estimated lifetime of 3.3 ms 
(Figure 4.5, upper left, black curve). 
A dyad maquette was prepared using an MZH3 mutant in which the tyrosine was 
removed and replaced with leucine.  Leucine was chosen over phenylalanine to avoid a 
structural disruption of the Due Ferro section of the protein, as was observed in a previous Due 
Ferro mutant (21).  As a result MZH3-Y168L/Heme B/ZnPCP has only two redox centers available 
to participate in electron transfer.  Transient absorption measurements were performed at pH 
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7.5, and fitting the Soret absorbance to a single exponential curve showed that the ground state 
recovery was 70 μs, 50 fold faster than in the monad (Figure 4.5).  The Y168L mutant behaved 
similarly at pH 9.5.  This demonstrates that heme B quenched the energy of the excited triplet 
state and is consistent with quenching by an electron transfer mechanism.  However, no Fe(II)-
heme Soret band at 432 nm is evident, even in a close-up view of the heme Soret region (Figure 
4.5, bottom). 
 
 
 
Figure 4.5: Monad and dyad transient 
absorption experiments 
The lifetime of the zinc porphyrin P* state 
in MZH3 is greatly reduced when heme B is 
also bound to MZH3.  Upper left: Scaled 
absorbance at 423 nm of the ZnNP monad 
(black square points) and the ZnPCP-Heme 
B dyad in MZH3-Y168L (red circular points) 
are fitted to single exponential curves 
(lines).  The P* lifetimes of the monad and 
dyad are 3.3 ms and 70 μs, respectively.  
Bottom: Dyad spectra show progression of 
the recovery of the ground state spectrum 
from 1 μs to 10 ms.  Inset: Close-up view of 
the area in the dotted box, where no 
reduced heme Soret is observed. 
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As expected, MZH3-Y168L containing heme B in the acceptor site and ZnPCP in the 
pigment site does not stabilize a long-lived charge-separated state; no peaks suggesting heme 
reduction were observed.  The results are consistent with the behavior of a redox active dyad; 
electrons are transferred from one cofactor to the other, but cannot trap the charge separated 
state for long enough for chemical reactions to occur. 
 
4.2.3  Triad with tyrosine in MZH3 
Some precautions were necessary to ensure that MZH3 triad transient absorption 
results were reproducible and did not contain artifacts from improper cofactor incorporation.  
First, given the impact of the second ZnPCP on the conformation of the tyrosine residue as was 
shown in Figure 3.16, only ~0.8 equivalents of ZnPCP per protein were added to ~3.5 μM MZH3 
samples for triad experiments.  This is to avoid the possibility of an extra ZnPCP binding to the 
metal cavity and interfering with electron transfer.  Second, MZH3 chelates metals, and after 
purification, MZH3 often contains bound metal ions, presumably Ni(II) from a Ni-NTA column.  
For this reason, it was necessary to treat MZH3 samples with a metal chelating agent such as 
100-500 μM ethylenediaminetetraacetic acid (EDTA), and then remove the chelator by desalting 
column or dialysis. 
 In transient absorption experiments where the signal-to-noise ratio is large and signals 
from different species do not overlap, the change in concentration of a species with time can be 
approximated by its absorbance at a single wavelength.  In MZH3 triad experiments, however, 
absorbance features from different species overlap extensively, as shown in Figure 4.4, and if 
the yield is low, the heme redox spectrum may be noisy.  For this reason, it was necessary to use 
singular value decomposition (SVD) to separate spectral components and determine the rates of 
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electron transfer reactions (22), following methods described in the appendix.  Quantum yields 
were calculated using an approximate ratio of −2.8 between the extinction coefficient at 423 nm 
at 1 μs (due to the ZnPCP excited triplet minus ground state) and the extinction coefficient at 
431 nm of the peak of the heme redox spectrum from SVD analysis.  In this way, rough 
estimates of the yields of the charge separated state for different triad experiments were 
calculated in a self-consistent manner in order to make comparisons between experiments with 
different MZH3 mutants and at varying pH.  For consistency, all of the following triad 
experiments used the following conditions: ~3.5 μM MZH3, 1.0 equivalent of heme B per 
protein, ≤ 0.8 equivalents of ZnPCP per protein, and 50 mM NaCl.  Experiments at pH 7.5 used 
10 mM 3-(N-morpholino)propanesulfonic acid (MOPS) as a buffer, and at pH 9.5, 10 mM N-
cyclohexyl-2-aminoethanesulfonic acid (CHES) buffer was used. 
 Transient absorption with wild type MZH3 at pH 7.5 produced results that had 
similarities to the MZH3-Y168L dyad, but a distinct peak at 432 nm was observed, consistent 
with the reduced heme difference spectrum in Figure 4.4.  SVD analysis showed that the 
recovery of the ground state of ZnPCP had a lifetime of 40 μs, similar to the 70 μs lifetime in 
Y168L, but the absorbance peak at 432 nm persisted for 4 ms.  The Q-band absorbance at 560 
nm could not be resolved.  The relatively weak putative heme Soret band at 432 nm 
corresponds to a quantum yield of the charge separated state of 2%.  The wild type MZH3 
transient absorption spectra are shown in Figure 4.6. 
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Figure 4.6: Transient absorption spectra of wild type MZH3 with heme B and ZnPCP at pH 7.5 
Inset: Close-up view of the region in the dotted box shows an absorbance feature at 432 nm, 
where the ferrous heme Soret band absorbs. 
 
 Given that tyrosine oxidation depends on protonation state, pH was expected to have a 
pronounced effect on electron transfer kinetics.  For this reason, the wild type MZH3 transient 
absorption experiment was repeated at pH 9.5.  The results were similar to the wild type results 
at pH 7.5 in some regards, with a weak feature at 432 nm corresponding to a quantum yield of 
2.5% and a triplet excited state lifetime of 50 μs.  However, the lifetime of the putative charge 
separated state increased to 150 ms at pH 9.5.  This is 38-fold longer than the 4 ms lifetime of 
the charge separated state at pH 7.5.  In addition, SVD analysis found that weaker absorbance 
features at 560 nm and ~533 nm were correlated with a stronger absorbance feature at 532 nm; 
this SVD component strongly resembled the heme redox spectrum from Figure 4.4.  The 
transient absorption spectra and SVD analysis are shown in Figure 4.7. 
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Figure 4.7: Transient absorption 
and SVD of wild type MZH3 with 
heme and ZnPCP at pH 9.5 
A: Transient absorption spectra.  
Inset: close-up of dotted box.  B: 
Time evolution of SVD component 
1 corresponding to ZnPCP ground 
state recovery (red points), and 
model fitting (large orange 
points).  C: Time evolution of SVD 
component 2 corresponding to 
the heme redox signal (green 
points), and model fitting (large 
blue points).  D: Spectrum of SVD 
component 2 (cyan points) and 
overlay of heme redox spectrum 
(black line). 
 
 The MZH3-L71H mutant was made to facilitate proton-coupled electron transfer 
reactions involving the tyrosine, similar to the interaction between tyrosine Z and a histidine 
side chain in photosystem II.  The crystal structure of MZH3-L71H was solved with heme B and 
Cd(II) bound, and the mutant succeeded in forming the intended histidine-tyrosine hydrogen 
bond, as was shown in Figure 3.21.  Transient absorption results show that the MZH3-L71H 
mutant also succeeded in increasing the yield of the charge separated state compared to the 
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wild type.  At pH 7.5, the calculated yield was 6%, and at pH 9.5 the yield was 4%.  The increased 
yield was accompanied by a decreased lifetime of the charge separated state.  The lifetimes of 
the MZH3-L71H charge separated state at pH 7.5 and 9.5 were 1.2 ms and 32 ms, respectively.  
Once again, the lifetime was shorter at pH 7.5 than at 9.5.  (Transient absorption results with 
tyrosine are summarized in Table 4.3). 
 Other MZH3 mutants were made to further examine the dependence of tyrosine 
oxidation kinetics on the presence of protonatable groups.  In photosystem II, the histidine that 
hydrogen bonds the redox active tyrosine Z shares a second hydrogen bond with the side chain 
of asparagine 298 on the D1 protein (23).  An exhaustive mutagenesis study of the 19 possible 
mutants at position 298 found that 12 mutants were incapable of oxygen evolving activity and 
the other 7 had significantly decreased activity and increased photosensitivity (24).  Evidently, 
this distal hydrogen bond plays a significant role in tyrosine oxidation kinetics.  To try to 
reproduce this effect, an aspartate residue was placed at position 31 in the mutant MZH3-L71H-
L31D.  Asp31 was meant to make a hydrogen bond to His71 to keep the His71 Nδ atom 
protonated so that the His71 Nε atom would accept a hydrogen bond from tyrosine.  In addition, 
the aspartate was intended to stabilize the protonated histidine imidazolium cation and increase 
the yield of the charge separated state in MZH3.  The intended structure is shown in Figure 4.8. 
 
Figure 4.8: Predicted structure of MZH3-L71H-
L31D double mutant 
The crystal structure of MZH3-L71H with 
Cd(II) and heme B is shown with carbon atoms 
in green.  The predicted preferred rotamer of 
D31 is overlaid onto the position of L31 in the 
crystal structure and colored with white 
carbon atoms.  The histidine and aspartate 
are within hydrogen bonding distance. 
Image rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC. 
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 Transient absorption experiments showed that the MZH3-L71H-L31D mutant succeeded 
in increasing the yield of the charge separated state over the yield of the MZH3-L71H mutant 
and the wild type protein.  The addition of Asp31 increased the yield to 8% at pH 7.5 and 12% at 
pH 9.5.  In addition, the lifetimes of the charge separated state decreased to 140 μs and 2.5 ms 
at pH 7.5 and 9.5, respectively; as with other MZH3 variants, the charge separated state lasted 
longer at higher pH.  The lifetime of the ground state recovery of ZnPCP was similar to other 
variants, about 30 μs at pH 7.5 and 50 μs at pH 9.5.  The MZH3-L71H-L31D transient absorption 
results at pH 9.5 are presented in Figure 4.9. 
 
 
 
  
 
 
Figure 4.9: Transient absorption and 
SVD analysis of MZH3-L71H-L31D with 
heme and ZnPCP at pH 9.5 
A: Transient absorption spectra.  Inset: 
close-up of dotted box.  B: Time 
evolution of SVD component 1 
corresponding to ZnPCP ground state 
recovery (red points), and model fitting 
(large orange points).  C: Time 
evolution of SVD component 2 
corresponding to the heme redox 
signal (green points), and model fitting 
(large blue points).  D: Spectrum of SVD 
component 2 (cyan points) and overlay 
of heme redox spectrum (black line). 
171 
 
 The tyrosine 168 side chain of MZH3 and MZH3-L71H makes a hydrogen bond to the 
metal-ligating residue glutamate 34 (see Figure 3.21).  This reproduces an interaction that is 
observed in Due Ferro proteins and natural diiron proteins such as bacterioferritin (25, 26).  In 
order to probe the involvement of Glu34 in tyrosine redox activity, the MZH3-L71H-E34A mutant 
was prepared.  Transient absorption results showed a significant drop in the yield of the charge 
separated state and a modest increase in lifetime.  At pH 7.5, MZH3-L71H-E34A had a yield of 
only 1% and a lifetime of roughly 3 ms.  At pH 9.5, the yield was about 3%, and the lifetime was 
about 40 ms.  The significant drop in yield upon removal of Glu34 suggests that Glu34 is involved 
in modulating the midpoint potential of the tyrosine, its pKa, or the efficiency of the proton 
transfer step in tyrosine oxidation. 
 Bacterioferritin binds heme B by bis-methionine ligation, and the Wydrzynski group has 
shown that a modified bacterioferritin can bind zinc chlorin e6 (ZnCe6) in place of heme B, and 
this pigment is able to photo-oxidize tyrosine amino acids in bacterioferritin (27, 28).  To our 
knowledge, methionine ligation of zinc tetrapyrroles has not been tested in protein maquettes.  
Substitution of a hydrophobic methionine ligand for a polar histidine could serve to raise the 
midpoint potential of a zinc tetrapyrrole to increase the yield of tyrosine and metal ion 
oxidation.  To test whether a methionine ligation of the zinc tetrapyrrole affects oxidation of 
tyrosine, the histidine in the pigment site was mutated to a methionine residue in the MZH3-
L71H-H124M mutant.  An ultraviolet/visible spectroscopic titration showed that MZH3-L71H-
H124M binds heme B with high affinity, albeit slightly more weakly than wild type MZH3.  The 
dissociation constant for ZnPCP binding was weakened from 10 nM with His124 to about 100 
nM with Met124.  The titration of ZnPCP into a solution of MZH3-L71H-H124M that contained 
heme B showed that the ZnPCP Soret band absorbance was centered at 420 nm, representing a 
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blue-shift of about 2 nm relative to the wild type.  Despite these differences between the 
histidine- and methionine-ligated ZnPCP, transient absorption experiments of MZH3-L71H-
H124M were not radically different from MZH3-L71H.  At pH 7.5, the yield was 8% and the 
charge separated state lifetime was 3.4 ms (compared to 6% and 1.2 ms for MZH3-L71H).  At pH 
9.5, the yield for MZH3-L71H-H124M was 5% and the lifetime was 60 ms (compared to 4% and 
32 ms for MZH3-L71H). 
 A summary of these transient absorption results is shown in Table 4.3.  In each protein 
tested, the lifetime of the charge separated state was extended by an increase in the pH.  In 
general, measurements of the lifetimes of the charge separated states were found to be highly 
reproducible, but yield estimates were subject to a larger error.  These transient absorption 
experiments do not provide direct experimental evidence of tyrosine oxidation, but the 
observed changes in electron transfer kinetics would be difficult to explain without invoking 
tyrosine redox activity.  The 
replacement of tyrosine with 
leucine completely eliminates 
detection of a long-lived charge 
separated state, and the 
introduction of polar groups 
near the tyrosine residue 
effects pronounced changes in 
yield and lifetime that are 
consistent with the known 
MZH3 mutant pH CS lifetime CS yield 
wt 7.5 ~4 ms 2% 
Y168L 7.5 N/A N/A 
L71H 7.5 1.2 ms 6% 
L31D/L71H 7.5 140 µs 8% 
E34A/L71H 7.5 ~3 ms 1% 
L71H/H124M 7.5 3.4 ms 8% 
wt 9.5 150 ms 2.5% 
Y168L 9.5 N/A N/A 
L71H 9.5 32 ms 4% 
L31D/L71H 9.5 2.5 ms 12% 
E34A/L71H 9.5 40 ms 3% 
L71H/H124M 9.5 60 ms 5% 
Table 4.3: Transient absorption results in MZH3 with heme 
B and ZnPCP 
Summary of quantum yields and lifetimes of charge 
separated (CS) states in MZH3 and MZH3 variants with 
Heme B and ZnPCP and in the absence of metal ions.  
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proton dependence of tyrosine oxidation. 
 
4.2.4  Triad with iron in MZH3 
 MZH3 was originally intended to function as a redox-active tetrad involving an iron or 
cobalt tetrapyrrole, a zinc tetrapyrrole, a tyrosine side chain, and a metal ion.  However, the 
ZnPCP-to-metal distance is close enough for direct electron transfer to occur, and tyrosine 
oxidation could be bypassed if the driving force and reorganization energy are favorable.  The 
metal-to-ZnPCP distance for Zn(II) is 10.1 Å, and it is 9.6 Å for Mn(II).  The metal dication that 
would be easiest to photo-oxidize in MZH3 transient absorption experiments would probably be 
Fe(II), because it should bind to the di-metal site with high affinity, and it has a lower midpoint 
potential than Mn(II) or Co(II).  Due Ferro maquettes and natural diiron proteins like 
bacterioferritin can alternately oxidize and reduce iron using oxygen and a reductant (26, 29-
31), so it is a natural starting point for tests of metal photo-oxidation in MZH3.  All transient 
absorption experiments with metal ions were carried out at pH 7.5 and not pH 9.5 because of 
the risk of precipitation of metal hydroxide complexes, which could complicate results. 
 Addition of large concentrations of FeCl2 (in excess of 500 μM) in transient absorption 
experiments with 3.5 μM MZH3 appears to have led to the use of Fe(II) as an unbound sacrificial 
electron donor.  Treatment of MZH3-L71H, MZH3-Y168L, and MZH3-L71H-E34A with high Fe(II) 
concentrations always resulted in the trapping of a reduced state of heme B for at least 10 s; 
recombination was not observed. 
 The MZH3-L71H-E34A mutant is likely to have impaired metal binding activity at the site 
closest to the ZnPCP, because Glu34 is a bidentate ligand of the metal at that site.  Removal of 
either of the corresponding bidentate axial glutamate residues from bacterioferritin results in a 
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protein that can only bind one Co(II) ion per bundle (32).  Therefore, it is likely that E34A 
prevents binding of metal ions to the site nearest the tyrosine.  Transient absorption 
experiments of 3.0 μM MZH3-L71H-E34A with heme B, ZnPCP, and 1 mM FeCl2 led to heme B 
remaining reduced for longer than 10 s, but when the experiment was repeated with only 10 
μM FeCl2, the lifetime of the charge separated state was roughly 5 ms, which is similar to the ~3 
ms lifetime that was observed in the absence of FeCl2.  In addition, the yields of MZH3-L71H-
E34A experiments with and without 10 μM FeCl2 were both about 1%, but at 1 mM FeCl2, the 
yield was 6%.  At 50 μM FeCl2, the yield and lifetime of the charge separated state were 1.5% 
and ~10 ms, which are only slightly different from the metal-free MZH3-L71H-E34A. 
 In contrast, MZH3-L71H, which binds metal ions with high affinity, had a dramatic 
increase in the lifetime of the charge separated state when only 10 μM FeCl2 was added.  In the 
absence of Fe(II) the lifetime was 1.3 ms, but the presence of 10 μM FeCl2 increased the lifetime 
to 300 ms.  The 10 μM FeCl2 experiment also had a modest increase in yield to 8% from 6% 
without FeCl2.  These results are presented in Figure 4.10.  The lifetime of the recovery of the 
ground state bleach of the ZnPCP was close to the lifetime without iron, 60 μs. 
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Figure 4.10: Transient absorption 
and SVD analysis of MZH3-L71H 
with heme, ZnPCP, and 10 μM 
FeCl2 at pH 7.5 
A: Transient absorption spectra.  
Inset: close-up of dotted box.  B: 
Time evolution of SVD component 
1 corresponding to ZnPCP ground 
state recovery (red points), and 
model fitting (large orange 
points).  C: Time evolution of SVD 
component 2 corresponding to 
the heme redox signal (green 
points), and model fitting (large 
blue points).  D: Spectrum of SVD 
component 2 (cyan points) and 
overlay of heme redox spectrum 
(black line). 
 
 
  
 The MZH3-Y168L mutant should be competent to bind metal ions, but its metal affinity 
might be weakened slightly, because the Tyr168 makes a hydrogen bond to Glu34, which 
stabilizes Glu34 in the metal-binding conformation.  The metal ligand Glu161 is intended to 
make a bidentate ligation of a metal ion in the same way that Glu34 ligates the other metal ion, 
and Glu161 has consistently higher temperature factors in its side chain than Glu34 in almost all 
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MZH3 crystal structures.  Glu161 lacks a second shell hydrogen bond to a tyrosine, which 
suggests a stabilizing role for the second shell tyrosine contact.  For this reason, removal of 
Tyr168 in MZH3-Y168L could weaken metal ion affinity.  When 10 μM FeCl2 was added to 3.5 
μM MZH3-Y168L for a transient absorption experiment, the results showed a clear heme redox 
signal with a low yield of approximately ~2% and a lifetime of roughly ~500 ms.  This charge 
separated lifetime is similar to the lifetime in MZH3-L71H with 10 μM FeCl2, which suggests that 
the tyrosine is not involved in formation of the charge separated state.  The decreased quantum 
yield in MZH3-Y168L compared to MZH3-L71H can be attributed to the presumed decreased 
affinity for metal ions. 
These results show that a bound iron ion can act as the electron donor in a redox-active 
triad in MZH3.  In MZH3-L71H, addition of 10 μM FeCl2 increases the lifetime of the charge 
separated state by a factor of 220.  The same concentration of FeCl2 does not significantly affect 
the lifetime of MZH3-L71H-E34A, a mutant that probably does not bind Fe(II) with high affinity 
at the metal site that is proximal to the pigment site.  The disparity in the effect of 10 μM FeCl2 
shows that at this low concentration, Fe(II) is not an effective sacrificial electron donor in 
transient absorption experiments.  Because 10 μM FeCl2 gives MZH3-L71H a longer lifetime and 
higher yield but eventually recombines after 300 ms, MZH3-L71H must be photo-oxidizing 
bound Fe(II) and not free Fe(II). 
Since heme reduction in MZH3-Y168L is not observed in transient absorption 
spectroscopy unless 10 μM FeCl2 is present, tyrosine 168 is not essential to photo-oxidation of 
bound Fe(II) in MZH3.  Therefore, MZH3 containing heme B, ZnPCP, tyrosine, and Fe(II) functions 
as a triad and not as a tetrad that involves the activity of tyrosine.  This could be the result of the 
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relatively low potential of iron compared to manganese or cobalt; Fe(II) may have a sufficiently 
high driving force for oxidation by ZnPCP that it can outcompete tyrosine oxidation. 
 A summary of the transient absorption results presented so far is given in graphical form 
in Figure 4.11. 
 
Figure 4.11: Summary 
of transient 
absorption results in 
graphical form 
Circular and square 
data points represent 
experiments at pH 
7.5 and pH 9.5, 
respectively.  Unless 
otherwise noted, 
data points represent 
experiments in the 
absence of metal 
ions. 
 
4.2.5  MZH3 reverts to dyad behavior in the presence of Zn, Cd, or Mn 
The addition of MnCl2 or ZnSO4 eliminated the long-lived charge separated state in 
transient absorption experiments.  Zn(II) is not redox active, but the potential of the 
Mn(II)/Mn(III) redox couple should make Mn(II) susceptible to oxidation in this system.  In one 
experiment with 2.4 μM MZH3-L71H with heme B and ZnPCP and no metal ions at pH 7.5, a 
charge separated state had a lifetime of 1.2 ms and a yield of 6%.  A ZnSO4 stock solution was 
added to a final concentration of 10 μM, and the experiment was repeated.  The ZnPCP Soret 
bleach was red-shifted with the addition of ZnSO4 by about 2-3 nm from 422 nm to 425 nm.  The 
heme redox signal was not observed in the presence of ZnSO4.  The lifetime of the recovery of 
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ZnPCP ground state was 70 μs with Zn(II), similar to the 60 μs lifetime in the absence of metal 
ions.  Evidently, Zn(II) binding to MZH3-L71H inhibits oxidation of the tyrosine. 
This experiment was repeated with 3.4 μM MZH3-L71H-L31D with heme B and ZnPCP.  
Despite the addition of Asp31 to increase the polarity of the tyrosine environment, the same 
result was observed; a charge separated state was trapped in the absence of metal ions, but 10 
μM ZnSO4 eliminated the heme redox signal. 
Preliminary results have shown that the same inhibitory effect and red-shifted ZnPCP 
Soret absorbance was observed in the presence of MnCl2.  No long-lived charge separated state 
was observed by transient absorption in MZH3-L71H-H124M with 10 μM MnCl2, MZH3-L71H 
with 4 mM MnCl2, or wild type MZH3 with 1 mM MnCl2 at pH 7.5.  All of these MZH3 variants 
trap a long-lived charge separated state in the absence of Mn(II), but lose the ability to do so in 
high yield when Mn(II) binds. 
 It is unclear why the binding of metal ions would inhibit formation of the charge 
separated state in MZH3.  One possibility is that metal binding alters the midpoint potential of 
the tyrosine.  The presence of the metal could alter the tyrosine potential by an electrostatic 
effect, but crystal structures show that Glu34 appears to shield the positive charge of the metal 
ion from the tyrosine.  In addition, at pH 7.5, the initial and final states of the tyrosine are both 
expected to be neutral, because the electron transfer is coupled to proton transfer.  This would 
make the electrostatic influence of the metal irrelevant if tyrosine oxidation follows a concerted 
PCET mechanism. 
It is unlikely that tyrosine 168 of MZH3 ligates a metal ion, which could change its 
midpoint potential from the expected value.  A tyrosinate-Fe(III) ligand has been detected in 
Due Ferro proteins, but not a tyrosinate-Fe(II) ligand (21, 33, 34).  A tyrosinate-Fe(III) spectral 
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signature was not observed in MZH3 (Figure 2.19), and crystal structures show that the distance 
between the tyrosine phenolic oxygen and metal ion is at least 3.2 Å.  This is much longer than 
the tyrosinate-Fe(III) ligand in Due Ferro variant DFsc, which has an Fe(III)-O bond length of 1.89 
Å (21).  In addition, the carboxylate group of Glu34 stands between Y168 and the metal to make 
a hydrogen bond with the tyrosine and a bidentate ligation of the metal.  The Tyr-to-Zn(II) 
distance is even longer than the Tyr-to-Mn(II) distance; crystal structure CS-A, which has one 
ZnPCP in the pigment site and Zn(II), has 3.7 Å between the tyrosine phenolic oxygen and the 
Zn(II).  Both Mn(II) and Zn(II) were shown to inhibit formation of the charge separated state, so a 
tyrosinate-metal ligand in MZH3 is not supported by experimental evidence. 
Metal binding may inhibit efficient deprotonation of the tyrosine.  It could be that when 
a metal ion binds, Tyr168 donates a hydrogen bond to Glu34 which cannot accept a proton 
because it is ligating a metal ion.  This would stabilize the proton on Tyr168 and inhibit 
oxidation.  However, a study of bacterioferritin shows that a tyrosine in an analogous hydrogen 
bonding interaction with an iron-ligating glutamate residue, Tyr25, is oxidized during normal 
function of the protein (29).  Another study in a modified bacterioferritin showed photo-
oxidation of this same tyrosine in the presence of manganese and further showed that tyrosine 
could not be photo-oxidized in the absence of metal ions (27, 28, 35).  The metal dependence of 
Tyr25 oxidation in bacterioferritin is the opposite of what is observed for Tyr168 in MZH3.  
Despite the difference in tyrosine oxidation activity, MZH3 and bacterioferritin have highly 
similar overall folds (see Figure 3.18); specific interactions may be significant in achieving 
tyrosine oxidation in the presence of bound metal ions.  Unlike the Tyr168 residue of wild type 
MZH3, which contacts only hydrophobic residues apart from the metal-ligating Glu34, Tyr 25 of 
bacterioferritin is surrounded by a total of four carboxylate amino acids: the metal-ligating 
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Glu94 as well as Glu44, Glu47, and Asp90 (36).  The difference in the polarity of the environment 
of the tyrosines in MZH3 and bacterioferritin might be the source of the difference in redox 
activity.  The highly polar environment around Tyr25 in bacterioferritin could facilitate proton 
transfer from Tyr25 even if Glu94 is unable to accept a proton. 
 The flexibility of MZH3 could play a role in tyrosine oxidation.  DF3 is known to have 
relatively low stability in the apo-state (33), and MZH3 does not crystallize in the absence of 
metal ions and its helicity and stability increase significantly in the presence of MnCl2 and CaCl2 
(Table 2.6 and Figure 2.20).  This metal-dependent stability suggests that apo-MZH3 may have 
structural fluctuations in the vicinity of the metal binding site that could increase solvent 
exposure of tyrosine 168.  Metal binding may restrict these motions and thereby lower the 
solvent exposure of Tyr168.  This would decrease the rate of deprotonation of the tyrosine so 
that its oxidation is no longer able to compete with the rate of reduction of ZnPCP•+ by Fe(II)-
heme B.  The 2-3 nm redshift in the ZnPCP Soret band when metal ions bind might also be 
caused by a decrease in the degree of penetration of solvent into the core of MZH3. 
 Photo-oxidation of manganese ions has been achieved before in modified natural 
proteins (27, 37, 38), and there is no reason why it can’t be done in a maquette.  Future work 
should seek to determine why metal binding inhibits tyrosine oxidation in MZH3 and how to 
oxidize Mn(II).  It may be possible to achieve efficient manganese oxidation by altering the 
driving forces by raising the pH, using a higher potential zinc tetrapyrrole, or altering the 
environment of the Mn(II) ion or Tyr168 through mutagenesis. 
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4.2.6  Photo-reduction of cobalt protoporphyrin IX 
 Cobalt protoporphyrin IX (CoPPIX) has been used for photo-catalytic hydrogen 
generation in modified natural proteins (39, 40).  Co(III)PPIX binds to wild type MZH3 with a 
dissociation constant of 250 nM, 35 times stronger than the Co(III)PPIX affinity of cytochrome 
b562 (39), as described in section 2.3.3.  For this reason, CoPPIX may be a viable candidate for 
catalytic hydrogen production in MZH3.  One of the natural proteins that promoted hydrogen 
evolution using CoPPIX was cytochrome b562, which uses a histidine and a methionine to ligate 
the cofactor (39).  In order to reproduce this His-Met ligation scheme, the MZH3-His110Met 
mutation was made. 
Before testing for photo-reduction of CoPPIX, reference spectra of Co(III)PPIX and 
Co(II)PPIX bound to MZH3-His110Met were determined in order to confirm binding and to aid 
data analysis.  The Co(III)PPIX state is more stable under aerobic conditions; the midpoint 
potential of the [Co(III)PPIX/Co(II)PPIX] redox couple was measured at 100 mV vs. SHE in 
myoglobin and 16 mV vs. SHE in cytochrome b562 (39, 41).  These potentials should make it 
possible for the excited state 3ZnPCP* cofactor to reduce Co(III)PPIX, since the 
[ZnPCP•+/3ZnPCP*] midpoint potential is −0.69 V.  The Co(III)PPIX Soret absorbance peak had a 
wavelength of 429 nm in MZH3-His110Met and 426 nm in wild type MZH3, similar to the 424-
430 nm range found for cobalt cytochrome b562 variants, cobalt myoglobin, and a four-helix 
bundle maquette (39, 41, 42).  Co(III)PPIX was reduced in MZH3-His110Met and wild type MZH3 
using dithionite, but the reduction was slow.  This is consistent with observations that the 
Co(III)PPIX/Co(II)PPIX transition in myoglobin and in maquettes is orders of magnitude slower 
than heme reduction, and these slow kinetics have been attributed to a structural 
rearrangement (41, 42).  During reduction of Co(III)PPIX in MZH3 variants, the decrease in the 
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Co(III)PPIX Soret band absorbance was accompanied by a concomitant increase in a weaker, 
broader Co(II)PPIX Soret band increase at 399 nm in MZH3-His110Met or 397 nm in wild type 
MZH3.  Similar Co(II)PPIX Soret absorbance wavelengths have been reported between 394 nm 
and 406 nm in myoglobin and at 401 nm in a four-helix bundle maquette (40-42).  The CoPPIX 
spectra in MZH3-His110Met and in myoglobin are shown in Figure 4.12. 
 
 
Figure 4.12: Co(II/III)protoporphyrin IX spectra in MZH3 and myoglobin 
Left: Spectra of 3 μM MZH3-His110Met bound to CoPPIX in 20 mM sodium phosphate, 50 mM 
NaCl at pH 7.5.  Red trace is Co(III)PPIX and black trace is Co(II)PPIX reduced with excess 
dithionite.  (Dithionite accounts for the steep increase in absorbance of the Co(II)PPIX trace 
near 319 nm).  The green and blue traces are mixtures of Co(III) and Co(II)PPIX collected 
before the slow reduction was complete.  Right: Literature Co(III)-myoglobin and Co(II)-
myoglobin spectra collected at pH 6.8 in a spectroelectrochemical cell.  Potentials at which 
spectra were measured are given vs Ag|AgCl (saturated KCl).  Figure reproduced from Li et al., 
2000 (41). 
 
 CoPPIX photo-reduction was tested by transient absorption spectroscopy in MZH3 
variants that also had ZnPCP bound.  The experiment was run at pH 7.5 and pH 9.5 using wild 
type MZH3 and MZH3-His110Met.  There was no sign of a Co(II)PPIX peak in any of the transient 
absorption experiments.  However, in all cases, the excited 3ZnPCP* triplet state lifetime was 
decreased from 3.3 ms in the ZnPCP-MZH3 monad to roughly 100 μs when Co(III)PPIX was 
present.  This could mean that Co(III)PPIX is transiently reduced to the Co(II)PPIX state, but that 
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reduction of ZnPCP•+ by Co(II)PPIX outcompetes tyrosine oxidation.  Energy transfer is another 
possible explanation for the reduced lifetime of the 3ZnPCP* excited state. 
 The fact that Co(III)PPIX reduction kinetics are slow might explain the absence of 
Co(II)PPIX in transient absorption.  To test whether CoPPIX reduction is possible in MZH3 over 
longer timescales, continuous illumination experiments were used to look for Co(II)PPIX 
production on a minutes to hours timescale.  A CUDA model I-150 halogen lamp with a 150 W 
bulb illuminated the sample using a fiber optic cable, and the anaerobic sample was held at 20°C 
using a Peltier temperature controller.  Anaerobic samples of ~3 μM wild type MZH3 and MZH3-
His110Met were prepared with CoPPIX and ZnPCP at pH 9.5 with 1 mM EDTA, 0.5-1 mM 
ascorbate, 50 mM NaCl, and 10 mM CHES buffer.  Under these conditions, a distinct Co(II)PPIX 
Soret peak was observed at 397-399 nm within a few minutes of the start of illumination, and it 
was accompanied by a concomitant decrease of the Co(III)PPIX Soret at 427-429 nm.  Reduction 
continued over the course of about 1 hour.  However, no CoPPIX reduction was observed when 
the pH was lowered to 7.5 or if either ascorbate or EDTA were not included in the sample. 
In previous maquettes, CoPPIX has been reported to dissociate from the maquette after 
reduction to the Co(II)PPIX state (42).  For this reason, the wild type MZH3 sample was tested 
for Co(II)PPIX dissociation.  After 2 hours of illumination, when reduction to the Co(II)PPIX state 
had been completed, the light source was turned off.  About 0.2 μM Co(III)PPIX was added to 
the anaerobic sample to test for binding; if Co(II)PPIX remains bound, then no Co(III)PPIX should 
bind to MZH3.  Unexpectedly, the added Co(III)PPIX was reduced within the time it took to 
record a spectrum (less than one minute).  This suggests that the solution potential had been 
lowered over the course of the experiment.  After removal of free CoPPIX by a PD-10 desalting 
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column (GE Healthcare Life Sciences), a Co(II)PPIX Soret peak at ~398 nm remained, suggesting 
that Co(II)PPIX remained bound to wild type MZH3 after reduction. 
 These results clearly establish that light-driven reduction of Co(III)PPIX to Co(II)PPIX 
occurs slowly in MZH3.  The requirements of high pH and the presence of both ascorbate and 
EDTA are not easily explained, but the pH dependence suggests involvement of the tyrosine in 
electron transfer.  It could be that either EDTA or ascorbate serves as the sacrificial electron 
donor, while the other performs an unexpected function such as storing reducing equivalents or 
directly interacting with the protein in a way that influences electron transfer rates.  This line of 
research is ongoing, but current results show that CoPPIX photo-reduction occurs in MZH3. 
 
4.3 Summary of electron transfer in MZH3 
4.3.1  ZnPCP binding to metal cavity is not consistent with transient absorption results 
If ZnPCP binds to the opening of the metal cavity in transient absorption experiments, it 
would push the tyrosine side chain out of the core, as observed in crystal structures CS-B and 
CS-C and shown in Figure 3.16.  This would break the hydrogen bond with the histidine in the 
MZH3-L71H mutant, and a more solvent-exposed tyrosine side might be easier to oxidize than a 
buried tyrosine, because it might be more stable in the charged tyrosinate form.  There are 
several reasons why it is unlikely that a second ZnPCP binds to the metal cavity. 
All transient absorption experiments were done with sub-stoichiometric ZnPCP to avoid 
the possibility of a second ZnPCP binding to the opening of the metal binding site cavity.  
Ultraviolet/visible spectroscopic titrations showed high-affinity binding of ZnPCP at neutral pH 
with a stoichiometry of 1:1, and changing the pigment site His124 to Met124 results in changes 
in binding affinity and creates a blue-shift in the ZnPCP spectrum.  Crystal structures CS-B and 
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CS-C showed a clear preference of the ZnPCP for the pigment site rather than the metal cavity.  
This suggests that ZnPCP is not present in the metal binding site under the conditions of the 
transient absorption experiments. 
If a ZnPCP molecule were to bind to the metal cavity in these experiments, it would be 
30 Å from the heme, meaning that this ZnPCP could not reduce the heme because the maximum 
rate of heme reduction by 3ZnPCP* to the heme would have a lifetime of about 1000 s.  The fact 
that heme is reduced on a μs timescale shows that a ZnPCP must be bound to the pigment site. 
Despite this reasoning, it may be worthwhile to confirm that ZnPCP does not bind to the 
opening of the metal cavity in transient absorption experiments.  One way to do this would be 
to repeat these experiments with zinc tetrapyrroles that are unlikely to bind to MZH3 at the 
metal site, such as NR117 or SE375 (see Table 2.4).  Another alternative is to make mutations to 
MZH3 that would destabilize the ZnPCP at the opening of the metal cavity and the interfacial 
conformation of the tyrosine. 
 
4.3.2  Analysis of transient absorption results 
 The rate of the electron transfer from the excited triplet state 3ZnPCP* to Fe(III)-heme B, 
kCS1, was consistently measured at about 104.5 s−1 (30 to 70 μs lifetime) for all transient 
absorption experiments.  This lifetime is more than an order of magnitude slower than the 
estimated 1 μs lifetime (106 s−1 rate of kCS1) calculated using the Moser-Dutton ruler (Equation 
4.1) from parameters in Table 4.2.  This discrepancy is surprising, but could be explained by an 
unusually large reorganization energy (~1.6 eV) or an uneven distribution of the 3ZnPCP* 
wavefunction that creates a longer effective distance RPA. 
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Regardless of reorganization energy or distance, the rate of charge recombination 
between the Fe(II)-heme and ZnPCP•+, kCR1, should be about 20 times faster than the forward 
electron transfer rate, kCS1.  Based on the measured rate of kCS1, this would put kCR1 close to 105.8 
s−1.  Therefore, less than 5% of the A-P+ intermediate should be observable in the dyad.  This is 
consistent with transient absorption results that did not detect the intermediate A-P+ state. 
At pH 9.5, around 30% of Tyr168 will be deprotonated before the flash, assuming a 
tyrosine pKa of 10.  Using the parameters in Table 4.2, tyrosinate oxidation by ZnPCP•+ should 
proceed with a rate kCS2 of 109.5 s−1, and the recombination rate, kCR2, should be 106.3 s−1, so the 
rate of charge separation is favored by a factor of 103.2.  Since the rate of the first recombination 
kCR1 is 105.8 s−1, the return to the ground state should proceed at a rate of 105.8−3.2 s−1, or 102.6 s−1 
corresponding to a lifetime of 2.5 ms.  Transient absorption experiments with MZH3-L71H-L31D 
are in agreement with this model; the measured lifetime of the MZH3-L71H-L31D charged 
separated state at pH 9.5 is 2.5 ms and the yield is 12%.  Other mutants that have lower yields 
and longer lifetimes of the charge separated state are consistent with higher tyrosine pKa values 
and corresponding lower midpoint potentials of the [Tyr-O−/Tyr-O•] redox couple. 
At pH 7.5, the fraction of tyrosine in the tyrosinate state is small, assuming a pKa of 10, 
and tyrosine oxidation might proceed through the tyrosyl radical cation, which would have a 
midpoint potential of ~1.34 V.  The 0.43 eV uphill driving force for tyrosine oxidation by ZnPCP•+ 
would have a lifetime of around 400 μs, and give <1% yield.  However, if the tyrosine potential 
were slightly lower, at 1.28 V, then 40 μs electron transfer could take place, and this could 
account for a 4% yield, assuming proton transfer can also take place in 40 μs.  This mechanism is 
consistent with the wild type MZH3 yield of 2% at pH 7.5. 
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Upon binding of Fe(II), the lifetime of the charge separated state becomes 300 ms.  This 
recombination rate is about 105.3 times slow than the dyad short circuit kCS1, and corresponds to 
a [Fe(II)/Fe(III)] midpoint potential of about 0.59 V.  This potential would be high for iron but is 
not unreasonable, as iron midpoint potentials in diiron proteins can vary across a wide range. 
 
4.3.3  Conclusion and future directions 
The transient absorption results presented in this chapter demonstrate that MZH3 can 
assemble a charge separating triad that involves heme B as the acceptor, ZnPCP as the pigment, 
and either tyrosine or Fe(II) as the donor.  A stable charge separated state is formed when 
tyrosine is present in the protein, and the quantum yield and lifetime of charge separation can 
be manipulated by hydrogen bonding interactions with the tyrosine.  Hydrogen bonding 
partners of the tyrosine seem to have the effect of increasing the yield of charge separation, but 
decreasing the lifetime.  It should be noted, however, that in photosystem II, the YZ• radical is a 
transient species that is not itself used for bond making and breaking; YZ• has a short lifetime so 
it can pass oxidizing equivalents to the OEC.  In MZH3, bound Fe(II) enables lifetimes of charge 
separation of 300 ms, long enough for chemical reactions to take place. 
The transient absorption results strongly support electron transfer from the donors, but 
the oxidized states of the donors could not be detected directly.  Future studies of this system 
by electron paramagnetic resonance may be able to detect a tyrosyl radical signal to confirm its 
oxidation. 
Cobalt tetrapyrroles are known to be capable of hydrogen production (39, 43).  
Preliminary results have shown that when CoPPIX is used as the electron acceptor in place of 
heme in MZH3, a charge separated state is not detected by transient absorption.  However, 
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continuous illumination experiments of MZH3 with CoPPIX and ZnPCP in the presence of 
ascorbate and EDTA suggest Co(III)PPIX photo-reduction to Co(II)PPIX, as evidenced by a large 
blue-shift of the Soret band of CoPPIX.  Experimental complications and uncertainties have so 
far left ambiguity as to whether direct electron transfer from ZnPCP to CoPPIX occurs, but 
CoPPIX is being investigated as a possible path toward hydrogen production. 
The MZH3 scaffold provides a starting point to begin to assemble a redox-active metal 
cluster akin to the oxygen evolving complex of photosystem II.  Photo-oxidation of tyrosine and 
Fe(II) have already been demonstrated in this chapter, and this represents an important first 
step toward a water oxidation catalyst.  If oxidation of Mn(II) can be achieved, it may be possible 
to use a photo-assembly mechanism to build a multinuclear metal center similar to the OEC of 
photosystem II.  The simple, robust reaction center maquette MZH3 could thus be used to 
investigate the properties necessary to build a functional water-oxidizing metal cluster. 
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Chapter 5: Oxygen binding and alternative heme ligations 
 Light-driven water oxidation and hydrogen evolution will require fine-tuning of the 
properties of the various cofactors.  One way to effect significant changes in heme redox 
properties is by altering the ligand sphere (1).  Wild type MZH3 ligates the heme B iron ion using 
two histidine imidazole groups from His9 and His110 to form hexacoordinate iron.  This bis-
histidine ligation scheme is similar to the heme coordination found in cytochromes b and b6 of 
the cytochrome bc1 and b6f complexes, where the heme is used for electron transfer functions 
(2, 3).  Changes to the coordination in the MZH3 acceptor site could modulate heme B and 
cobalt protoporphyrin IX (CoPPIX) midpoint potentials and possibly enable hydrogen evolution 
activity from a cobalt tetrapyrrole. 
Different heme ligation schemes in natural hemoproteins help to impart diverse 
functions.  For example, P450 enzymes ligate heme with a cysteine residue (4), bovine liver 
catalase uses a tyrosinate ligand (5), cytochrome c and cytochrome b562 use a His-Met ligation 
pattern (6, 7), and cytochrome f uses a histidine and an N-terminal amino group as heme ligands 
(8).  Myoglobin and hemoglobin ligate heme B with only one histidine, and the other site is left 
open for a small molecule such as oxygen to bind (9, 10).  This chapter will show heme B binding 
by MZH3 mutants in which acceptor site histidine residues were changed to either tyrosine, 
lysine, methionine, or alanine.  The His110Ala mutant exhibits evidence of high-affinity oxygen 
binding and a slow rate of autoxidation, similar to myoglobin and hemoglobin. 
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5.1 MZH3 mutants bind heme B with ligands other than histidine 
 Wild type MZH3 ligates heme or CoPPIX in the electron acceptor site using His9 and 
His110, and this section presents heme binding by MZH3 mutants His9Cys, His110Cys, His9Lys, 
His9Tyr, His110Met, and His110Ala.  All of these mutants retain the ability to bind heme B, as 
evidenced by their ultraviolet/visible (UV/vis) spectra.  Unbound ferric heme B in aqueous 
solutions has a relatively weak, broad absorbance at about 390-395 nm, whereas all of the 
MZH3 heme site mutants exhibit strongly absorbing Soret bands between 407 and 424 nm.  In 
addition, MZH3 heme site mutants bind heme B in vivo during overexpression in E. coli.  Figure 
5.1 shows absorbance spectra of MZH3 variants after cell lysis and purification by Ni-NTA 
column; no heme was added to these spectra. 
 
Figure 5.1: Heme B binds to MZH3 mutants His110Met and His110Ala in vivo 
Conditions for wild type MZH3: 150 mM NaCl, 6 mM sodium phosphate, pH 7.4.  Conditions 
for MZH3-His110Met and His110Ala mutants: 100 mM NaCl, 600 μM EDTA, 30 mM Tris 
buffer, pH 8.0.  (His6 tags of the mutants had not yet been cleaved by TEV protease when 
these spectra were collected, but the wild type MZH3 did have its His6 tag cleaved.  
Subsequent studies showed that the His6 tag does not affect the spectrum). 
 
 Figure 5.2 shows the spectra of three more MZH3 variants with ferric heme bound.  
These spectra were collected after adding heme B to the maquettes in vitro. 
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Figure 5.2: Spectra of heme B bound to MZH3 
mutants His9Lys, His9Cys, and His110Tyr 
These purified MZH3 mutants were 
reconstituted with ferric heme B in vitro.  The 
His9Lys and His9Cys spectra are shown in 
comparison to wild type MZH3 (bis-His).  The 
MZH3-His9Cys UV/vis spectra were very similar 
to MZH3-His110Cys and were very similar.  The 
MZH3-His110Tyr spectra are shown in the 
oxidized state and ferrous state (reduced with 
dithionite).  
 
 In Figure 5.1 and Figure 5.2, absorbance is shown in arbitrary units, because extinction 
coefficients of heme B in MZH3 mutants have not been determined.  Assuming similar heme 
extinction coefficients in the different mutants, roughly 5-10% of samples of MZH3-His110Met 
and His110Ala contained heme B from E. coli after lysis and purification by Ni-NTA column.  
MZH3-His9Lys appeared to overexpress with approximately 15-20% heme B incorporation (data 
not shown).  The fact that MZH3 binds heme B in vivo similarly regardless of the ligation state 
indicates that heme binding is not wholly dependent upon coordination by ligating amino acids; 
other factors such as the shape of the binding pocket play a significant role in heme binding in 
MZH3. 
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Of particular interest is the fact that heme binds to MZH3-His110Ala, which only has one 
histidine in the heme binding site.  Previous maquettes from the Dutton group lacked the ability 
to bind heme B using only one histidine instead of two, and this feature has been used to create 
tetrapyrrole binding sites that select for zinc tetrapyrroles over iron tetrapyrroles (11, 12).  In 
addition, the heme B of MZH3-His110Ala remains in a reduced ferrous state even after several 
hours of exposure to oxygen during cell lysis, Ni-NTA column purification, and dialysis.  Ferric 
heme B in MZH3-His110Ala has a Soret absorbance band at 415 nm, but Figure 5.1 (black trace) 
shows that the Soret absorbance of MZH3-His110Ala is 425 nm immediately after purification, 
which is consistent with an oxygen-bound oxyferrous state (1, 12).  Other heme binding 
maquettes, including other MZH3 variants, are rapidly oxidized in the presence of oxygen.  The 
oxyferrous MZH3-His110Ala species will be examined more closely in section 5.3. 
 
5.2 Heme B midpoint potentials in MZH3 mutants 
 Alteration of heme-ligating amino acids can lead to new functions by changing the 
midpoint potential of the heme.  The midpoint potentials of iron porphyrins are particularly 
sensitive to the ligating amino acids, presumably because the redox active electron in iron 
porphyrins is localized to the iron ion; in some cases, amino acid substitutions can lead to 
midpoint potential shifts of over 600 mV (13).  Using a honeycomb spectroelectrochemical cell 
(Pine Research Instrumentation), heme B midpoint potentials were determined for wild type 
MZH3 and the mutants His9Lys, His9Tyr, His110Met, and His110Ala at pH 7.5.  The methods 
used for the spectroelectrochemical midpoint determinations are detailed in the appendix. 
 To demonstrate reproducibility, the midpoint potential of wild type MZH3 (with bis-His 
heme ligation) was measured using the spectroelectrochemical honeycomb apparatus and the 
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result was compared to the redox titration method described in section 2.2.9.  The redox 
titration previously showed a reversible one-electron transfer event at a midpoint of −180 mV 
(Figure 2.22).  Figure 5.3 shows that the results from the honeycomb spectroelectrochemical cell  
are in agreement with the redox titration result.  The heme redox spectrum from the  
 
 
Figure 5.3: Spectroelectrochemical 
midpoint determination of wild type MZH3 
with heme B 
The ferrous minus ferric heme redox 
difference spectrum of wild type MZH3 was 
the primary component of SVD analysis, as 
shown in (A) the oxidizing and (B) reducing 
directions.  An n=1 Nernst curve (large blue 
points) was fitted to the SVD component 1 
population (small green points) in (C) the 
oxidizing and (D) reducing directions.  (E): 
Absorbance spectra from the oxidizing scan 
going from high potentials (ferric heme, 
purple traces) to low potentials (ferrous 
heme, green traces). 
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spectroelectrochemical measurement was identified by SVD and fitted to a Nernst equation that 
gave a one-electron reaction with a potential of about −183 mV in the oxidizing direction and 
−195 mV in the reducing direction, demonstrating negligible hysteresis.  The estimate of −190 
mV using the spectroelectrochemical cell is within error of the −180 mV value from the redox 
titration. 
 The spectroelectrochemical apparatus was used to determine midpoint potentials of 
MZH3 mutants including MZH3-His110Ala (Figure 5.4).  As with the wild type, MZH3-His110Ala 
showed no sign of hysteresis, and Figure 5.4 shows the data from both the reducing and 
oxidizing directions analyzed together.  The low reducing potentials created an anaerobic 
environment, and there was no sign of an oxygen-bound ferrous heme state in the reduced 
spectra of Figure 5.4 (C); note the difference in Q-band shape between 500 and 600 nm in Figure 
5.1 (black trace) compared to Figure 5.4 (C) (blue and purple traces).  (This is shown more clearly 
in Figure 5.5A).  The midpoint potential of heme B bound to MZH3-His110Ala was estimated at 
−110 mV vs. SHE. 
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Figure 5.4: Midpoint potential of MZH3-
His110Ala with heme B 
The MZH3-His110Ala spectroelectrochemical 
curves were similar in the oxidizing and 
reducing directions.  The heme redox 
spectrum of MZH3-His110Ala (A) was the 
primary component of SVD analysis.  (B): An 
n=1 Nernst curve (large blue points) was 
fitted to the SVD component 1 population 
(small green points).  Absorbance spectra 
from the oxidizing scan going from low 
potentials (ferric heme, red traces) to high 
potentials (ferrous heme, purple traces). 
 
 In contrast to other mutants, heme B in MZH3-His110Met exhibited signs of hysteresis.  
A partially reversible midpoint potential was observed at +70 mV vs. SHE, but in the reducing 
direction, there was a second distinct midpoint at approximately −80 mV.  This secondary −80 
mV potential may represent a state similar to the MZH3-His110Ala ligation state in which the 
protein contributes only one amino acid ligand and the potential is −110 mV.  The fact that this 
secondary low potential transition is only observed in the reducing direction may be because 
methionine is a soft ligand that forms a stable interaction with the soft Lewis acid Fe(II) of 
ferrous heme, but has a much weaker affinity for the hard Lewis acid Fe(III) of ferric heme.  The 
increased affinity of methionine ligands for ferrous heme over ferric heme has been shown to 
stabilize the reduced state in other His-Met hemoproteins (14).  The MZH3-His9Lys and His9Tyr 
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mutants were found to have reversible Nernstian one-electron transfer events at midpoint 
potentials of −65 mV and −180 mV, respectively.  The MZH3 mutant spectroelectrochemistry 
results are summarized in Table 5.1. 
 
Table 5.1: Summary of heme B properties in different MZH3 mutants  
The properties of heme B in MZH3 variants and natural proteins with similar ligation schemes 
are compared.  Table is adapted from Moser et al., 2016 (1). 
 
5.3 Oxygen binding in MZH3-His110Ala 
 Many important medical procedures depend on blood transfusion to save lives and 
improve health.  The fact that this blood comes from voluntary donors means that healthcare 
systems are susceptible to blood shortages, and blood transfusions present the risk of 
transfusion-transmissible infections.  An oxygen transport maquette that reproduces the 
function of hemoglobin or myoglobin could potentially provide a safe, inexpensive blood 
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substitute.  This section examines the unexpected MZH3-His110Ala property of stable, high-
affinity oxygen binding and the possibility of developing it into a novel blood substitute. 
 
5.3.1  Introduction to oxygen transport proteins 
 Oxygen transport proteins including myoglobin and hemoglobin use ferrous heme B to 
bind oxygen at the heme iron; the oxidized ferric state cannot form a stable interaction with 
oxygen.  The relatively low potential of heme B compared to oxygen means that the heme is 
vulnerable to oxidation to the inactive ferric state, and the protein environment must modulate 
the redox properties to prevent electron transfer.  At room temperature, free heme B in 
aqueous solutions autooxidizes within seconds, but myoglobin and hemoglobin autooxidation 
takes hours or days (15, 16).  Myoglobin and hemoglobin bind oxygen with dissociation 
constants in the hundreds of nanomolar range: 830 nM for sperm whale myoglobin (17). 
 Oxygen binding has been observed in de novo-designed maquettes and redesigned 
natural proteins.  In these model systems, autooxidation is generally orders of magnitude faster 
than in myoglobin or hemoglobin.  In one example, human serum albumin (HSA) was redesigned 
to introduce a heme B binding pocket.  The modified HSA had an autooxidation lifetime of ~10 
minutes, and its oxygen affinity in two different conformational states was 2.8 and 0.4% of the 
myoglobin oxygen affinity (17, 18).  In a series of maquettes from the Dutton group, an 
oxyferrous state was identified with an autooxidation lifetime of seconds to tens of seconds at 
16°C, and one maquette had an oxygen affinity that was 5% of the myoglobin oxygen affinity 
(12, 17, 19, 20).  These results demonstrate significant progress toward a designed oxygen 
transport protein, but the oxyferrous stability and oxygen affinity must be increased significantly 
before such a protein could become useful for medical applications. 
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5.3.2  Oxygen binding results in MZH3-His110Ala 
 Natural oxygen transport proteins and previous oxygen binding maquettes show a clear 
difference in the UV/vis absorbance spectra in the ferric, deoxyferrous, carboxyferrous, and 
oxyferrous spectra.  MZH3-His110Ala spectra at pH 7.5 (Figure 5.5A) are similar to those of the 
earlier maquette BT6, which binds two hemes B via bis-histidine ligation and is able to bind 
oxygen and carbon monoxide (Figure 5.5B) (12).  In both MZH3-His110Ala and BT6, anaerobic 
reduction of ferric heme (green traces) to deoxyferrous heme (blue traces) yields a significant 
red shift in the Soret band from ~412-415 nm to ~426-431 nm and a significant sharpening and 
increase in the intensity of the Q-bands at ~530 and ~560 nm.  Exposure of the deoxyferrous 
species to oxygen produces the oxyferrous state (red traces), and exposure to carbon monoxide 
produces the carboxyferrous state (black traces).  The oxyferrous and carboxyferrous spectra 
have Soret bands that peak between the ferric and deoxyferrous Soret peaks and Q-bands that 
are red-shifted and are more pronounced than the ferric Q-bands but less pronounced than the 
deoxyferrous Q-bands.  Further confirmation that MZH3-His110Ala binds oxygen comes from 
comparison to spectra of bovine myoglobin (purchased from Sigma).  Figure 5.5C shows the 
deoxyferrous minus oxyferrous difference absorbance spectra of myoglobin (orange) and MZH3-
His110Ala (black).  While the relative intensities of the absorption bands differ slightly, the 
wavelengths of each band and the overall shapes of the spectra are similar. 
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Figure 5.5: Ferric, deoxyferrous, carboxyferrous, and oxyferrous spectra 
(A): MZH3-His110Ala spectra are shown with heme B in ferric (green), deoxyferrous (blue), 
carboxyferrous (black), and oxyferrous (red) states.  Samples were prepared in 50 mM NaCl, 
10 mM MOPS buffer at pH 7.5 and are scaled to approximately the same concentration (~6 
μM).  Inset: Q-band region of MZH3-His110Ala spectra.  (B): Reference spectra reproduced 
from earlier bis-His two-heme maquette BT6 publication (Farid et al., 2013) (12), following 
same color scheme as in (A).  (The dotted red line is the oxyferrous species with only one 
heme B bound to BT6 instead of two).  (C): Deoxyferrous minus oxyferrous difference spectra 
of myoglobin (orange trace) and MZH3-His110Ala (black trace). 
 
 The seconds to minutes lifetimes of oxyferrous states of earlier designed oxygen 
transport proteins is too short for a blood substitute (12, 17-20), but the oxyferrous state of 
MZH3-His110Ala is detectable for hours after cell lysis and protein purification (Figure 5.1).  In 
order to determine the rate of autooxidation, oxyferrous MZH3-His110Ala was prepared by 
reduction of ~10 μM ferric MZH3-His110Ala with 10 mM ascorbate in 50 mM NaCl, 10 mM 
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MOPS buffer at pH 7.5 at room temperature.  Reduction with ascorbate was slow, probably 
because of the relatively low heme B midpoint potential of MZH3-His110Ala of −110 mV vs SHE.  
After one hour, reduction was complete, and ascorbate was removed by filtration through a PD-
10 desalting column (GE Healthcare Lifesciences).  The ~6 μM sample was exposed to ambient 
oxygen and UV/vis spectra were recorded every 0.25 to 4 hours for about 4 days.  SVD fitting 
identified two spectral components that were similar to the oxyferrous and ferric species shown 
in Figure 5.5A.  The oxyferrous lifetime was about 38 hours (Figure 5.6). 
  
Figure 5.6: Autooxidation of oxyferrous 
heme B in MZH3-His110Ala 
(A): UV/vis spectra show the oxyferrous 
state converts to the ferric state over days.  
(B): SVD analysis identified components 1 
(red, oxyferrous) and 2 (green, ferric).  Inset: 
Q-bands of SVD components.  (C) The 
population of SVD component 2 (ferric state, 
green points) fitted to a simple exponential 
function shows an oxyferrous lifetime of 38 
hours. 
 
  
There is no requirement for a blood substitute to use heme B, and other iron 
tetrapyrrole cofactors might be preferable to heme B.  MZH3 binds the higher potential Fe(III) 
2,4-diacetyl deuteroporphyrin IX (Fe-DADPIX) with high affinity, as described in section 2.3.3.  As 
with heme B, MZH3-His110Ala is able to stabilize an oxyferrous state of Fe-DADPIX.  A sample of 
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30 μM MZH3-His110Ala bound to Fe-DADPIX was incubated with 150 μM ascorbate for several 
hours to prepare the oxyferrous state, and ascorbate was removed using a PD-10 column.  The 
sample was kept exposed to ambient oxygen at room temperature at pH 7.5, and autooxidation 
was monitored by the decay of the Fe-DADPIX oxyferrous Soret band at 447 nm for 6 days.  
About ~8% of the MZH3-His110Ala sample contained heme B leftover from expression instead 
of Fe-DADPIX, but the absorbance difference between the ferric and oxyferrous states of heme 
B is very small at 447 nm.  Fitting the autooxidation curve at 447 nm with a simple exponential 
fit gave an Fe-DADPIX oxyferrous lifetime of ~80 hours, or 3.3 days (Figure 5.7). 
 
Figure 5.7: Autooxidation of oxyferrous Fe-DADPIX in MZH3-His110Ala 
Left: Absorbance spectra of MZH3-His110Ala with Fe-DADPIX at selected time points after 
beginning the autooxidation reaction.  Right: Absorbance at 447 nm fitted to a single 
exponential curve gives oxyferrous Fe-DADPIX lifetime of roughly 80 hours or 3.3 days. 
 
 Carbon monoxide tends to bind to ferrous heme more tightly than oxygen, so 
introduction of carbon monoxide should be able to convert oxyferrous MZH3-His110Ala to the 
carboxyferrous state.  The carboxyferrous and oxyferrous spectra are similar, but can be 
distinguished by the large difference in the extinction coefficient of the Soret band (see Figure 
5.5A, black and red traces, respectively).  To test for the displacement of oxygen by carbon 
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monoxide, a 1 mL sample of MZH3-His110Ala with ferric heme B was degassed and reduced 
with dithionite.  Addition of 15 μL of water containing ambient oxygen led to a mixture of ferric 
and oxyferrous MZH3-His110Ala.  About 10 mL of carbon monoxide gas was bubbled through 
the anaerobic sample, and a slow increase in the Soret band at 425 nm was monitored over the 
ensuing 40 minutes.  After 40 minutes, more dithionite was added to sample to reduce the 
oxygen and ferric heme B.  The result was an immediate significant increase in the Soret 
absorbance at 425 nm corresponding to rapid binding of carbon monoxide to ferrous heme B.  
The result in Figure 5.8 shows that the presence of oxygen inhibited carbon monoxide binding to 
MZH3-His110Ala, limiting its binding rate to tens of minutes.  When oxygen was eliminated by 
reduction with dithionite, carbon monoxide binding was complete within seconds. 
 
Figure 5.8: Displacement of oxygen ligand by 
carbon monoxide in MZH3-His110Ala with 
ferrous heme B 
UV/vis spectra show slow carbon monoxide 
binding when oxygen is present and fast 
carbon monoxide binding once oxygen is 
reduced.  Red trace: mixture of oxyferrous 
and ferric heme B.  Blue traces: after adding 
carbon monoxide, Soret band slowly rose 
over 40 minutes in the direction of the arrow.  
Spectrum after 40 minutes is shown in 
slightly darker blue.  Black trace: addition of 
dithionite reduced ferric heme B and 
eliminated oxygen, allowing rapid carbon 
monoxide binding in seconds or less. 
  
 Nature calibrated the dissociation constants of oxygen binding by myoglobin and 
hemoglobin to be in the hundreds of nanomolar range (17, 21-23) so that these proteins can 
bind oxygen from oxygen-rich environments and release it in oxygen-poor environments.  To 
probe the oxygen affinity of MZH3-His110Ala, a 5.6 μM sample in 50 mM NaCl, 10 mM MOPS 
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buffer at pH 7.5 was degassed for 3.5 hours with argon that was bubbled through an acid 
vanadyl sulfate-granular zinc oxygen scrubbing gas train (24).  An ascorbate stock solution was 
purged similarly, and ascorbate was added to the sample to a 500 μM final concentration at 
time t=0 in Figure 5.9, below.  The sample was purged continuously with argon throughout the 
experiment.  A peak began to increase at the oxyferrous Soret band wavelength of 425 nm.  No 
sign of a deoxyferrous state with a sharp Q-band feature at 560 nm was observed.  Presumably, 
oxyferrous formation was allowed by a slow leakage of oxygen into the cuvette.  After 15 hours, 
the rate of increase of absorbance at 425 nm had leveled off, and the cuvette was opened and 
exposed to ambient oxygen.  The oxyferrous spectrum decreased slightly, then increased to a 
maximum after about 28 hours, showing that the oxyferrous spectrum depends on the presence 
of oxygen. 
 
Figure 5.9: Oxyferrous state formation 
in MZH3-His110Ala during anaerobic 
argon purging 
500 μM ascorbate was added to MZH3-
His110Ala with ferric heme B at time 
t=0.  The absorbance difference of 424 
minus 404 nm represents the rise of the 
oxyferrous state.  At the arrow, the 
anaerobic cuvette was opened and the 
sample was exposed to ambient 
oxygen.  Conditions: 50 mM NaCl, 10 
mM MOPS buffer, pH 7.5. 
 
 In the first 15 hours of the experiment in Figure 5.9, the solution was purged 
continuously with anaerobic argon, but the oxyferrous spectrum increased and was stable, 
suggesting that the dissociation constant for the MZH3-His110Ala-heme B-oxygen complex was 
less than the concentration of dissolved oxygen under these low-oxygen conditions.  The 
oxyferrous state was also stable for many hours if a glucose oxidase/catalase oxygen scrubbing 
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system was introduced to the sample or if a weak vacuum was applied to the cuvette.  These 
results show that the affinity of MZH3-His110Ala for oxygen is greater than that of hemoglobin 
or myoglobin, which release oxygen under low-oxygen conditions.  Preliminary experiments 
suggest that deoxyferrous MZH3-His110Ala is able to absorb oxygen from oxyferrous myoglobin.  
This would indicate that the dissociation constant for oxygen binding by deoxyferrous MZH3-
His110Ala is less than hundreds of nanomolar.  More work is need to determine a precise 
dissociation constant. 
 
5.3.3  Oxygen binding conclusions and future directions 
 The results presented here demonstrate that MZH3-His110Ala with heme B binds 
oxygen.  The stability of the oxyferrous state is 38 hours at room temperature at pH 7.5; the 
autooxidation rate is orders of magnitude slower than the rates observed in earlier maquettes 
and redesigned natural proteins (12, 18-20).  This 38 hour lifetime at room temperature is 
comparable to the hours to days lifetimes of various myoglobins and hemoglobins under similar 
conditions (15, 16).  For example, at pH 7.2 and 25°C, sperm whale oxymyoglobin is stable for 
150 hours (16, 25), Aplysia kurodai myoglobin autooxidizes in 9 hours (25), and the chicken 
gizzard oxymyoglobin lifetime is 59 hours (26).  In addition, preliminary results suggest that the 
oxygen affinity of MZH3-His110Ala appears to exceed that of maquettes, redesigned natural 
proteins, and even natural myoglobins and hemoglobins by orders of magnitude.  Extensive 
purging with anaerobic argon does not convert oxyferrous MZH3-His110Ala to the deoxyferrous 
state even over the course of hours. 
 It is not surprising that MZH3-His110Ala can bind oxygen; after all, several maquettes 
and redesigned natural proteins have already demonstrated this ability, and MZH3-His110Ala 
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has only one amino acid ligand available to ligate the heme iron, and the other site is left open.  
However, the high oxygen affinity of MZH3-His110Ala and its oxyferrous state stability are very 
much unexpected, and deserve explanation.  The crystal structures of wild type MZH3, which 
has bis-histidine heme B ligation, show low solvent access to the heme iron.  It is likely that the 
MZH3-His110Ala mutant is similar.  A dry hydrophobic core might increase the oxygen affinity 
because water molecules do not need to be displaced for oxygen to bind (15).  The BT6 
maquette and related mutants demonstrated that water access to the heme increases the rate 
of autooxidation via water-catalyzed inner sphere electron transfer (12).  However, solvent 
inaccessibility alone cannot account for the extremely high affinity and stability observed in 
oxyferrous MZH3-His110Ala. 
 Natural myoglobins and hemoglobins usually form a hydrogen bond between the 
oxygen ligand and a distal histidine on helix E, HisE7 (27).  This hydrogen bonding interaction 
plays a pivotal role in stabilizing the oxyferrous state.  The oxygen is the hydrogen bond 
acceptor and the histidine donates a hydrogen bond from the protonated Nε atom.  While 
myoglobins tend to remain functional when HisE7 is replaced by glutamine, which may also 
donate a hydrogen bond to oxygen, many substitutions to the E7 position result in a 
catastrophic increase in autooxidation rate and decrease in binding affinity (15).  For example, 
the HisE7Gly mutation in sperm whale myoglobin accelerates autooxidation from a lifetime of 
150 hours to 17 minutes (16) and decreases the oxygen affinity from 830 nM to 11 μM (17).  
Similar results are observed for other mutations at the E7 position (15).  These HisE7 mutations 
weaken the oxygen binding and oxyferrous stability of myoglobin to the level of oxygen binding 
maquettes and redesigned natural proteins, which have lifetimes and dissociation constants on 
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the orders of seconds to minutes and tens of micromolar, respectively (12, 18-20).  These 
designed proteins are presumed not to have an oxygen-amino acid hydrogen bond. 
 Crystal structures of wild type bis-His MZH3 show that there are two hydrogen bond 
donors in helix 2 that could potentially form a hydrogen bond to a bound oxygen molecule in 
MZH3-His110Ala (Figure 5.10).  The backbone amide of Gly92 and the hydroxyl group of Thr91 
are both relatively close to where oxygen might be expected to bind (~3.5-4 Å).  The Gly92 
amide N-H group is perpendicular to the direction of the heme iron, and might not have the 
proper geometry to form a stable hydrogen bond with a bound oxygen ligand.  However, Thr91, 
which makes a stable 2.8 Å hydrogen bond with heme-ligating His110 in wild type MZH3, 
appears to have about the right distance and geometry to make a hydrogen bonding contact 
with a bound oxygen molecule.  The absence of a ligating His110 in MZH3-His110Ala might 
result in a change in conformation that brings the threonine hydroxyl closer to the heme iron to 
 
Figure 5.10: Possible H-bond to O2 in oxyferrous MZH3-His110Ala akin to HisE7-O2 H-bond of 
myoglobin  
Left: Wild type MZH3 crystal structure CS-D shown with His110 carbons in white and Thr91 
and Gly92 carbons in yellow.  Thr91 or Gly92 might form a hydrogen bond to bound oxygen in 
MZH3-His110Ala.  Right: Crystal structure of human myoglobin in oxyferrous state shows 
HisE7 with yellow carbons making hydrogen bond to bound oxygen molecule.  Structure is 
from PDB-ID: 1MBO (9).  Images rendered using The PyMOL Molecular Graphics System, 
Version 1.7 Schrödinger, LLC. 
210 
 
make a hydrogen bond closer to the His-O2 hydrogen bond length found in natural myoglobins 
of ~2.8 Å (9, 28). 
 Future work on oxygen transport in MZH3 should be directed toward fine tuning the 
dissociation constant for oxygen binding so that it better resembles natural myoglobins and 
hemoglobins.  The dissociation constant for MZH3-His110Ala should be determined precisely, 
followed by mutagenesis studies to elucidate the source of the high oxygen affinity and long 
oxyferrous lifetime.  For example, study of a Thr91Val or Thr91Ala mutant might show whether 
Thr91 plays an important role in stabilizing the oxyferrous state.  Given the stability of the 
complex and the fact that wild type MZH3 is readily crystallizable, it may be possible to solve the 
structure of oxyferrous MZH3-His110Ala by X-ray crystallography.   
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Chapter 6: Conclusion 
 In this thesis, a photosynthetic reaction center maquette has been designed that can 
assemble iron and cobalt tetrapyrroles as electron acceptors, various zinc tetrapyrroles as 
pigments, and tyrosine and metal ions as electron donors.  MZH3 is a singularly structured and 
highly stable canonical left-handed four-helix coiled coil with high affinity for all of its designated 
cofactors.  High resolution X-ray crystal structures show that all of the intended cofactors bind 
to MZH3 simultaneously, and that MZH3 shares a high degree of structural similarity with the 
natural four-helix bundle proteins cytochrome b and bacterioferritin, despite low sequence 
identity.  Transient absorption results indicate that MZH3 traps a charge separated state 
involving ferrous heme B and a tyrosyl radical for up to 150 ms at pH 7.5.  In addition, binding of 
ferrous iron allows MZH3 to hold heme reduced for 300 ms at pH 7.5 before recombination.  An 
unexpected oxygen binding function was also detected in an MZH3 mutant.  The MZH3-
His110Ala mutation led to a stable oxyferrous heme state with a lifetime comparable to natural 
myoglobins and hemoglobins and with higher oxygen affinity than the natural proteins.  These 
results offer new perspectives on four-helix bundle design and advance the field toward more 
sophisticated functions. 
  
6.1 Four-helix bundle protein design strategy 
Robertson et al. described the first de novo hemoprotein in 1994 (1).  Since then, a 
number of groups have pursued high resolution structural characterization of porphyrin binding 
maquettes, and some have solved apo-state structures that lend insight into the structure-
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function relationship of four-helix bundle heme maquettes (2-4).  Until now, holo-state 
structures have not been reported.  Without experimental structures in the active state of the 
maquette, it is difficult to identify essential structural elements that give rise to function or to 
evaluate the degree to which maquettes fold into the intended structures. 
The Dutton group has worked with a series of four-helix bundle maquettes designed by 
simple binary patterning to achieve diverse functions including light-driven electron transfer, 
iron-sulfur cluster assembly, inter-protein electron transfer, and oxygen binding (5-8).  This 
binary patterning is appealing as a way to simplify the design approach and minimize the 
complexity of the sequence to tease out essential elements of the sequence-structure 
relationship.  However, simple binary patterning alone does not always lead to singularly 
structured functional proteins, and it becomes less reliable in the design of increasingly complex 
proteins.  Furthermore, simple sequences do not necessarily translate into simple structures; 
some maquettes lack the standard knob-into-hole interactions of coiled coils, fold with the 
uncommon mixed parallel/antiparallel helical topology, and have a slight right-handed, 
superhelical twist as opposed to the left-handed supercoil in normal coiled coils (2, 9).  In 
addition, heme binding in some maquettes triggers a significant structural change that rotates 
the helices and buries glutamate residues (10).  Many interesting functions have been achieved 
in this type of heme maquette, but the unusual structural properties and lack of a high 
resolution structure in the holo-state complicate our interpretation of the structure-function 
relationship and sometimes make redesign difficult.  A more robust design procedure was 
necessary to design the multi-cofactor reaction center maquette MZH3. 
In the successful design of MZH3, a broad and detailed view of the factors influencing 
protein structure was used to strike a balance between the stability needed to decrease the 
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entropic cost of cofactor binding, and flexibility, which is needed to decrease the enthalpic cost 
of binding (11-13).  The sequence of the metal binding section of MZH3 was taken from Due 
Ferro proteins (14-16), but the tetrapyrrole binding section was designed from scratch.  A 
truncated version of MZH3 that only has a tetrapyrrole section, DDH2, is stable, helical, and 
binds heme with high affinity.  This shows that even in the absence of the Due Ferro section, the 
tetrapyrrole section of MZH3 is functional.  The design process relied on close attention to 
interface widths, cofactor binding cavities, core packing using a layering approach, and negative 
design by charge patterning.  This is an empirical design method in the sense that it relies 
primarily on takeaway messages derived from a variety of studies on natural and designed 
proteins that have qualities in common with the desired design, as opposed to being an 
intuition-driven approach guided by heptad repeat patterning.  Ultimately, this method proved 
to be fruitful, yielding the first high resolution structure of a maquette with tetrapyrroles bound 
and the first maquette that separates charge for long enough for chemical reactions to occur.  
This puts us on a path toward artificial photosynthesis in a de novo designed protein maquette. 
 Despite these successes, it is not clear whether the design strategy is robust.  MZH3 and 
DDH2 are promising results, but represent only two examples of proteins in which this empirical 
approach to de novo four-helix bundle design has been used.  Analysis of MZH3 crystal 
structures in the apo-state suggests that interfacial leucine-leucine hydrophobic interactions 
across g-g interfaces might be among the most stabilizing forces in MZH3, and they might play a 
more important role in folding than layering of core amino acids or inter-helical charge pairing 
interactions, which were originally expected to be the most important features of the maquette 
sequence.  In addition, the design strategy used for MZH3 is limited by its dependence on 
observations of natural and designed protein structures and their modes of cofactor binding.  
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MZH3 design was heavily influenced by the extensive literature on natural heme binding 
proteins, carboxylate-bridged di-iron and di-manganese proteins, photosystem II, and a variety 
of maquettes.  An empirical approach to four-helix bundle design would not be suitable to the 
design of a maquette that binds an unusual cofactor not found in nature or one that has an 
atypical fold or function that has no precedent.  However, when natural proteins that are 
structurally similar to the target design exist, their structural attributes can serve to guide 
design; MZH3 has striking structural similarities to cytochrome b and bacterioferritin despite 
negligible sequence similarity.  This shows that natural and designed protein structural features 
can be readily included in the design of new maquettes with dissimilar sequences. 
 
6.2 Light-driven electron transfer 
Previous work has demonstrated light-driven oxidation of tyrosine side chains and metal 
ions in redesigned natural proteins (17-22), but MZH3 is the first example of this function in a 
maquette.  The fact that MZH3 was designed from scratch gives it certain advantages.  MZH3 
was engineered to be highly stable, and the simplicity of its overall fold makes it amenable to 
redesign.  The maquette was specifically designed to arrange cofactors so that charge 
separation can take place.  Efficient redox-active triads have been synthesized chemically (23, 
24), but the MZH3 triad is able to stabilize a charge separated state in an aqueous environment 
for orders of magnitude longer than synthetic triads. 
Transient absorption results support the conclusion that tyrosine and Fe(II) ions are 
photo-chemically oxidized in MZH3 to stabilize the charge separated state.  The MZH3-Y168L 
mutant, which lacks a tyrosine, fails to stabilize a charge separated state, and the introduction of 
hydrogen bonding networks involving the tyrosine in the MZH3-L71H and MZH3-L71H-L31D 
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mutants significantly affects the yield and lifetime of charge separation.  The crystal structure of 
MZH3-L71H showed a 2.6 Å hydrogen bond between tyrosine 168 and histidine 71, similar to 
the tyrosine-histidine hydrogen bonds of photosystem II.  The L71H mutation results in a 
pronounced increase in the yield of charge separation, and this yield is further increased by the 
introduction of an aspartate predicted to be within hydrogen bonding distance of His71 in the 
MZH3-L71H-L31D mutant.  This histidine-aspartate interaction might play a role in tyrosine 
oxidation that is similar to D1-Asn298 in photosystem II.  Addition of Fe(II) in MZH3 enables 
charge separation with a lifetime of 300 ms at pH 7.5 whether or not tyrosine is present.  In 
contrast, the MZH3-L71H-E34A mutant, which is deficient in its metal binding capacity, did not 
exhibit a significant difference in charge separation behavior when Fe(II) was added.  This shows 
that bound Fe(II) is involved in charge separation. 
These results provide compelling evidence of tyrosine oxidation and Fe(II) oxidation in a 
working reaction center maquette, but further development is necessary to achieve the long-
term goal of in vivo generation of oxygen and hydrogen.  Direct evidence of tyrosine oxidation 
might be derived from electron paramagnetic resonance (EPR) detection of the EPR-active 
tyrosyl radical.  Energy conversion might be made more efficient if the excited singlet state of 
the zinc tetrapyrrole can be used for rapid electron transfer before it relaxes to the lower energy 
triplet state.  This would require the insertion of an additional cofactor close to the zinc 
porphyrin, perhaps by using a modified version of the unexpected zinc porphyrin binding site at 
the opening of the metal binding cavity observed in crystal structures CS-B and CS-C (Figure 
3.16).  In extending the electron transfer chain, a second electron acceptor cofactor might 
further stabilize charge separation and expedite the slow cobalt porphyrin reduction that will be 
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needed for hydrogen evolution.  Future work is needed to establish manganese oxidation, which 
would be a crucial step toward photoassembly of an oxygen evolving cluster in a maquette. 
6.3 Oxygen binding 
The MZH3-His110Ala mutation gave rise to a long-lived oxyferrous heme state.  Other 
heme maquettes and redesigned natural proteins have demonstrated oxygen binding capacity 
(5, 6, 25, 26), but the MZH3-His110Ala oxyferrous lifetime is orders of magnitude longer at 38 
hours, commensurate with the lifetimes of oxygen-carrying proteins in nature.  Preliminary 
results suggest that the oxygen affinity of MZH3-His110Ala exceeds the affinity of myoglobin 
and hemoglobin, and that this affinity will need to be decreased in order to create a potential 
blood-substitute protein. 
Oxygen binding in MZH3-His110Ala was not unexpected, given that it has a vacant 
coordination site on the heme iron and a proximal histidine ligand similar to myoglobin, but the 
stability and oxygen affinity are remarkable.  Unanticipated specific interactions may be 
responsible for the serendipitous oxygen-carrying properties of MZH3-His110Ala.  The hydroxyl 
group of threonine 91 might be poised to make a hydrogen bond with bound oxygen, thereby 
stabilizing the oxygen in the manner of HisE7 in myoglobin and hemoglobin (27).  The backbone 
amide nitrogen of glycine 92 might also be close enough to make a hydrogen bonding contact 
with oxygen.  Given the long lifetime of the oxyferrous state and the fact that MZH3 is readily 
crystallizable, it may be possible to resolve these questions by X-ray crystallography of the 
MZH3-His110Ala mutant in the oxyferrous state.  Mutagenesis studies may also be able to 
determine whether Thr91 plays a role in oxygen binding, and could allow the fine-tuning of the 
maquette to make its oxygen binding behavior more similar to natural proteins.   
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6.4 Summary 
This thesis demonstrates the design, structure and action of a working photosynthetic 
reaction center maquette.  The design procedure applied detailed design rules laid out by 
decades of research on the sequence-structure relationship in four-helix bundle proteins.  High 
resolution X-ray crystallographic structures revealed the assembly of multiple redox cofactors 
into an electron transfer chain that can separate charge for hundreds of milliseconds, as verified 
by transient absorption spectroscopy.  Without copying natural sequences, the maquette folds 
into a structure that strongly resembles structures of natural proteins that were used to guide 
the design.  Ultraviolet/visible spectroscopy showed that this maquette binds oxygen in a 
complex with a stability comparable to oxygen transport proteins in nature.  There is still a vast 
divide between the range of functions expertly covered by natural proteins and the developing 
field of de novo protein design.  This thesis helps to narrow the gap and advance protein design 
toward the goal of artificial photosynthesis to serve human energy needs. 
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Chapter 7: Appendix 
7.1 Protein expression and purification 
A gene encoding MZH3 including an N-terminal His6-tag and TEV protease cleavage 
sequence was purchased from DNA2.0 in a pJexpress414 vector with codons optimized for 
expression in E. coli.  After finding that TEV cleavage was slow due to the proximity of a proline 
to the TEV cleavage site, Gly22 in the sequence below was inserted using site-directed 
mutagenesis.  The TEV protease cleavage site is between Q21 and G22; G22 becomes G1 in the 
protein used for experimental studies in this thesis.  Primers for mutagenesis were purchased 
from Invitrogen, and mutant plasmids were PCR amplified using AccuPrime™ Pfx SuperMix 
(Invitrogen).  Other mutations including Y168L, L71H, L31D, E34A, and H124M were prepared 
similarly.  The final amino acid sequence of the protein expressed for experimental studies was:  
 
MGKGGHHHHHHGGDGENLYFQGSPELRQEHQQLAQEFQQLLQEIQQLGRELLKGELQGIKQLREASEKAR
NPEKKSVLQKILEDEEKHIELLETLQQTGQEAQQLLQELQQTGQELWQLGGSGGPELRQKHQQLAQKIQQLL
QKHQQLGAKILEDEEKHIELLETILGGSGGDELRELLKGELQGIKQYRELQQLGQKAQQLVQKLQQTGQKLW
QLG 
 
The plasmids were transformed into BL21-(DE3) competent cells (New England Biolabs), 
and bacteria were grown to 0.6 OD at 600 nm.  Expression was induced with between 40 μM 
and 1 mM IPTG for 4 hours at 37˚C.  The cells were pelleted by centrifugation, resuspended in 20 
mM sodium phosphate buffer at pH 7.4 with 500 mM NaCl, 40 mM imidazole, 1% w/v 
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octylthioglucoside, ~0.1 mg/mL DNAse, and lysed by homogenization or sonication.  The lysate 
was centrifuged at 25,000 g for 30 minutes, and the supernatant was applied to a 5 mL Ni-NTA 
HisTrap FF prepacked column (GE Healthcare Life Sciences) on an Akta FPLC.  The protein was 
treated with TEV protease and incubated at 4°C for up to 2 weeks, applied to an Ni-NTA column 
again, and finally purified by size exclusion chromatography (SEC) using an XK 16/70 column (GE 
Healthcare Life Sciences) packed with 110 mL of Superdex 75 prep grade gel filtration medium 
(GE Healthcare Life Sciences).  Where noted, an additional purification step by high performance 
liquid chromatography (HPLC) was done with a Waters reverse-phase HPLC system using a C4 or 
C18 HPLC column (Grace Davison Discovery Sciences).  HPLC-pure samples were lyophilized and 
resuspended in >6.5 M GdnHCl, refolded by dilution, and the monomeric MZH3 protein was 
isolated by SEC.  Sample purity and molecular weight estimations were made using denaturing 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). 
 
7.2 Ultraviolet/visible spectroscopy 
Ultraviolet/visible spectroscopy (UV/vis) was performed using a Varian Cary-50 
spectrophotometer at room temperature.  Cofactor binding titrations were performed by 
preparing a 1 mL protein sample near 1 μM in a quartz cuvette, unless otherwise noted.  
Concentrations were determined using an extinction coefficient of ε280nm=12490 M−1cm−1 for 
MZH3, based on the predicted absorbance of the two tryptophan and one tyrosine amino acids.  
A stock solution of cofactor was titrated into the protein solution until at least three equivalents 
of cofactor per protein had been added.  Cofactor was typically added in steps of 0.1 equivalents 
of cofactor per protein until after the binding capacity of the protein appeared to have been 
reached, at which point 0.2 equivalents of cofactor per protein were added for each step.  At 
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least 10 minutes were allowed for equilibration before adding the next aliquot.  Heme B stock 
concentrations were measured by hemochrome assay (1).  Stock concentrations of other 
tetrapyrrole cofactors and Co(NO3)2 were estimated by mass measurements.  Soluble cofactor 
stocks were prepared in water, and insoluble tetrapyrrole stocks were prepared in dimethyl 
sulfoxide.  Tetrapyrrole stock solutions were 100-200 μM and the Co(NO3)2 stock was 17 mM in 
water. 
Estimates of the amounts of heme B incorporated into MZH3 during overexpression 
were made by UV/vis measurements.  The heme concentration was determined from the 
absorbance at 415 nm using an extinction coefficient of 115,000 M−1cm−1, and the protein 
concentration was estimated by the difference in the absorbance between 280 nm (where apo-
MZH3 absorbs with an extinction coefficient of 12490 M−1cm−1) and 317 nm.  The low 
absorbance of heme B at 317 nm serves as a baseline for the protein peak at 280 nm, because 
heme B absorbance is similar at 280 and 317 nm. 
 
7.3 Circular dichroism 
 Circular dichroism measurements were made using an Aviv Model 410 instrument.  Far 
UV CD spectra were measured from 190 to 260 nm and were performed in a 0.1 cm path length 
quartz cuvette.  Thermal denaturation was measured at 222 nm for 5 seconds with a 2 nm 
bandwidth, and data were collected every 2°C with a heating rate of 10°C/min followed by a 4 
minute incubation time.  The mean molar ellipticity per residue, θMMR, was calculated by dividing 
the measured ellipticity by 196 residues.  Measurements of exciton coupling in the Soret region 
of the spectrum were made at 25°C from 370 nm to 470 nm in either a 1 cm or 0.1 cm path 
length cuvette, as noted.  Spectra were collected with a 1 nm bandwidth every 1 nm for 5 
225 
 
seconds per data point, and each reported spectrum was the average of three spectra that were 
measured consecutively.  
 
7.4 Redox titration 
 A redox titration was performed as described previously (2).  A sample of 7 mL of ~40 
μM MZH3 with heme B was prepared in 15 mM NaCl and 10 mM sodium phosphate, pH 7 in a 
cuvette modified for this technique.  The sample was kept anaerobic by continuously flushing 
with argon scrubbed with an acid vanadyl sulfate/granular zinc bubble train, as described 
previously (3).  Changes in the absorption of the Q-bands of heme B were monitored as a 
function of solution potential, which was measured by a calomel electrode (Radiometer 
Analytical).  The solution potential was lowered by addition of 1 μL aliquots of dithionite 
(reducing direction) or 5 μL of ferricyanide (oxidizing direction).  The Nernst curves in both 
directions were compared to look for hysteresis.  Redox mediators are needed to bring the 
measuring electrodes into equilibrium with the redox state of the cofactor, because biological 
redox centers usually cannot transfer electrons to and from the electrode because the protein 
shields the cofactor (2).  The following redox mediators were used: duroquinone (25 μM), 
pyocyanine (10 μM), indigotrisulfonate (10 μM), 2-hydroxy-1,4-naphthoquinone (10 μM), 
phenazine (10 μM), anthroquinone-2-sulfonate (20 μM), and benzyl viologen (10 μM). 
 
7.5 Crystallography methods and crystal structure statistics 
 Protein samples for crystallography were purified as described in section 7.1 .  Protein 
samples for crystal structures CS-F and CS-G were purified by HPLC using a C4 column, followed 
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by lyophilization, denaturation by GdnHCl, refolding, and SEC.  No other samples were purified 
by HPLC, lyophilized, or denatured.  All crystals of MZH3 were grown in hanging drops at 4°C.  
MZH3 stock solutions contained 20-40 mM NaCl and 10-20 mM piperazine-N,N′-bis(2-
ethanesulfonic acid) (PIPES) buffer at pH 6.5, and were stored at 4°C. 
Addition of heme B was done after the final SEC purification step.  In order to prevent 
aggregation and precipitation of heme B, the MZH3 sample was diluted to ≤100 μM and was 
kept stirring at room temperature.  Heme B was added dropwise from a stock solution of ≤1 mM 
heme in dimethyl sulfoxide (DMSO) up to 0.9 equivalents of heme per protein.  At this point, a 
more dilute heme B stock solution, typically ≤200 μM, heme B was titrated into the MZH3 
solution until 1.0 equivalents heme B per protein had been added.  Full occupancy of heme B 
was verified by diluting the sample to ~2 μM and adding ~0.1 equivalent of heme B per protein. 
If the difference spectrum showed signs of additional heme binding, more heme was added to 
the MZH3 stock until binding stopped.  A similar method was used for the addition of ZnPCP.  
Sample buffers were exchanged to the low salt PIPES buffer using 5 kDa MWCO Vivaspin Turbo 
15 concentrators (Sartorius AG) by centrifuging to concentrate the sample and diluting with the 
new buffer several times.  Table 7.1 gives the MZH3 stock concentrations, cofactors bound to 
MZH3 in the stock solution, well solutions for the hanging drop experiments at 4°C, drop 
volumes, and cryoprotectant for each crystal structure.  Crystal structures CS-B and CS-C were 
grown from crystal seeds starting from crystals that lacked ZnPCP using a Seed Bead kit 
(Hamilton).  Crystal structure CS-H used streak seeding with a cat whisker. 
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Crystal 
Structure 
MZH3 
stock 
(μM) 
Cofactors Well solution Drop volumes 
(well solution: 
protein stock) 
Cryoprotectant 
CS-A 
(Tray 7, 
D5) 
550 Heme B, 
ZnPCP, 1.5 
mM ZnCl2 
3.6 M NaCl, 100 
mM NaAc pH 4.5 
1 μL:1 μL 30% glycerol, 3.5 M 
NaCl, 100 mM NaAc 
pH 4.4 
CS-B 
(Tray 54, 
A2) 
600 Heme B, 
ZnPCP, ~35 
mM MnCl2 
3.0 M NaCl, 100 
mM NaAc pH 4.9 
1.2 μL:2.5 μL 
and 0.5 μL seed 
stocka 
30% glycerol, 3.5 M 
NaCl, 100 mM NaAc 
pH 4.4 
CS-C 
(Tray 52, 
D5) 
600 Heme B, 
ZnPCP, 2 mM 
MnCl2 
3.0 M NaCl, 100 
mM NaAc pH 4.8 
1.2 μL:2.5 μL 
and 0.5 μL seed 
stockb 
30% glycerol, 3.5 M 
NaCl, 100 mM NaAc 
pH 4.4 
CS-D 
(Tray 1, 
B2) 
630 Heme B, 1.5 
mM ZnCl2 
2.7 M NaCl, 100 
mM NaAc pH 4.5 
1 μL:1 μL 30% glycerol, 3.5 M 
NaCl, 100 mM NaAc 
pH 4.4 
CS-E 
(Tray 53, 
B4) 
540 Heme B, 1 mM 
MnCl2 
1.2 M Li2SO4, 0.5 M 
(NH4)2SO4, 150 mM 
Na citrate, pH 5.9 
1 μL:1 μL 28% glycerol, 1.25 
M Li2SO4, 0.5 M 
(NH4)2SO4, 100 mM 
Na citrate, pH 5.85 
CS-F 
(Tray 32, 
B6) 
500 Heme B, 
ZnPCP, 1.5 
mM ZnCl2 
19.5% w/v PEG 
8000, 100 mM 
CdCl2, 100 mM 
NaAc pH 4.2 
1 μL:1 μL 40% v/v glycerol, 
100 mM CdCl2, 100 
mM NaAc pH 4.2  
CS-G 
(Tray 21, 
D4) 
560 Heme B, 1.5 
mM ZnCl2 
24% w/v PEG 1500, 
100 mM CdCl2, 100 
mM NaAc pH 4.8 
1 μL:1 μL 2-methyl-2,4-
pentanediol 
CS-H  
(Tray 73, 
A5) 
630 
(L71H 
mutant) 
Heme B 24% w/v PEG 1500, 
70 mM CdCl2, 100 
mM NaAc pH 4.6 
5 μL: 1 μL, 
seedsc 
40% v/v glycerol, 70 
mM CdCl2, 100 mM 
NaAc pH 4.6 
Table 7.1: Crystallization conditions used to obtain MZH3 crystal structures 
Crystals were quickly dipped in the indicated cryoprotectant for no more than 30 seconds 
immediately prior to flash freezing in liquid nitrogen or a nitrogen gas stream at 100 K.  PEG 
8000 and PEG 1500 stand for polyethylene glycol with an average molecular weight of 8000 
and 1500 g/mol, respectively.  NaAc stands for sodium acetate. 
a Seed stock was prepared from similar crystals grown with heme, ZnPCP, and 2 mM MnCl2 
over 3.0 M NaCl, 100 mM NaAc, pH 4.8, which in turn were grown from the seed stock used 
for CS-C (see note b) 
b Seed stock was prepared from crystals grown with heme and 1 mM MnCl2 over 2.8 M NaCl, 
100 mM NaAc, pH 4.7 that did not contain ZnPCP 
c Streak seeded with cat whisker from crystals grown with the same protein stock solution 
hanging over 25% PEG 1500, 80 mM CdCl2, pH 4.6 
 
All X-ray crystallographic data sets were collected from single crystals at 100 K.  X-ray 
diffraction data for crystal structures CS-A and CS-D were collected at the National Synchrotron 
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Light Source, beamline X6A using an ADSC Q270 CCD x-ray area detector.  X-ray diffraction data 
for crystal structures CS-B, CS-C, CS-E, CS-F, CS-G, and CS-H were collected using a Rigaku 
Micromax-007 HF rotating copper anode X-ray generator and VariMax HF optics with a Rigaku 
Saturn 944 HG CCD detector. 
 Multiwavelength anomalous dispersion (MAD) data was collected to solve crystal 
structure CS-A.  Data were integrated with XDS (4) and initial phases were calculated using 
SOLVE (5).  All other crystals used the CS-A crystal structure as a model for molecular 
replacement using Phaser (6).  Software packages CCP4i (7) and PHENIX (8) were used 
throughout the structure solution and refinement process.  Intensities were scaled using SCALA 
(9).  Refinement was done using REFMAC5 (10), phenix.refine (11), and PDB_REDO (12).  Real 
space refinement was done by manually fitting models into electron density maps in Coot (13).  
Model bias removal was done using prime-and-switch phasing (14) and density modification was 
done with RESOLVE (15). 
 Statistics for the three data sets collected for MAD to solve crystal structure CS-A are 
given in Table 7.2. 
Measurement Zn K edge Zn K inflection point Remote energy 
Wavelength 1.2824 Å 1.2831 Å 1.0781 Å 
Space group P41212 P41212 P41212 
Resolution 2.1 Å 2.1 Å 2.0 Å 
Completeness 99.1% 99.1% 99.4% 
I/σ 18.15 19.53 16.8 
Rmerge 6.6% 6.3% 8.5% 
Rmerge (outer shell) 49.9% 53% 97% 
Table 7.2: Multiwavelength anomalous dispersion (MAD) statistics for crystal structure CS-A 
 
 Data collection and refinement statistics for all eight crystal structures reported in this 
thesis are given in Table 7.3. 
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Crystal CS-A CS-B CS-C CS-D CS-E CS-F CS-G CS-H 
Resolution, high (Å) 2.0 2.02 2.10 1.45 1.90 2.01 1.78 2.02 
Resolution, low (Å) 61.43 61.17 38.90 61.38 59.64 19.58 18.36 71.54 
Wavelength (Å) 1.0781 1.54178 1.54178 1.0781 1.54178 1.54178 1.54178 1.54178 
X-ray Source NSLS Cu Kα Cu Kα NSLS Cu Kα Cu Kα Cu Kα Cu Kα 
Space group P41212 P41212 P41212 P41212 P41212 C2 C2 P21 
Cell dimensions:         
a (Å) 43.749 44.14 44.243 43.747 44.968 91.777 89.692 44.467 
b (Å) 43.749 44.14 44.243 43.747 44.968 25.206 23.693 25.872 
c (Å) 245.74 244.7 244.95 245.52 238.29 73.165 72.756 73.623 
α (°) 90 90 90 90 90 90 90 90 
β (°) 90 90 90 90 90 102.12 99.93 103.67 
γ (°) 90 90 90 90 90 90 90 90 
Total reflections 130,054 205,441 198,057 382,473 253,427 71,446 47,861 72,034 
Unique reflections 17,105 16,830 15,112 43,568 20,059 10,978 14,127 10,744 
Redundancy:         
All data: 7.6 12.2 13.1 8.8 12.6 6.5 3.4 6.7 
Outer shell: 7.4 4.3 10.8 5.2 5.2 2.3 1.7 3.3 
Completeness (%):         
All data: 99.4 99.2 99.7 99.7 98.4 96.5 95.1 97.3 
Outer shell: 98.8 89.1 96.1 96.1 86.6 61.8 68.9 71.0 
I/σ(I):         
All data: 16.80 18.32 22.65 15.30 22.22 15.47 17.12 25.98 
Outer shell: 2.52 1.58 4.63 1.26 1.66 3.40 3.79 9.46 
Rmerge (%):         
All data: 8.5 10.4 8.6 9.9 8.9 7.9 4.7 5.1 
Outer shell: 97.0 97.2 54.6 133.7 105.3 22.8 17.5 10.1 
Final refinement:         
Rwork (%) 22.5 22.4 22.6 20.4 22.4 23.9 19.8 20.7 
Rfree (%) 27.2 27.1 28.0 23.7 25.5 30.0 23.3 25.5 
Rwork (last shell) (%) 35.5 37.1 26.9 35.2 38.4 30.6 21.6 20.7 
Rfree (last shell) (%) 40.7 43.7 30.3 39.0 35.9 49.9 21.0 29.7 
Table 7.3: Data collection and refinement statistics 
 
7.6 Transient absorption 
 Transient absorption experiments were performed at 20°C with a 10 Hz Q-switched 
frequency-doubled Nd:YAG laser (532 nm, DCR-11 Spectra Physics).  The laser pulse duration 
was 2 ns long.  A Xe flash lamp emitted probe beams of white light into split fiber optic cables at 
times t after the laser flash to measure the change in absorbance spectra as a function of time 
after the laser flash.  The gate width of the Xe flash was either 600 ns or 1 μs, with the exposure 
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beginning at time t.  The split fiber optic cables were used to direct one probe beam through the 
laser-pumped (experimental) region and the other probe beam through the dark (reference) 
region of the sample in the cuvette.  Each probe beam was collected by a fiber optic bundle and 
flattened into a line of fibers at the entrance slit of an Acton SP-2156 spectrograph.  The images 
from the exit slit of the monochromator were focused onto a Princeton Instruments PiMax-3 
ICCD camera.  Delay times t were set by a Stanford Research System DG 535 digital delay 
generator.  A ThorLabs beam shutter allowed the 10-Hz laser repetition rate to be lowered to 
seconds for measurements at times t longer than 100 ms.  
 
7.7 Singular value decomposition (SVD) 
Absorbance spectra were collected at varying times or potentials, depending on the 
experiment, and the raw absorbance data were compiled into a matrix A.  Matrix A contained 
one spectrum per column so that each column had λ absorbance values and there were t 
columns, where t is the number of spectra collected.  Singular value decomposition was 
performed using the built-in “SingularValueDecomposition” function in Mathematica 10.3.  
Calling the function with matrix A as the input variable returned three output matrices U, S, and 
V, such that A = USVT.  Matrix U had dimensions λ by λ, V had dimension t by t, and S was a 
diagonal matrix with dimensions λ by t. 
 The V matrix was used to fit a kinetics model in which ordinary differential equations are 
used to describe the development of the electron transfer system with time.  In the monad case, 
where a pigment (P) is alone in the maquette, the model includes the rate of decay of the 
excited state (P*) to the ground state.  In this case, the P* minus ground state difference 
spectrum is the only spectrum of interest, and model fitting gives this spectrum and its rate 
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constant.  In the dyad case, rates of electron transfer from P* to the electron acceptor (A) and 
from A- to P+ are included in the model.  (It is assumed that P+ goes back to the ground state 
when it accepts the electron from A-, because the return to the P* state is negligible).  The dyad 
model therefore includes two difference spectra: P* minus the ground state and P+/A- minus 
the ground state.  In the triad case, when an electron donor (D) is included, the model includes 
electron transfer from D to P+ and from P to D+.  If the rate of electron transfer from D to P+ is 
significantly faster than from P to A, then the population of the D/P+/A- state will not be 
observable and the D to P+ rate constant will not be resolved. 
 Model fitting followed a variation of the methods of Henry and Hofrichter (16).  The 
model described above was used to calculate an expected population matrix P with maximum 
dimensions t by t.  A square transformation matrix C with maximum dimensions t by t was 
applied to P, and the mean square difference between V and the CP product was minimized 
using the “FindMinimum” function in Mathematica 10.3.  Electron transfer rates and the 
elements of matrix C were allowed to vary during minimization.  The minimization followed a 
quasi-newton procedure starting with various initial estimates of the rates and C matrix 
elements.  The best initial estimates were identified by comparing the residuals of the 
minimization procedures.  The final values of the rates and the C matrix elements were used to 
reconstruct the elemental spectra from the raw data and the electron transfer kinetics that best 
explain the absorbance measurements. 
 
7.8 Spectroelectrochemistry 
 Midpoint potential measurements of heme B in MZH3 variants were made using a 
spectroelectrochemical setup.  A CH Instruments Electrochemical Analyzer was used to set 
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electrode potentials in a honeycomb spectroelectrochemical cell (Pine Research 
Instrumentation).  The sample was placed in the 0.18 cm path length cuvette with a fine gold 
honeycomb working electrode modified with cystamine to prevent protein adsorption to the 
electrode.  The reference electrode was Ag/AgCl (3 M NaCl), which has a potential of 209 mV 
with respect to the standard hydrogen electrode (SHE).  Ultraviolet/visible absorbance spectra 
were collected using an Ocean Optics DH-2000 Deuterium-Halogen Light Source that emitted 
light through a fiber optic cable through the honeycomb working electrode and through another 
fiber optic cable to an Ocean Optics spectrometer.  To speed redox equilibration, redox 
mediators were added to the sample including 1,2-naphthoquinone (25 µM), 2,3,5,6-
tetramethylphenylenediamine (25 µM), phenazine methosulfate (20 µM), phenazine ethosulfate 
(20 µM), duroquinone (50 µM), phenazine (20 µM), pyocyanine (10 µM), 2-hydroxy-1,4-
naphtoquinone (25 µM), anthraquinone-2-sulfonate (20 µM), indigo trisulfonate (6 µM), and 
benzyl viologen (20 µM) (2). 
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